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ABSTRACT
A generic model of cell growth and division cycles (CELCYMUS) is proposed. 
It is a one dimensional population balance model based on cell age. The 
model can describe changes in cell age distribution, in teractions with a 
multi-component medium and changes in cytological sta te . A specific cell 
cycle model fo r  the mm321 hybridoma cell line, which produces antibody to  
paraquat, has been developed within CELCYMUS.
This specific model is based on the four conventional cell cycle phases, 
however, a number of modifications have been made to th is structu re : the 
division of the G1 phase into two parts , Gla and Gib; the addition of a 
quiescent phase, GO, and a death phase, D; the probability of transition  
from  Gib to S is a function of the cumulative glutamine content in Gib; the 
ra te  of cell death depends on the prevalent ammonia concentration; and 
consumption and production kinetics of glutamine, glucose, ammonia, lac ta te  
and antibody are  also cell cycle dependent.
This model is successfully f itted  to  post-synchronisation cultures. The 
model, thus fitted , is capable of predicting the growth of th is  cell line 
in conventional shake-flask and s ta tic  flask  cultures, in a s tirred  
ferm enter and in a  chemostat. Finally, the model is used to  predict the 
behaviour of th is cell line in repeated-batch culture and in continuous 
culture subjected to  periodic perturbations.
The objectives of th is research have been met; a successful cell cycle 
model has been developed fo r the mm321 cell line. In addition, CELCYMUS has 
proven capable of exhibiting highly non-linear behaviour. It is concluded 
th a t an understanding cell cycle kinetics is im portant fo r  the bioprocess 
engineer. Finally, i t  has shown th a t cyclic propagation stra teg ies  are  
highly cell cycle dependent, however they can produce significant increases 
in product yield.
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CHAPTER 1
INTRODUCTION
Since Crick and Watson unravelled the s truc tu re  of DNA in the early 
(1 2 )1950’s ’ , there  has been a continual growth of in terest in the potential 
fo r the commercial exploitation of micro-biological systems. More recently, 
advances in the fields of molecular biology and genetic engineering have 
begun to  realise  th is potential. The work presented in th is dissertation, 
focuses on the application of m athematical models to the understanding of 
m icro-biological behaviour in cell culture and the use of such descriptions 
fo r the design and operation of industrial processes.
Mathematical models have been used successfully by process engineers within 
the chemical industry fo r many years. Such models have applications in 
process design, process development and optimisation, and process 
simulation and control. However, in the bioprocess engineering field  the 
application of m athem atical models has been more limited. This is 
particu larly  tru e  in the large scale m anufacture of monoclonal antibodies.
Since the development of media capable of sustaining mammalian cell
(3 4)cultures in suspension ’ , m icro-biologists, biochemists and, more 
recently, engineers, have adopted a keen in terest in the production of the 
mammalian proteins, especially human proteins, which can be expressed by 
these cell lines. A class of proteins which is of g rea t in te rest to  these 
scien tists  and engineers are  the immunoglobulin, or antibody, proteins; 
th is  is due to  th e ir potential fo r commercial exploitation as diagnostic 
and therapeutic tools.
Throughout the 1960’s, and the early 1970’s, a number of in vivo 
manuf acturing techniques were developed f  or the production of antibody 
proteins. However, it  soon became clear th a t the use of such techniques on 
a large scale would produce economic, as well as ethical, problems due to  
the large number of animal hosts required. Furtherm ore, these techniques 
yielded non-specific polyvalent an ti-sera , with the attendan t possibilities 
of unknown side-effec ts.
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Early a ttem pts to  m anufacture antibody protein, by cost effective and
scalable in vitro  production techniques, met w ith minimal success. This was 
mainly due to  the inherent m ortality  of the lymphocyte cell lines 
responsible fo r the production of these proteins. In 1976, Kohler and
( 5 )
Milstein successfully fused a B-lymphocyte cell and a cancer cell. This 
produced an immortal cell line, called a hybridoma, capable of expressing 
antibody proteins. Furtherm ore, the careful selection and cloning of a
specific cell allowed the development of immortal cell lines capable of 
expressing monoclonal antibodies.
Since the development of the f i r s t  hybridoma cell line, much research  and 
development work has been conducted into the production of monoclonal
antibodies. However, two inherent problems have persisted  throughout th is 
work: i) the long doubling tim es associated w ith these cell lines; and, ii)
the ir low specific antibody production ra te s . Both of these problems resu lt 
in very low concentrations of antibody being expressed in the supernatant.
A number of a ttem pts have been made to  modify b ioreactor design in order to 
improve the yield of monoclonal antibody. These have mainly focused on the 
need to increase significantly the cell densities within the b ioreactor. 
Such developments include continuous and perfusion bioreactors, hollow 
fib re  b ioreactors and entrapm ent or immobilisation techniques. However, 
these b ioreactors crea te  additional problems such as the maintenance of 
sterility*6*, heat and mass tra n s fe r  limitations*7* and, in some cases, a 
requirem ent fo r modular scale-up*8*.
It is notable th a t considerably less e ffo rt has been made in the 
optim isation of b ioreactors in existing m anufacturing processes. The main 
reason fo r th is derives from  simple short term  economics. Typically the 
downstream processing can account fo r over 70% of the production costs in
(9)
the bioprocess engineering industry and, due to  the low concentrations 
of antibodies in the supernatant, th is is generally g rea te r in the large 
scale production of monoclonal antibodies. Therefore, in the short term , it 
is f a r  more cost effective to  optimise the downstream processing. However, 
th is s tra tegy  neglects potential medium term  advantages which can be gained 
from  eliminating one or more downstream steps, due to  a significant 
increase in the supernatant product concentration, or the long term
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advantages of being able to operate a fully optimised process in a
competitive market.
There is another reason fo r th is preference fo r optimising downstream 
processing steps, ra th e r than bioreactor performance: successful
optim isation requires a detailed description of the process under
consideration. However, the kinetics of the processes within a bioreactor 
are  significantly more complex than those typically encountered in 
downstream processing and are  more d ifficu lt to describe in m athematical
term s.
Empirical descriptions of bioreactor kinetics have little  or no application 
w ith regard  to  process optimisation. Even simple m athem atical descriptions, 
unstructured  d istributed models(10), although useful in some cases, have a 
limited application due to the nature of the ir inherent assumptions. Such 
models neglect the s ta te  of the biophase, only accounting fo r the amount 
present. Furtherm ore, they ignore the d iscrete nature of micro-biological 
system s by describing the biophase with a single lumped param eter; as a 
resu lt they cannot distinguish between cell grow th and reproduction. 
Therefore, these models cannot adequately describe phenomena such as lag 
periods, sta tionary  periods, rapid growth, or grow th on multiple 
substra tes . However, it  should be pointed out th a t they have been applied 
very successfully to  the kinetics of chem ostats. Despite th is, the 
successf ul application of m athematical modelling techniques to  the 
simulation of b ioreactor kinetics really  requires a more detailed 
description of the behavior of cells and the ir in teraction  w ith the ir 
environment; in the terminology of bioprocess modelling a structu red , 
segregated model(10) is required.
There is nothing novel about th is conclusion, indeed a number of previous 
a ttem pts have been made by process engineers to  develop a general 
m athem atical fram ework, which would provide a suitable basis fo r  the 
sim ulation and optimsation of bioreactor kinetics; the most notable being 
the population balance approach adopted by Fredrickson and his colleagues 
in the 1960’s and early 1970’s. However, these a ttem pts have received 
little  or no atten tion  in the wider context of the bioprocess engineering 
industry. There were two main reasons fo r th is omission. F irs t, these
3
In troduction
models a re  m athematically complex, they require rigorous and 
computationally exacting solution methods; a t the time of th e ir development 
the com putational power required f  or the ir solution was not readily 
available. Second, the models were based on cell size and cell age; until
recently  many of the techniques required to  measure these variables and
th e ir associated param eters did not exist.
An a rea  which has recently received some attention, w ith regard  to 
modelling cellu lar proliferation, is th a t of the cell cycle. The cell cycle 
consists of four d istinct periods or phases, through which every cell must 
pass before i t  can divide. The cell cycle phases are  denoted as the Gl, S, 
G2 and M phases^11*. Many workers have considered the successful 
description of the cell cycle to be cen tral to the understanding of 
cellular proliferation. However, even though a g rea t deal of work has been 
conducted w ith regard  to the modelling of the cell cycle, very little  of
th is work has been applied in a process engineering context.
A number of studies of the cell cycle of lymphocyte and hybridoma cells
suggest a strong  relationship between the cell cycle and the expression of 
(12—18)antibody protein  . This indicates th a t a m athem atical description of
the hybridoma cell cycle is necessary f  or accurately describing antibody 
production kinetics. It also suggests th a t novel operational and 
optim isation s tra teg ies  may exist through the manipulation of the cell
cycle. Therefore, from  a process engineering point of view, a struc tu red  
and segregated model of the cell cycle would be desirable fo r the
successful description of bioreactor kinetics. The aim of th is d issertation  
is to  show th a t a s tructu red  and segregated model of the cell cycle, can be 
used successfully to simulate and predict the grow th and production
kinetics of a hybridoma cell line.
To achieve th is aim, the following objectives were identified fo r th is
research  work:
a) to  develop a generic mathematical model of the cell cycle;
b) to  develop a specific model of the cell cycle fo r a  particu la r cell 
line; and,
c) to use th is model to describe and predict the kinetics of th is cell
line over a wide range of culture conditions and propagation methods.
CHAPTER 2
A REVIEW OF THE LITERATURE 
2.1 INTRODUCTION
The earlies t recorded attem pts to  maintain and study the viability of
mammalian tissue in vitro  date back to the la te  1880’s(15). However, i t  was
not until the early 1950’s th a t a medium capable of sustaining the growth
(3 4)of several mammalian cell lines ’ was developed. Until recently, the
cultivation of mammalian cells has been used prim arily as a valuable tool
fo r the study of animal cell physiology. The only large scale application
(15)of mammalian cell culture being confined to  virus vaccine production 
The main drawbacks in the large scale production of animal cell proteins 
from  mammalian cells were: the low concentrations of protein expressed, the 
loss of protein during purification and the fin ite  life span of normal 
cells in v itro '15\  The development of the hybridoma in the mid-1970’s was 
a m ajor breakthrough in the potential fo r large scale production of protein 
from  mammalian cells(15).
2.2 HYBRIDOMA CELLS AND MONOCLONAL ANTIBODIES
The hybridoma cell was f i r s t  developed by Kohler and M ilstein(5) in the 
mid-1970’s. A hybridoma is produced as a resu lt of cell fusion between an 
antibody secreting cell, such as a B-lymphocyte, and a myeloma cell. The 
subsequent hybridoma cell is endowed with the antibody secreting qualities 
of the B-lymphocyte and the im mortality of the myeloma cell. The selection 
and cloning of a single hybridoma cell resu lts  in a cell line, which is 
capable of producing a monoclonal antibody.
(19)Antibodies have been used as a diagnostic tool fo r about four decades 
Until recently, the production of polyvalent an ti-se ra  has been conducted 
almost exclusively using in vivo  production techniques. With the 
development the hybridoma and improvements in in v itro  production 
techniques, the use of monoclonal antibodies as a diagnostic tool has 
expanded*20*. The main advantages of monoclonal antibodies produced in
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v itro , over the more conventional polyvalent an ti-sera , are: the
(21)specificity of the antigen binding site  , a dram atic reduction in the
(21 22)possibility of cross-reactiv ity  and the ability to  produce large
(15)
quantities of product w ith highly consistent properties
Other applications f  or monoclonal antibodies have been suggested in the
(20 23)purification of biologically active substances ’ and in th e ir use as
biosensors. However, the ir potential use in therapeutic medicine has
(15)a ttra c te d  the most atten tion  . Monoclonal antibodies have been developed
(21 24)to  many virulent organisms ’ and they also have potential uses in
(25—28)ta rg e t-d irec ted  drug therapy . A number of monoclonal antibody
(29)products are  now widely available
2.3 THE PRODUCTION OF MONOCLONAL ANTIBODIES FROM HYBRIDOMAS
The production of monoclonal antibodies in vivo, by the growth of tum ours
in mice, fa ils  to capitalise on the inherent advantages of using cells,
which can be readily cultured by the use of in vitro  production 
(15)techniques . In  vitro  production eliminates the possibility of product
contamination from  the host, and problems associated w ith the grow th of
(15)human hybridomas in rodents . Another consideration is the increased 
demand fo r monoclonal antibodies. In  vivo  production techniques may be 
suitable fo r supplying milligram or even gram quantities of monoclonals. 
However, the large scale production of kilogram quantities of monoclonals 
in vivo, would require the use of numerous hosts; it  has been estimated*20* 
th a t it  takes some 20,000 animals to produce 1 kg. The ethical and logistic 
lim itations of such an exercise must be considered carefully.
Hybridomas can be grown in vitro, e ither in suspension, or while
immobilised or entrapped*20*. Various reac to r designs have been proposed
and developed on a laboratory, pilot plant and production scale. However,
fo r large scale production, a ir l if t bioreactors seem most popular; such
(20) 3systems have been developed by, amongst others, Birch (1 m ),
(30) 3 3Rhodes (2 m )  and CELLTECH (1 m ). The advantages and disadvantages of 
various reac to r designs are  considered in more detail la ter.
6
Literature Review
2.4 FACTORS AFFECTING MAMMALIAN CELL KINETICS
Many of the fac to rs  which influence the growth and monoclonal antibody 
production kinetics of hybridoma cells have been investigated. These 
include the e ffec t of serum, nutrients, w aste products, oxygen and 
b ioreactor design.
2.4.1 Serum  and S e ru m -fre e  Medium
A g rea t deal of research  has been conducted into reducing, or even
(31)eliminating, the requirem ents fo r serum in mammalian cell culture . For
in vitro  production of monoclonal antibodies from  hybridoma cells th is  has
two im portant advantages. F irst, serum is one of the most expensive
(32)components of the growth medium . Indeed, in some cases i t  has been
(33)shown to  contribute over 80% of the cost of the grow th medium 
Secondly, the use of a very low or serum -free growth medium can be of g rea t
(6 32}benefit in reducing downstream processing costs ’ ; serum has been
estim ated to  contain a t least 500 d ifferen t proteins*345. Another
consideration is the undefined nature a of serum-supplemented medium. There
is a need to  sa tisfy  licensing authorities, who may require th a t a 
particu la r product be derived from  a defined medium*65, in which all the 
components are  known. The consistency of serum quality is also a problem, 
th is derives f  rom variations in the diet and health of the source
(34)animals . This can in tu rn  lead to variability  in cell and antibody 
. . , (34)yields
The kinetics of hybridoma growth and antibody productivity in low-serum  
media have been studied extensively*32,35 395. A number of these
, (3 2 ,3 5 ,3 7 ,4 0 ) 1 1 1 1  • 1studies have dem onstrated th a t serum concentration can be
reduced from  10% to 5%, without any detrim ental e ffec ts  upon cell grow th or 
antibody productivity. However, it has also been dem onstrated th a t reducing 
the concentration fu rth e r, to 1%, does have a significant e ffec t upon the
(35—38)peak yields . This problem has been solved by using Prim atone RL or
(32)Pluronic F-68 as serum additives . It has been shown th a t serum 
requirem ents fo r successful cell growth can be fu rth e r reduced if  high
density cultures are  used*415 and i t  has been demonstrated*38,425 th a t 
the relationship between in itia l serum concentration and in itia l grow th
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ra te  can be described by a Monod type relationship. It has also been shown 
th a t variations in initial serum concentration do not seem to  a ffec t the 
ra te  of cell death(40).
Since the discovery th a t murine B-lymphocytes could be cultivated on a
( 4 3 )
defined, serum -free medium , many attem pts have been made to develop
(37 44-51)defined media fo r hybridoma cells ’ . A number of these defined
(44)media are  supplemented with insulin and tran sfe rr in  , together w ith a
(37 4 5 -4 7  50 -54)variety of other chemicals ’ ’ . Others rely on the basal media
with one or two supplements*48,49,55*. Antibody production ra te s  have been
f  ound to  be comparable*51* or greater*52* than those observed in
serum-supplem ented media. However, the peak cell densities were often 
(34 52)lower ’ . I t has even been suggested th a t serum could inhibit antibody
(37)productivity . However, variations in the way d ifferen t hybridoma cell
lines grow in d ifferen t, defined media, has made any attem pt to develop an
(34)all-purpose defined media d ifficu lt . It has been suggested th a t
problems encountered in adapting cell lines to  serum -free media*56*, could
(57)be solved by cultivating cell lines on defined media immediately a f te r  ,
or even during*58,59*, the fusion procedure. I t should also be noted tha t,
in some instances, the cost of adding known supplements to the growth
(33)media, can be more expensive than simply using serum . A comprehensive 
review of the application of serum -free media to  hybridoma culture has been
(52)compiled by Glassy e t al
2.4.2 The K inetics o f Glucose and G lutam ine Consumption
Mammalian cells are  generally grown with glucose as the main nutrien t
source*6*. However, glutamine is an im portant a lternative nu trien t source
(62)fo r many mammalian cells including hybridomas . Glucose has been found
(38)to  be the m ajor biomass precursor , while glutamine is the m ajor energy 
and nitrogen source*60,61*. A number of investigations have been conducted
, • . . ~ ! . (42 ,62 ,63 ) (42 ,62 ,64 ,65 )into the kinetics of glutamine and glucose
consumption, and th e ir effect upon cell grow th and antibody productivity. 
(42)It has been shown th a t the consumption of both glucose and glutamine 
exhibit Monod type kinetics. It has also been observed th a t cell growth
(40 42) (42)ra te  appears to  be independent of glucose ’ and glutamine a t 
concentrations over ImM. However, specific glucose consumption ra te  has
8
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been found to  increase with residual glucose concentration*66*, but only up 
to  a concentration of 5mM*65*. Similar resu lts  have been obtained fo r
(63)glutamine . The inter-dependence of glutamine and glucose metabolism has
(62 67)also been studied in hybridomas ’ . Such studies have revealed th a t
final antibody concentrations were higher in cultures supplied with both
(62)glucose and glutamine . However, glucose to  glutamine ra tio  has been 
shown to  have little  e ffec t upon peak cell densities and antibody
(67)concentrations over a range from  about 0.8 to  6 (glucose: glutamine). 
Finally, it  has also been shown th a t serum concentration can a ffec t the
(38 41) (38)consumption kinetics of both glucose ’ and glutamine
2.4.3 The E ffe c ts  o f Ammonia and L ac ta te
The m ajor w aste products of glutamine and glucose metabolism are  ammonia
(68)and lac ta te  respectively . Ammonia has been observed to  inhibit cell 
grow th in a number of mammalian cell lines*69,70*. For hybridomas, i t  has 
been shown th a t an increase in ammonia concentration can reduce the growth 
rate*42’68,70,71*, although specific antibody production ra te  was 
unaffected*68*. It has also been observed th a t lac ta te  levels as high as
(42)40mM did not directly a ffec t hybridoma grow th ra te  . However, other
(71 72)w orkers have observed th a t lactate  does exhibit a growth inhibitory 
(73)or even cytotoxic e ffec t on hybridoma cells. The consumption of
(32 64)lac ta te  has been observed in the la tte r  stages of batch culture ’ and
the addition of lactic acid a t concentrations below 2.5 mg ml 1 has been
(62)shown to  enhance peak cell concentration and antibody yield . I t has
also been reported  th a t increased lac ta te  concentration can enhance
(6 8 )specific antibody production ra te  . However, it  has been reported  th a t
the addition of both ammonia and lac ta te  can increase the overall metabolic
rate*68’71*. The possibility th a t ammonia or lac ta te  can in itia te  cell
death has also been studied*40*. It was concluded th a t the levels of
lac ta te  and ammonia typical a t the onset of cell death in batch culture,
would not trig g er cell death*40*; a sim ilar conclusion was reached in
(73)studies on leukemia cells . Finally, it  should be pointed out th a t 
a ttem pts have been made to model the kinetics of ammonia accumulation in 
hybridoma cultures*74*.
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2.4.4  The E ffe c t o f Dissolved Oxygen C oncen tration
As w ith other mammalian cells, oxygen is vital fo r the successful grow th of 
hybridoma cells*6*. Therefore, the provision of sufficien t amounts of 
oxygen, especially in large scale and high density culture, is vital*6*. As
a resu lt, i t  is very im portant to understand the effect of dissolved oxygen 
concentration upon cell growth and antibody production.
Oxygen requirements*75* and the influence of oxygen availability*62’76 79* 
on cell grow th and antibody production have been studied extensively. It
has been reported  th a t dissolved oxygen tension (DOT) has no e ffec t upon
cell growth, glucose utilisation or lac ta te  production a t concentrations
(75) (52 76)from  8%-1007o . However, other authors ’ have reported  th a t there  is
an optimal DOT of about 50%, fo r maximum cell grow th in mammalian cells. It
has also been found th a t DOT did not directly a ffec t antibody production
rate*62,79*. However, a t lower DOT levels, cells remained viable fo r longer
periods of time and as a resu lt produced more antibody in to ta l. An
increase in antibody productivity has been observed a t DOT levels which
(77)were sub-optim al fo r cell growth and it  has also been reported  th a t
(75)oxygen becomes grow th limiting a t a concentration of about 10% . The
e ffec t of DOT in serum-supplemented and serum -free media has also been
(78)investigated . In serum-supplemented media both cell grow th ra te  and
antibody production ra te  were independent of DOT over a wide range, while
in serum -free media DOT had a strong effec t on antibody production 
. (78)ra te
2.4.5 A ntibody P ro d u c tiv ity  and G row th R ate
There is now much evidence available in the lite ra tu re  which suggests th a t
(38 75 77 80)antibody production is not directly rela ted  to grow th ra te  ’ * ’
Antibody accumulation has been observed in batch culture during the
sta tionary  phase and the decline phase*32’41,75’77’81*. It has been
suggested th a t th is accumulation is due to the release of in tra -ce llu la r
(32)antibody upon cell lysis . However, other evidence points to  a d irect 
relationship between the level of cell viability and ra te  of antibody 
production*41,81*. It has also been suggested th a t there are  two d istinct 
populations within certain  hybridoma cell lines, one with a high antibody
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(g2) (83)secretion ra te  and one with a low , or even non-existent , antibody 
secretion ra te . Finally, a number of observations suggest th a t specific
antibody production ra te  may increase as specific grow th ra te
, (80) decreases
2.5 BIOREACTOR DESIGN AND OPERATION
2.5.1 D if fe re n t  P ropagation  Methods
The e ffec t of d iffe ren t propagation methods is of g rea t importance, 
especially when the optimisation of the product yield is required. Much of 
the work discussed above was conducted on a small scale using conventional 
batch culture techniques. The main disadvantage of these techniques is th a t 
the grow th environment continually changes during the course of a single 
run. Cells are  inoculated into an environment rich  in nu trien ts and ideal 
fo r growth. However, these conditions rapidly deterio ra te  as the cells 
convert these nu trien ts to  metabolic w astes and more cells have to  compete 
fo r more limited resources. Eventually, the resu lt is a catastrophic drop 
in cell viability. These facto rs  may be responsible fo r the comparatively 
low peak cell and antibody yields obtained in batch culture.
Fed-batch and semi-continuous propagation techniques allow the build up of 
w aste products to  be limited by the controlled f  eeding of the 
n u trien ts(84,85,80). However, it is the kinetics of continuous culture
• i , (1 5 ,5 3 ,5 4 ,6 3 ,6 5 ,7 5 ,7 6 ,8 3 ,8 6 -9 6 )which have been most extensively studied
There are  a number of advantages in using continuous culturing techniques,
which include: exposure to  a stable cellular environment, the ability  to
keep w aste product levels low and a more constant and consistent product
flow (6). However, contamination problems from  the feed stream  and, more
im portantly, concerns regarding the genetic stab ility  of hybridoma cell
lines, over the long periods of operation envisaged fo r  such 
(85)techniques , have, so f  ar, limited the production scale application of 
continuous cultures.
A number of studies have compared batch operation w ith continuous 
(75 89)culture ’ . In general such studies have found th a t continuous culture
can produce peak cell and antibody yields, several tim es higher than in
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conventional batch culture*6*. Reuveny e t al^91) compared batch, fed-batch, 
semi-continuous, tw o-stage, and perfusion propagation methods. They found 
th a t antibody productivity increased in th a t order, with the productivity 
in the perf usion system being over 40 tim es higher than in batch
(97)culture
2.5.2 B io reac to r Design
Various bioreactor designs have been proposed fo r the cultivation of 
hybridoma cells. The kinetics of conventional s tirred  tank bioreactors have
(98-99)been studied by a number of authors . However, a m ajor lim itation
with such reac to rs  is successful oxygen transfer*100*. It has been observed
th a t high s t i r r e r  speeds, which are  required in large b ioreactors to
provide adequate mixing, can cause reductions in specific growth ra te  and
cell viability*98’101’101*. This has been a ttribu ted  to  cell damage*100*.
(99)Other workers have reported  th a t gas sparging may cause cell damage
However, th is may be reduced by the addition of m aterials to  change the
(99)surface tension, i.e. Pluronic . It has also been noted th a t the 
presence of serum can reduce damage due to  agitation*100’102*. A irlift 
b ioreactors can solve many of these problems by utilising pneumatic mixing 
techniques. These b ioreactors provide suitable oxygen tra n s fe r  ra te s  and 
mixing w ith low levels of shear*20*. Other advantages include a simple 
construction and a safe  sterile  technique*50*. The kinetics of such systems 
have been studied on a small scale*50’76’77* and large scale designs have
. , ,(2 0 ,3 0 )also been used
Perfusion bioreactors have also a ttrac ted  much atten tion  recently*103*. 
This technique involves the continual feeding and removal of the growth 
medium. However, in th is case, the cell population is not removed, as 
opposed to  conventional continuous culture. Many perfusion bioreactors use 
a filte rin g  system which is non-permeable to  the cells being grown; 
dialysis systems have also been used*94’104’105*. Other perfusion systems 
use immobilised or entrapped cells. This allows very high cell densities to 
be obtained. Various techniques have been used to  immobilise or entrap
cells so th a t they can be cultured in both perf usion and conventional batch
TT , ,  (103,106,107) , (103,108,109)systems. Hollow fibres , entrapm ent or
micro-encapsulation*110* in membranes, immobilisation of cells in the
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in te r-p a rtic le  pores of a packed fixed bed*111* and m icro-carriers*112*, 
have all been reported.
2.6 THE MATHEMATICAL MODELLING OF BIOLOGICAL SYSTEMS
Mathematical models of biological systems are  now commonplace throughout 
almost every a rea  of biological study. They range from  simple empirical 
descriptions of the shape and nature of growth curves*113 115* to  models 
which include numerous, and sometimes complex, in teg ro -partia l d ifferen tial
equations. The la tte r  are  capable of accounting fo r behaviour under a much 
wider variety  of conditions*116*. Almost all models have potential uses to 
help co rre la te  experim ental data, to  quantitatively predict, or even 
optimise, a system ’s performance, to aid in experimental design or in 
helping to  elucidate the tru e  nature of a system*117*
2.7 THE FUNDAMENTALS OF MODELLING BIOLOGICAL SYSTEMS
2.7.1 D escrib ing  a  Typical Batch G row th Curve
The grow th of m icro-organism s in conventional batch ferm entation or cell 
culture will usually exhibit four distinct growth periods: a lag period
(during which very little  or no growth occurs), an exponential period 
(during which the population multiplies rapidly), a s ta tionary  period 
(again w ith no growth) and finally a decline period (during which the 
population dies)*118*. Arguably the most im portant of these grow th periods
is the exponential period. The simplest mathem atical model of biological 
p ro liferation  describes the exponential period only. Malthus’ law*118* 
assumes th a t the ra te  of increase of cell mass is d irectly  proportional to 
cu rren t cell mass. This approach, although simple, does yield a param eter 
which is of g rea t significance in the mathem atical in terp re ta tion  and
modelling of biological systems, the specific grow th ra te , {j l , which is
defined as follows:
d x  1 ,01l
f1 =  - t z   ( 2 . 1)d t  x
where jc is the concentration of biomass and t  is time. Plants, tum ors and 
populations of m icro-organisms have all been found to  exhibit a constant
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specific growth some stage during the ir growth cycle*113*.
Modifications to th is approach have been proposed in order to  incorporate 
other aspects of the batch growth curve. An inhibitory term  was added to 
Malthus’ law by assuming th a t growth inhibition is proportional to the 
biomass squared*119,120*. Integration of th is equation yields the Logistic 
equation. A term  which accounts approximately f  or the h istory  of the 
biophase has also been introduced*121* and as a resu lt th is model can 
describe a decline period.
2.7.2 S u b s tra te  L im ited K inetics
M’Kendrick and Pai*114* were the f i r s t  to  suggest th a t the specific growth
ra te  could be re la ted  to the concentration of a particu la r sub stra te  in the
(115 122)grow th medium. This approach was also adopted by Monod ’ who
proposed an em pirical description of exponential grow th in a  ferm entation
process. In the Monod equation (see Table 2.1) i t  is assumed th a t the
production of biomass is limited by the concentration of a particu la r
substra te  in the growth media. It is also assumed th a t the consumption
kinetics of th a t substra te  can be described by the Michaelis-Menton
(123)equation proposed fo r enzyme kinetics . The Monod equation has been
applied to  the growth kinetics of many biological systems.
(124)Semi-empirical equations fo r simple diffusion have been developed ,
which are  sim ilar in form  to the M’Kendrick-Pai model*114*. It should also
be noted th a t when the Michaelis-Menton constant is sufficiently  high on
both sides of the cell membrane, the Monod equation will reduce to  a simple
(124)diffusion type relationship ; th is is known as fac ilita ted  
diffusion*124*. Other empirical relationships have been suggested*118’125* 
which are  subject to  lim itations sim ilar to  those of the Monod equation.
Contois*126* has modified the Monod equation by re la ting  the
Michaelis-Menton constant, K , to biomass concentration. This relationship
M
accounts fo r the effects of cell concentration. The Monod equation can also
(127)be modified by the inclusion of a substra te  inhibiting term  . Various 
product inhibiting term s have also been introduced into the Monod equation. 
Such relationships can account fo r non-competitive inhibition*128 13°*,
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destructive or toxin inhibition*131* and the acceleration of degradative
(132)processes
The introduction of a maintenance energy term  into the Monod equation has 
been considered by a number of workers^133 135). Dabes e t  a i (136) have 
suggested th a t the Monod equation can be described by the ‘m aster reaction
M a l t h u s ’ law  (19th C ) (122) dx
a t  =  M  *
V e r l h u r s t  ( 1838)*1 2 8 * = k x  (1 -  13 x )
M’K e n d r ic k  P a i (1910 ) (123) dxd t  =  k s
(124)Monod e q u a t io n  (1949)
j  V  s  d X  _  m a x
d t  K + S
Van U den ( 1 9 6 9 ) (134) dx _t j -  =  y  D S  Xa t  s p
T e i s s e r  (1 9 3 6 ) (135) dx , - ( s / K  h  -T— =  f l  x  ( 1 -  e  i ) a t  m a x
C o n to i s  (1 9 5 9 )* 137* dx x  s  d t  ^max B X + S
M oser (1 9 5 8 ) (136) dx xd t  ^rna x , , T. -A  ^( 1 + K S )
A ndrew s (1 9 6 8 )* 138 * dx s  x—rr- = f l ---------------------------------a t  max T, , 2 ,T,  x K + s  + ( s  /K  )m p
A ib a  ( 1968) ( 140 * dx -k p  s— T —  = U e  ---------d t  max K + Sm
A ib a  ( 1 9 6 9 )( 141 *
^ K dx _ „  s  p
d t  ^max K + S  K + p  m p
( 1 44 1H e r b e r t  (1958) dx , . . d t  =  ^  '  e *
TABLE 2.1
Some Com m only E n c o u n te re d  U n s t ru c tu r e d  D is t r ib u te d  M odels
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concept’, a ttrib u ted  to Blackman(136). They have also derived a new
(137)relationship which is based on two ra te  limiting steps . Equations 
which account fo r multiple grow th limiting substrates have been introduced 
by Megee e t  a j (132»137) ancj Ryder and Sinclair*1385. The possibility of 
such lim iting substra tes  being in the gas phase has been considered by 
Finn*1395 and Aiba e t  al*1405. Ramkrishna e t  ai*1315 have analysed a series 
of ‘staling  e ffe c t’ models, based upon the Monod equation; these models are 
capable of describing the decline phase. Finally, Leudeking and Piret*1415, 
amongst others, has proposed an equation fo r product form ation based upon 
the Monod equation*1175.
2.7.3 U n stru c tu re d  D is trib u ted  Models
All of the relationships introduced above are  unstructured distributed
(142)models ; they are  summarised in Table 2.1. D istributed models consider 
the population of cells or micro-organisms to  be a single uniform*1315,
(142) (143)continuous , homogeneous or lumped biophase. Such models a re  also 
re fe rred  to  as non-segregated*1175 or continuum*1425 models. When 
considering distributed  models, the unstructured approach re flec ts  the fa c t 
th a t the biophase is described only in term s of its  quantity, and not of 
its  quality*1205. Furtherm ore, biophase growth is simply re la ted  to  the 
extensive properties of the system. Fredrickson e t  al*1175 have developed a 
general m athem atical fram ework fo r an unstructured distributed model.
This lack of consideration of internal s tru c tu re  of the biophase,
highlights the main limiting assumption of all these em pirical
descriptions. This is th a t the properties of the individuals w ithin the
biophase, must be constant in relation to one another, i.e. the average
(122)s ta te  of the biophase does not change. As Monod has pointed out, th is 
can only be true  during the exponential growth phase. This lim itation has 
yielded the definition of balanced growth which s ta te s  th a t every extensive 
property  of the growing system changes by the same f  actor*1445. More 
recently some investigators have suggested th a t any attem pt to  describe the 
growth kinetics of a cell population by assuming a unstructured d istributed  
biophase must be limited to a balanced growth situation*1185.
It is clear th a t the neglect of a qualitative component in the description
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of the biophase can be a severe limitation; fo r example in describing 
grow th in a rapidly changing environment(117). It should also be noted th a t 
only a few  of the empirical relationships mentioned above can model the 
decline phase, and none of them can model directly the lag period. However, 
even w ith these lim itations, such relationships have been found to  be 
useful. Perhaps the ir most successful application has been in the 
m athem atical description of chemostat theory*145 147*; under steady s ta te
(142)conditions, balanced growth seems a more rea lis tic  proposition 
Another m ajor advantage of these relationships is th a t they generally give 
rise  to  relatively simple, linear d ifferen tial equations. Such equations 
can e ither be solved analytically or by simple numerical techniques.
These advantages have led to  many workers adopting th is approach in the 
modelling of numerous biological systems. Recent work includes models 
describing bacterial culture*148 150*, yeast culture and ethanol 
production*151 154*, mammalian cell culture*42’92’155’156*, immobilised 
cell culture*157’158* and growth on solid substrate*159*.
2.8 STRUCTURED MODELS
Structured models require some qualitative description of the biophase. 
Many d iffe ren t approaches have been used in order to  introduce s tru c tu re  
into the biophase. However, structured  models can generally be divided into 
two types; those which simply consider the prim ary metabolism and those
(142)which attem pt to  model the internal biochemistry in some detail
The sim plest method of introducing struc tu re  into the biophase is to  define
a number of in ternal pools or compartments. This approach has given rise  to
a class of s tructu red  distributed*10* models, based on prim ary metabolism,
(142)known as compartment models . The most common approach is to  define two 
compartments. Williams*160* defined one compartment as representing a 
s tru c tu ra l or genetic component within the biophase, fo r example a protein 
or DNA pool, and the other compartment as representing a synthetic 
component consisting of precursor molecules and m-RNA. Biophase boundary 
in teractions are  then considered between these com partments and the grow th 
medium, as well as the interactions between the com partm ents themselves. 
Three and four compartment models have also been proposed*142,161’162*; the
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inclusion of more compartments allowing a clearer distinction to  be drawn
(142)
between nature of the constituents of these compartments
A sim ilar approach which includes the addition of a bottleneck step, has 
been employed(163). In th is case, the growth ra te  of the biophase is 
re s tric ted  by the concentration of some c ritica l interm ediate which is 
central in controlling the s ta te  of the biophase. In many instances the 
in tra -ce llu la r concentration of m-RNA is considered to constitute the
(142)bottleneck, due to  its  cen tral role in protein synthesis
More recently  an approach to  the modelling of prim ary metabolism has been 
proposed by Ramkrishna e t a [(164,165) called cybernetic modelling. This 
approach assumes th a t through ‘natural selection’ microbes have developed 
the ability  to control the ir regulatory processes. As a resu lt they are  
able to  optimize the ir growth patterns*166*. This approach can explain many 
of the phenomena observed fo r growth on mixed substrates*166 17°* and has 
been used fo r slow growing cultures*170’171*. It is also possible to
establish the optimal solution fo r growth under specific
. ,  . (166,169,172)c rite r ia
Much of the f  undamental work into the kinetic behaviour of reaction
(173 174)networks was conducted by Dean and Hinshelwood ’ . However,
s tructu red  models which attem pt to  describe the in ternal biochemistry of 
organisms are  less common than those which describe prim ary metabolism. The 
reason fo r  th is is the large number of equations and param eters which must 
be considered in th is approach. Despite these lim itations, models have been 
proposed which are  based on repressor/inducer control*175*, catabolite 
repression*176* and single cell metabolism*177 179*. A more detailed review
(142)of these types of models can be found elsewhere
2.9 SEGREGATED MODELS
None of the models discussed above, whether they include a s truc tu red  
biophase or not, recognise a very basic fa c t which is common to  all 
biological systems; all such systems consist of numerous individuals*10* 
and these individuals d iffer from one another in term s of cells age and 
cell size. The recognition of th is fac t in the term s of the modelling
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of biological system s leads to  the definition of s e g r e g a t e d  models
2.9.1 U n stru c tu re d  Segregated  Models
U nstructured segregated models consider the individuals within the system 
to  be indistinguishable from  one another(10). The main distinction between 
these models and unstructured distributed models, is the fa c t th a t the 
reproduction of individuals is considered. These models can describe 
reproduction e ither stochastically or determ inistically. The stochastic 
approach considers cell division to be a partly  random process. Using a 
probability density function and given the initial s ta te  of the system, 
relationships can be derived fo r the s ta te  of the system a t any subsequent 
time. The determ inistic approach considers cell division to  be an explicit
function of the s ta te  of the system only, independent of time. These types 
of models are  considered fu rth e r by Tsuchiya e t  a l (10).
2.9.2 S tru c tu re d  S egregated  Models
Many w orkers have studied the distribution of cellular generation tim es fo r 
a variety  of m icro-organism s and mammalian cells; th is is reviewed in more 
detail la te r  (Section 2.12.1). A number of models have been proposed which 
considered the continuous distribution of cellular age; the earlies t being
a ttrib u ted  to Sharpe in 1911(180). Both determ inistic and stochastic(181)
mechanisms have been proposed in order to  describe the changes in these 
population density f  unctions(180). Stochastic models which have adopted 
continuously d istributed f  unctions of cell size have also been
(182-184)considered . A determ inistic approach to the d istribution of cell
mass was considered by Koch and Schaecter(185) in which cell division could 
only occur once cells had reached a minimum size.
D iscrete descriptions of s ta te  define small populations of cells within 
specific s ta te  boundaries. Bernardelli(186) and Leslie*187’188* have both 
proposed models which utilise the properties of m atrices to  define such 
small populations. However, these models only consider determ inistic 
mechanisms to  describe a change of sta te . Pollard*180* has adopted a simple 
stochastic approach to describe changes of s ta te  of such m atrices. Specific 
stochastic models which consider additive errors*189,190*, branching
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processes*189 191) and random transition  matrices*189* have also been 
considered.
(192)Fredrickson and Tsuchiya were the f i r s t  to introduce the concept of 
population balance modelling to the trea tm ent of biological systems. They 
considered a  d iscrete sem i-em pirical description of the s ta te  of a cell in 
term s of cell age; which they defined as the length of time elapsed since 
the b irth  of th a t cell. Probabilistic functions were then introduced in 
order to  describe the behaviour of cells of a certain  age. From th is basis, 
the equations of conservation of age, or population balance equations, were 
proposed. The population age distribution was then derived. This stochastic 
trea tm en t of the behaviour of cells w ith regard  to  the ir age distribution
(193 194)has also been considered in other models
2.9.3 A Fram ew ork  f o r  a G eneral S tru c tu re d  S egregated  Model
A general s tructu red  segregated modelling framework has been proposed by
Fredrickson e t  al*116*. This approach defines the system by using th ree
s ta te  vectors. The physiological s ta te  vector, each element of which
represents the amount of some biochemical entity, the medium s ta te  vector
which is defined as the concentrations of each substance in the grow th
medium, and the grow th ra te  vector, which is used to represen t the ra te  of
change of each element in both the physiological s ta te  vector and the
medium s ta te  vector. The to ta lity  of all possible physiological s ta te
vectors is the physiological s ta te  space. If a small volume of th a t space
is now considered, a density function can be defined which will represen t
the number of cells of a known sta te . From th is point population balance
equations can be derived fo r the conservation of each component in the 
(116)system
(143)Ramkrishna has highlighted the fac t th a t a determ inistic approach is 
inadequate fo r  dealing with small populations of cells. In such cases a 
stochastic mechanism is necessary*117*. A detailed mathem atical analysis of 
the population balance approach has revealed th a t the general population 
balance equation*195’196* derived by Fredrickson e t  al*116* is the prim ary 
relationship in a hierarchy of equations which derive from  the theory of 
stochastic point processes*143*.
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In general, the approach discussed above gives rise  to  complex
in teg ro -partia l d ifferen tial equations. A number of solution methods have
(143)been considered fo r these equations, both analytical and numerical 
Detailed analysis of structu red  segregated models can be found in other
(116,143)reviews
2.10 MODELS OF HYBRIDOMA GROWTH AND ANTIBODY PRODUCTIVITY
Simple unstructured  mathematical descriptions of hybridoma growth have been
( A ?  74 Q? 15S 1Q7 1QR1proposed based upon Monod type kinetics » » » > » . such models
have been used to  simulate the growth of hybridomas in batch and fed-batch
cultures. Glacken e t a j (42,197,198) have used a modified Contois*126* type
expression, which also includes term s to account fo r inhibition by ammonia
and lac ta te , to  account fo r specific growth ra te . Glutamine consumption is
non-growth associated, glutamine decomposition is also taken into account
and antibody and ammonia are  assumed to be produced a t fixed ra te s . Glacken 
(197 198)e t al ' have also introduced a term  which accounts f  or serum 
deactivation.
In the model proposed by Bree e t al*155* glutamine is the grow th limiting 
substra te . Both lacta te  and ammonia are  toxic and have an inhibitory a ffec t 
upon specific grow th ra te . Cell death is dependent upon low levels of 
glutamine and lethal levels of toxins. In tra-cellu lar antibody production 
is non-grow th associated and hence related  to viable cell concentration, it 
is also a function of glutamine concentration. The ra te  of excretion is 
determined from  a single ra te  constant. Ammonia and lac ta te  are  produced in 
fixed stochiom etric yields from  glutamine and glucose respectively. 
Finally, glutamine consumption is determined from  biomass, antibody and
ammonia production and glucose consumption is accounted fo r  a through yield
coefficient and a maintenance requirement.
(199-203)Other workers have proposed structu red  kinetic models and have
used them to simulate antibody production in continuous culture, fo r both 
steady state*1" ’202* and transien t conditions*203*. In these models, a 
three-com partm ent s tru c tu re  is proposed. The com partments rep resen t the
endoplasmic reticulum  (ER), the Golgi body and the ex tra -ce llu la r 
environment. The antibody is assumed to  be production in the ER
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com partment, transported  to the Golgi a t a fixed ra te  and then secreted to 
the ex tra -ce llu la r environment. This model can predict both positive, 
negative and no correlation between antibody production ra te  and specific
. i . (202)grow th ra te
More recently, a d ifferen t structu red  approach, incorporating the concept 
of the cell cycle has been proposed*94’204’205*. Before considering these 
models in more detail, the nature of the cell cycle must be reviewed.
2.11 THE CELL CYCLE
The concept of the cell cycle was f ir s t  proposed by Howard and Pelc*11* as 
a resu lt of th e ir work on root meristems in the early 1950’s. Howard and 
Pelc w ere the f i r s t  to separate DNA synthesis from  mitosis*11’206* and 
identify a d istinct ‘gap’ between each process. As a resu lt they proposed 
th a t every cell must pass through four d istinct physiological s ta tes , which 
they called phases, between each mitosis. They defined these four phases as 
follows: the G1 phase (the ‘gap’ between mitosis and DNA synthesis), the S 
phase (DNA synthesis), the G2 phase (the ‘gap’ between DNA synthesis and 
mitosis) and the M phase (mitosis) (see Figure 2.1).
Since the segregation of the in ter-m ito tic  period into w hat have become
widely regarded as the f  our conventional cell cycle phases, much
inform ation has been gathered with regard  to  the cell cycle in bacteria,
algae, yeasts, plant cells and mammalian cells, both in vivo  and in vitro.
It is almost impossible to conduct a detailed review of all the lite ra tu re
generated w ith reference to the cell cycle and cell cycle regulation since
(208)the early  1950’s. Indeed, P rescott highlighted the fa c t th a t in 1986 
more than 200 papers on the cell cycle and its  regulation were published 
every week. As a resu lt, th is section of the lite ra tu re  review can be no 
more than a  synopsis of the more significant cell cycle concepts introduced 
in the la st four decades, with the emphasis placed upon the inform ation 
which has most heavily influenced th is dissertation.
2.11.1 The G1 Phase
Conventionally the cell cycle is considered to s ta r t  with the G1 phase. The
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f i r s t  few  hours of the G1 phase are  mainly concerned w ith the newborn cell
(207)recovering from  m itosis . There are  obvious physical changes from  which
(208)the cell must recover and reduced protein synthesis has been noted
(209)during th is p a rt of the G1 phase . The re s t of the G1 phase is then
responsible fo r preparing the cell fo r DNA synthesis. I t has remained
unclear exactly what a cell must do in order to in itia te  DNA
(207)synthesis , although some cells do seem to be able to en ter the S phase 
immediately a f te r  the recovery stage(210).
It should also be noted th a t in many unicellular organisms*211*, in the
(212)cells of a t least one m ulticellular organism (Hydra), and in a few
(213 214)mammalian cell lines ’ , there  is no apparent G1 phase, i.e. DNA
synthesis follows mitosis immediately. In such cases, the S phase tends to
(208)be slightly shorter than average while the G2 phase is a lot longer
Many early  embryo cells exhibit no G1 phase. Some of them even lack a G2
period as well and in many cases the S phase may be shortened compared to 
cells a t la te r  embryo stages(208).
2.11.2 The DNA S ynthesis Phase
The DNA synthesis phase, or S phase, is relatively well understood. Most of
the biochemical reaction steps required to  synthesise DNA are  known to
various degrees*215* and the tem poral organisation of the events in the S
(208 215)phase has been found to  be highly ordered * . F o r  eukaryotic cells,
the f i r s t  stage in the S phase is the division of the DNA fib res  into
replicating units, term ed replicons*216*. Once all of the chromosomes have 
been duplicated they then become progressively more folded and
compact(207). The duration of the S phase is typically 6 to  8 hours*216*. 
However, i t  can range from  10 minutes in Schizosaccharom yces pombe to  as 
long as 35 hours in mouse ear skin*216*.
2.11.3 The G2 Phase
The second gap phase, or the G2 phase, has been studied the least out of
all the cell cycle phases. Indeed, no specific cytological or molecular
(208)events have been identified to define its  existence . However, it  does 
seem to  have some relationship with the processes which lead to chromosome
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(207 217)condensation ’ . It is clear th a t protein synthesis must occur during
the G2 phase since inhibition of synthesis in mammalian cells blocks entry
(218 219)to  the M phase ’ . The G2 phase is probably of g rea tes t importance
in preparing cells fo r mitosis*216*.
2.11.4 The M Phase
Mitosis has been sub-divided into four d istinct physical process or phases; 
the prophase, the metaphase, the anaphase and the telophase*216*. 
Chromosome condensation occurs during the prophase; th is  involves the 
f  olding and coiling of each DNA strand. The nuclear envelope also 
disappears a t th is  stage of mitosis. During the metaphase, the chromosomes 
arrange themselves in the centre of the cell. The individual chrom atids 
separate  themselves, however they do remain connected a t  a single point 
called the centrom ere. The chromatids separate  and m igrate to  either end of 
the cell during the anaphase. The apparatus required fo r the alignment and 
m igration of the chromatids is the m itotic spindle. However, the exact 
nature of the mechanism behind these processes is s till unclear*216*. 
During the telophase a circu lar furrow  develops around the middle of the 
cell; the daughter chromosomes decondense and new nuclear envelopes form. 
The final process of mitosis is th a t of cytokinesis, when the cell actually 
divides*216*. In mammalian cells the duration of the m itosis phase is 
typically between 1 and 2 hours.
2.12 THE ORIGIN OF VARIATION IN THE CELL CYCLE
2.12.1 V aria tions in  C ellu la r G eneration  Times
V ariations in individual generation times, the time from  one m itosis to  the 
next, were f i r s t  reported in bacteria  in the early 1930’s*220’221*. 
Subsequently, many researchers have studied th is variation in bacteria , 
protozoa, yeasts and a variety of mammalian cell lines (see Table 2.2).
Many consistent observations have been made in the study of cellular
generations times. F irs t, the average generation time fo r  a population of
(222)cells is very reproducible, under constant environmental conditions 
However, w ithin such a population there is a normal d istribution of
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C la s s  i f  i cation 0 r  g a n i sm Source
B a c te r i  a
E . C o l i „  i i  ( 2 2 0 )Ke 1 ly
E . C o l i d  u ( 2 2 1 )R ahn
B a c i l l u s  m e g a t e r i u m d  1 i ( 2 4 7 )Pow el 1
C h r o m o b a c .  p r o d i g i o s u m  
P s e u d o m o n a s  a e r u g i n o s a  
S t r e p t o c o c c u s  f a e c a l i s
n  i i ( 2 4 8 )Pow el 1
A e r o b a c t e r  C l o a c a e  
S e r r a t i a  M a r c e s c e n s  
S t r e p t o c o c c u s  F a e c a l i s  
P s e u d o m o n a s  A e r u g i n o s a
„  . . ( 2 2 3 )  P ow el 1
E . Co l  i B / r * Kub i ts c h e k (225)
E . Co l  i B / r Kub i ts c h e k (237)
E . C o l i Kub i ts c h e k (249)
P ro to z o a
T e t r a h y m e n a  G e l e i i  HS P r e s c o t t (224)
E u g l e n a  G r a c i l i s ~  , ( 2 2 2 )  C ook
Y e a s ts
S c h i z o s a c c h a r o m y c e s  pom b e m  ( 2 5 0 )N ur se
S c h i z o s  a c c h a r  o m y c e  s  pom be 4. ( 2 5 1 )  F a n te s
A nim al 
Cel 1 s
H eL a . .  , , ( 2 5 2 )M oorhead
H eL a H s u '2531
K i t t e n  L u n g  a n d  
F e r n a n d e s  H um an A m n i o n S i s k e n ( 246}
Mo u s e  L c e l l s . . . .  ( 2 3 0 )McQui lk in
S 6 /1  ( R a t  s a r c o m a ) I-. ( 2 3 1 )Dawson
Mo u s e  F i b r o b l a s t s . ( 2 5 4 )Ki  1 la n d e r
H um an A m n i o n  c e l l s 0 . , ( 2 2 6 )  S i sken
S3 H eL a w  . ( 2 2 7 )M ar in
TABLE 2.2 
Som e S tu d ie s  in to  th e  V a ria tio n  o f 
In d iv id u a l  I n te r - m i to t ic  D u ra tio n s
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(222-227)generation tim es around the mean population generation tim e , and
in alm ost all cases th is distribution is skewed tow ards longer generation 
(222—228)tim es . Finally, varying the environmental conditions (for example:
medium make-up, pH, tem perature) can change the average cellular generation
(222,229)time
Positive correlations in the generation times between s is te r  cells have
, . ^ + • (223,225) . (222) , . .been observed m bacteria , protozoa and in mammalian
cells*231 233). However, Prescott*224* observed a negative s is te r-s is te r
(234)correlation  in another protozoa, Tetrahymena Geleii HS. Terisim a
observed no s is te r-s is te r  correlation a t all in another mammalian cell
line, S3 HeLa. M other-daughter correlations were found to  be not as
significant in mammalian cells*231,232* and certain  bacteria*223* and
(225)alm ost non-existent in other bacteria . However, some bacteria  do shown 
positive sister-cousin  correlations*223*.
(221)Rahn was the f i r s t  to propose th a t the variations in individual
generation tim es were due to temporal e rro rs  in gene m ultiplication. This
(235 236)concept was enhanced Kendall ’ to include all the processes which
(224)lead to  cell division. P rescott proposed th a t the variations w ere due 
to an unequal division of cellular machinery. The correlations between the 
generation tim es of rela ted  cells led Sisken and Kinosita*232* to  propose 
th a t the variations were due to an unequal division of genetic m ateria l as
(231)well as non-genetic m aterial; a concept also supported by Dawson
(237)Finally, i t  should be noted th a t Kubitschek’s observations suggest 
th a t widely d iffe ren t types of cells have very sim ilar prim ary mechanisms 
which control division.
2.12.2 The S tudy o f Cell Cycle K inetics
By the mid-1960’s researchers were studying variations in individual 
generation tim es in term s of the cell cycle. These studies were greatly
enhanced by the development of techniques capable of producing synchronised 
i . .  _ . .  (226 ,229 ,234 ,238-245) _  „  . . » , .populations of cells . Cell populations have been
synchronised by two d ifferen t methods: physical selection or grow th a rre s t.
(235)Mitotic selection is a method of physical selection which produces a
high degree of synchronisation. Cells in the la tte r  p a rt of the m itosis
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phase of the cell cycle are  selected visually; th is is the only time when
two nuclei are  visible. Cells have also been synchronised on the basis of
(245)size . However, th is  assumes th a t there is a d irect correlation between
cell size and cell age.
Growth a rre s t was achieved through nu trien t starvation  or metabolic 
inhibition. Starvation techniques arrested  cells in the G1 phase and were 
considered to induce an out-of-cycle or quiescent s ta te , th is  is reviewed 
below in Section 2.13.1. Metabolic inhibitors block a specific event
necessary fo r progression around the cell cycle. Once the en tire  population
reaches th is point, the block could be removed and the resu ltan t cell
population was synchronised. Colcemid has been used to block cells in the
(245)m etaphase portion of mitosis . Various substances have been used to 
inhibit DNA synthesis; m ethotrexate(15) and 5-fluorodeoxyuridine(1S) 
inhibit DNA synthesis by in terfering  with methylation. A lternatively, high
(238) (243)concentrations of thymidine , deoxyadenosine or deoxyguanosine
inhibit DNA synthesis by feedback effects on the other nucleotide
(15)precursors
It has been a general conclusion f  rom such studies th a t variations in
individual generation time are  prim arily due to variations in the length of
, ,  , (226 ,229 ,234 ,246 ,249) .the G1 phase . This conclusion has come, in the main,
from  the observation th a t the combined length of S, G2 and M was almost 
(229 234)constant ’ . In general changes in the average generation time,
induced by some environmental change, are  a d irect resu lt of variations in
(208)the average duration of the G1 phase
2.13 THE REGULATION OF PROGRESS AROUND THE CELL CYCLE
The observations made in the work cited above, suggest th a t the G1 phase is 
the most im portant of the cell cycle phases, in regulating progress around 
the cell cycle. However, the exact mechanism which controls progress 
through the G1 phase and the transition  into DNA synthesis rem ains open to 
much debate. Some of the ideas and concepts which have been introduced in 
the la st th ree  decades are reviewed below.
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2.13.1 C e llu la r Q uiescence
It has been known fo r some time, th a t mammalian cells can survive fo r long
(255-257)periods without dividing, both in vivo and in cell
culture*258 26°*. This condition, cellular quiescence or grow th a rre s t, can 
be induced in certain  human and rodent cell lines by subjecting the cells 
to conditions which re s tr ic t growth: the lim itation of an essential
(2 6 0 -2 6 3 ) . . . (264) ,nutrien t or amino acid , the inhibition of protein
synthesis*261*, high density culture*261’265* (contact inhibition*258*) or,
, , , . , , . . .  (261,264,266-275)more commonly, partia l or to ta l serum deprivation
In most cases, these quiescent cells remain viable, i.e. capable of 
division. They also have the DNA content of cells in the G1 phase of the
cell CyCie(258>260>276»277^ However, it  has been reported th a t certain
„  , . ,  . (278-280) , . . .  (281,282) ,mammalian cells, both in vivo and in vitro  , can be
arrested  in the S or G2 phases of the cell cycle. Many virally transform ed
cell lines seem incapable of entering a quiescent state*258,264’273*. It
has been observed th a t such cell lines have a much less stringent
(276)requirem ent fo r serum . This observation has been fu rth e r enhanced by
the recent development of serum -f ree media f  or many tra n s f  ormed cell
(31,283)lines
Cells which have been induced into a s ta te  of quiescence, can be stim ulated 
to  re -en te r  the cell cycle. In general, re -en try  is into the phase from
which they entered the quiescent s ta te; as mentioned above, th is is almost 
always the G1 phase. However, it  has been a consistent observation of cells 
in th is s ta te , th a t the period of time from  stim ulation to  the initiation
of the S phase, is f a r  g rea te r than the period of time from  m itosis to  the
P , . , .  n  . „  (264 ,273 ,277 ,284)S phase, m exponentially growing cells
It has been suggested th a t there are  d ifferen t s ta tes  within th is quiescent
(282 ,285,286) n  , i i * t r*s ta te  ; the longer a cell is arres ted  the deeper the s ta te  of
quiescence which is induced*287*. Scott and colleagues*288’289* have
identified d ifferen t s ta te s  of quiescence through which certain  cells must
pass before they can become fully d ifferentiated , and fully d ifferen tia ted
(290)cells may be regarded as being irreversibly arres ted
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2.13.2 R egulating  Cell G row th by C ellu lar Quiescence
It has been proposed, th a t the regulation of the transition  between the G1
phase and a quiescent s ta te , is central to  the control of cellular
prolif eration(291). L ajtha e t a l (255) was the f ir s t  to propose th a t
mammalian cells could regulate the ir growth by entering selectively the
cell cycle from  a s ta te  of quiescence and the kinetics of such a model have
been investigated*292 294). Pardee(261) has proposed the existence of a
(208)unique res tric tion  point, sometimes re fe rred  to as the G1 switch . This 
is a point in the G1 phase, where a cell either becomes quiescent or 
committed to division. A sim ilar point has been identified in budding
(208) (272)yeasts . Yen and Pardee identified a major serum dependent event 
w ithin Gl, where the absence of serum stim ulates entry to a quiescent 
sta te .
The exact location of any specific point within the Gl phase from  which 
cells can e ither progress into a quiescent s ta te  or continue around the 
cell cycle, is s till the subject of much debate. Some researchers have 
located switches a few  hours before the S phase in mid-Gl(261,295), w hilst 
others have located sw itches only 10-15 minutes before the S phase, almost 
a t the Gl-S boundary *264,272,296). However, Zetterberg  and Larsson(295) 
have located a serum re la ted  event in Swiss 3T3 cells in early Gl. Scott 
and colleagues have identified three d istinct points fo r grow th a rre s t
(297 298)which are  induced by d ifferen t phenomena ’
Another problem is the exact nature of cellular quiescence: quiescent cells 
may be in a separate physiological s ta te , often re fe rred  to  as the GO
(299) (217)phase or they may be merely trapped in a prolonged Gl phase and
cycling very slowly(300). Current evidence has determined th a t a d istinct,
(291)non-cycling s ta te , does exist fo r cells in vivo  and fo r many cell
(291 301)lines in vitro  * ; th is s ta te  can be operationally distinguished from
(302)Gl , however the physiological and biochemical differences between GO
, . . (302)and Gl remain unclear
On a molecular level, it has been proposed cell cycle progress or en try  to
(303  304)GO, is controlled by positive and negative elements ’ . These
(304)elements signal a cell to  either stay in or out of the cell cycle and
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it  is the balance between these two processes th a t regulates cellular 
proliferation*303,305*. Many of the elements in the positive ‘c ircu it’ have
(304)been identified as oncogenes . While, elements of the negative circu it 
are  the ‘tum our supressor’*303,305* genes, such as gas  (growth a rre s t
.„ .  .(3 0 4 ,3 0 6 )  (303 ,307) c _(303 ,308) ,  _  . ,specific) , ras  , p53 or RBI (retinoblastom a
(3 0 9 )susceptible) . It is thought th a t the negative elements can lead to  a
reversible quiescent s ta te  (GO phase) or an out-of-cycle s ta te  (i.e.
(303)differentiation) . The growth of tumours is thought to  be controlled by 
a combination of oncogene activation and gas  deactivation*305*; this
suggests th a t the two circu its are  connected*304*.
2.13.3 D e te rm in is tic  C ontrol o f C ellu lar P ro life ra tio n
The earlies t idea fo r the regulation of progress around the cell cycle was 
th a t of a c ritica l point somewhere in Gl phase. This is a point where the 
cell must meet a metabolic or physical requirem ent before i t  can proceed 
around the cell cycle. Many workers have suggested th a t th is  point is 
re la ted  to  a  c ritica l or minimum cell size*310*. Mazia and Ruby*311* 
identified a ‘point of no re tu rn ’ within the cell cycle, a f te r  which a cell 
is committed to division under almost any environmental conditions, th is
(312)was a concept also considered in a model proposed by Voit
The main drawback with many determ inistic models of cellular grow th, is
th a t even though they are capable of providing a good description of the
grow th of a cell population as a whole, they cannot account fo r the wide
range of individual generation times observed in cell populations*220-254*. 
(313)However, Koch has dem onstrated th a t w ith fu rth e r  assumptions
determ inistic models can account fo r such variability.
(314)More recently, Cantrell and Smith have identified a c ritica l threshold 
of in teractions between interleukin-2 and its  receptors, which are  proposed 
as a control step fo r cellular proliferation. The variability  in cellular 
generation time being explained by the log-normal distribution of the IL-2 
receptor density.
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2.13.4 S tochastic  C ontrol o f C ellu lar P ro life ra tio n
Two groups proposed independently what has become popularly known as the
(299 300)transition  probability model of the cell cycle ’ . This model divides
the cell cycle into two parts , usually designated the A and B sta tes . It is 
proposed th a t the B s ta te  contains all of the S, G2 and M phases of the 
conventional cell cycle and probably the early p a rt of Gl(300), while the A 
s ta te  contains the re s t of the Gl phase. The B s ta te  is assumed to  be 
determ inistic in nature and has a fixed duration. However, the A s ta te  is 
probabilistic in nature and has a variable duration. Once a cell en ters the 
A s ta te  i t  is immediately capable of re-en tering  the B sta te . The ra te  a t
which th is random event occurs is determined by a fixed probability, which 
in tu rn  is dependent upon the prevailing environmental conditions, such as
. . .  (267,315,316) , ,  . . . . .  .  , (317)serum concentration or the addition of hormones
The possibility th a t a single random event could be source of the
regulation of cellular proliferation is an a ttrac tive , simple idea which
has received considerable attention. The kinetics of th is model have been
(318-328)investigated intensively in various mammalian cell lines and in
(329 330)yeasts ’ . The kinetics of th is model can be analysed by the
construction of sem i-logarithm ic plots of the number of undivided cells
(318)versus time, a  plots , and sem i-logarithmic plots of the number of 
sibling cell pairs w ith generation time differences g rea te r than time, t,
(318)against time, /3 plots . Both plots generate linear relationships 
indicating f i r s t  order kinetics.
Extended versions of the transition  probability model have been proposed by 
(331)Svetina , who included a time dependent ra te  constant, and Brooks et
(332) (333)al by the addition of another random transition . Rigney has also 
studied the kinetics of multiple random transitions and has dem onstrated
th a t they can exhibit conventional transition  probability kinetics. However 
it  is the inclusion of some determ inistic step, specifically a  c ritica l 
cell size, which has a ttrac ted  more recent attention*334 336).
2.13.5 C ellu la r Clocks
Another concept which has also been proposed to  account f  or cellular
31
Literature Review
(337)prolif eration  is th a t of quantised generation times . This approach 
considers generation tim es to be quantised into multiples of between 3 and 
4 hours and th a t cells can only divide a f te r  completing an integer multiple 
of these quantum periods. However, th is approach does require an 
explanation as to  how each quantum period is m etered within the cell and
(338)how it  is re se t upon mitosis
2.13.6 Combined Cell Cycle R egulation
(334)Shields e t al dem onstrated th a t the average cell cycle time fo r a 
population of small cells, was five hours longer than th a t fo r a population 
of large cells. However, they also observed th a t both populations did
(334)exhibit transition  probability kinetics. This led Shields e t al to
conclude th a t cells must reach a minimum size before they can in itia te  any 
random transition . This conclusion was also reached in studies of yeast 
cells(339). Nurse e t  a l (335) suggested th a t almost all of the data
suggesting a determ inistic mechanism f  or regulation of cellular 
p ro lifera tion  have been obtained from  microbial cells, w hilst data  
suggesting a random transition  have been obtained from  mammalian cells. 
Therefore, it  was reasonable to conclude th a t in microbial cells, where the 
pro liferation  ra te  is very high, cell size was the controlling fac to r and
in mammalian cells, w ith much lower proliferation ra te s , th a t a random 
transition  was the controlling facto r.
(340)A model of the cell cycle has been proposed which encompasses both the
concepts of a minimum or critica l cell size and a random transition .
Wheals(341) has also adopted th is approach in the ‘sloppy’ size control
model, in which it  is proposed th a t the probability of entering the B s ta te  
increases w ith size.
2.13.7 Biochem ical R egulation  o f th e  Cell Cycle
On a molecular level, two key checkpoints have now been identified where
cell cycle progress can be delayed in most organisms, the Gl-S checkpoint
(34 2 -3 4 7 )and the G2-M checkpoint . It has been concluded th a t these ex ist in
order fo r the cell to  repair any DNA damage to prevent: i) any damage being
(348)copied in the replication of DNA (Gl-S checkpoint delay) , and; ii) the
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(347 348)loss of genomic m aterial (G2-M checkpoint delay) ’ . These
(349)checkpoints have been identified in a wide variety  of organisms , but
(348)are  best understood in mammalian cells and yeasts . It is also proposed
th a t these are  key steps in the regulation of the cell cycle.
In yeasts, the protein kinase p3 4 cdc2/cdc28 jias been identified as a
controlling element a t  both checkpoints*350 353); p85cdcl° has also been
(344)identified as being critica l fo r Gl-S transition  . The Gl-S checkpoint,
re fe rred  to  as START in the yeast cells, has been identified as two
distinct points in la te  G1(354-356)f START A and START B. True cell cycle
( 3 5 7 )
commitment occurs a t START B, with START A being a necessary precede
qdc28At the G2-M checkpoint p34 is the catalyst f  or the cell cycle
(358-361)regu la to r MPF (M phase promoting factor) which triggers  entry  to
» i  u (359,362)the M phase
More recently, p3 4 cdc2/cdc2S regulation of the Gl-S checkpoint in higher 
eukaryotes has been identified*346’354*. However, in X enopus egg  cells
cd c2 /cd c2 8p34 is not required fo r the G2-M checkpoint and it  appears th a t
th is checkpoint is regulated by another cdc2 protein kinase, p32cdc2*346*. 
Elevated levels of a cdc25 protein have also been observed in X enopus egg
„  (364)cells
In yeasts, the timing of the s ta r t  of the cell cycle, as measured by the 
Gl-S transition , is clearly related  to  the attainm ent of a c ritica l
. (3 3 9 ,3 5 5 ,3 6 5 ,3 6 6 ) , , , ,  „ . . . .  . . .size , but the expression of certain  genes can a lte r  th is
critica l size*365,367*, as can the prevailing environmental 
conditions*368*. The attainm ent of a critica l protein content (369»370) or
(371)
a critica l protein synthesis ra te  have both been proposed as control
points fo r the initiation of START B. Although, it  is unclear exactly how a
(357)cell could monitor these param eters , it  has been proposed the cell
cycle commitment is determined by the ra te  of accumulation of unstable
(372 373)proteins ’ (G l-specific cyclins), through the ir in teraction w ith the
_ . c d c2 /cd c2 8  A . . . (367 ,374-377)p34 protein kinase
Currently, there  is only limited knowledge of how the cdc2/cdc28 proteins
(349)and Gl and G2 cyclins, kinases, phosphatases and proteases control
(362 378)these processes on a molecular level ’ and how they are  sequentially
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(349)ordered . However, the understanding of these processes is a key issue 
in cell cycle research*3795.
2.14 MATHEMATICAL MODELS OF THE CELL CYCLE
2.14.1 Sim ple U n stru c tu red  Models
Simple unstructured models divide the cell population up into a number of 
sub-populations or sta tes . The most well known cell cycle model of th is 
type is the transition  probability model proposed by Smith and Martin*3005. 
The mathem atical implications and validity of th is approach have been
(318-330)extensively studied . Other models consider the in teraction  of
(292 380)cycling populations with non-cycling ones; GO-type models ’ . The
(293)model proposed by Moebs also combines the transition  probability
approach w ith the concept of a GO phase.
2.14.2 D iscre te  D escrip tions o f th e  Cell Cycle
Discrete descriptions of s ta te  using cell age have already been reviewed in
(381—383)Section 2.9. Hahn and Kallman was the f i r s t  to  consider th is
approach and adopted a s ta te  vector approach to describe cells of d ifferen t 
(381)chronological ages ; th is is sim ilar to the more general approach
described by Fredrickson fo r microbial cells*1165. Hahn has used th is model
to  describe exponential growth*3815, the kinetics of
(381) (382)desynchronisation , the effects of ionizing rad ia tion  and
(383)chem otherapeutic agents . Hahn’s model has been adopted by other
. (38 4 -3 8 7 )workers
2.14.3 Continuous D escrip tions o f th e  Cell Cycle
A number of w orkers have considered describing each cell cycle phase with
(388—390)an independent probability density functions . These functions
describe the distribution of durations within each cell cycle phase.
Stochastic descriptions of cellular behaviour have been considered by
(388)B arre tt , who considers the f  our conventional cell cycle phases only,
(3 8 9 -3 9 0 )and Fried , who introduced a new phase which leads to  cell death.
(391)Mode , also considers only the four conventional cell cycle phases,
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but describes the progress of cells between cell cycle phases
(312)determ inistically, using the concept of branching processes. Voit has
also proposed a determ inistic model which considers a single control point
sometime during the cell cycle.
2.14.4 Combined Models o f th e  Cell Cycle
As has been mentioned above, there is evidence to  support the concept of
p ro liferation  controlled by both cell size and a  random transition . In the
la te  1960’s a d iscrete model of proliferation which described cells by both
(392-396)th e ir age and th e ir size was proposed . Increments in age and size
were assumed to  be determ inistic, while division was assumed to  be
probabilistic. However division could only occur once a cell had reached a
(397 398)critica l or threshold volume. More recently, Tyson and Hannsgen ’
(399 400)and Webb ’ have also adopted continuous descriptions of both cell 
age and cell size. Their models also incorporate both random transitions
and the control of cellular events by cell size(397’398,400). Webb and 
Grabosch’s (400) model also allows fo r the inheritance of properties from  
mother to daughter.
2.15 ANTIBODY PRODUCTION AND THE HYBRIDOMA CELL CYCLE
2.15.1 Cell Cycle D ependent Antibody P roduction  in  Lym phocytes
It has been dem onstrated th a t antibody production in lymphocyte cells is a
cell cycle dependent phenomenon(12 14). Johns and Hoare(12) studied
antibody synthesis, accumulation and secretion in a mouse plasmacytoma
derived cell line, Cl. It was concluded th a t antibody synthesis occurred in
la te  Gl and S, accumulation occurred in S and G2 and secretion was
res tric ted  to  la te  S, G2 and M. In another mouse plasmacytoma, maximum
(13)antibody synthesis and secretion was observed in la te Gl and early  S ,
while during la te  S, G2 and M they were minimal. It was also observed th a t
(14)synthesis occurred in early Gl. Golding e t al have observed th a t if 
cells are  a rres ted  in Gl, the percentage of antibody secreting cells 
increases and th is indicates th a t antibody is secreted in the Gl phase.
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2.15.2 Cell Cycle D ependent Phenom ena in  Hybridom a Cell Lines
Recently, studies have been conducted on hybridoma cell lines to determine 
cell cycle dependence of antibody production*15 18) and other variables. 
Ramirez and M utharasan(16) have estim ated th a t higher ra te s  of antibody 
secretion occur in the G1 phase of the cell cycle. They also observed a 
d irect correlation between cell size and cell cycle phase and a reduced 
oxygen uptake ra te  fo r sm aller or non-cycling cells.
Kromenaker and Srienc(17) studied the differences in antibody synthesis and 
secretion around the cell cycle in both producer and non-producer cell 
lines. They observed high antibody accumulation ra te s  in the G1 phase, 
lower ra te s  in S and negative ra te s  in G2 + M. They also emphasised the 
need fo r a segregated approach to the modelling of the kinetics of antibody 
production in hybridomas.
(18)The e ffec t of tem perature on the cell cycle has also be investigated 
Lower tem peratures arres ted  cells in the G1 phase of the cell cycle.
However, no increase in average antibody production ra te  was observed fo r 
cultures trea ted  in th is way.
2.15.3 Models o f th e  H ybridom a Cell Cycle
The cell cycle dependence of antibody secretion in hybridoma cell lines has
been included in models. A simple structu red  model of the hybridoma cell
cycle has been proposed by Suzuki and Ollis(204). In th is model, cells can
exist in any of the four cell cycle phases (Gl, S, G2 or M) or in an
arrested  s ta te  (A). The fraction  of the cell population in each phase is
(204)determined f  rom a f  requency f  unction. Suzuki and Ollis investigated
the behaviour of th e ir model in continuous and perfusion culture by fittin g  
it  to published data. From this study they have concluded th a t antibody is 
often produced a t a higher ra te s  in Gl and th a t methods to  a r re s t  
hybridomas may contribute to higher antibody productivity.
( 9 4 )
A sim ilar approach has also been adopted by Linardos e t al . In th is
case cells can reside in one of th ree states: i) cycling in s ta te  A; ii)
cycling in s ta te  B; or, iii) arrested  in s ta te  A. This is sim ilar to  the
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Smith and Martin model(300). Again, th is model has been f itted  to  data 
published fo r continuous culture and it was concluded th a t specific death 
ra te  was a function of the number of cells arres ted  in Gl.
2.16 CONCLUDING COMMENTS
In th is  chapter, the lite ra tu re  in three d istinct areas has been reviewed: 
hybridoma cell culture, m athematical modelling of biological systems and 
the cell cycle. It was necessary fo r th is review to  be somewhat selective, 
however, th is inform ation will provide the foundation fo r the re s t of th is 
d issertation.
It is evident from  th is review, th a t hybridoma cell culture is an expanding 
and commercially appealing technology. It is also clear th a t, despite the 
wealth of data  generated in th is area, good quantitative descriptions of 
hybridoma grow th and antibody production kinetics a re  scarce. Recent 
experim ental evidence(15 18), indicating cell cycle dependency fo r antibody 
production, implies th a t any mathematical model should adopt a s tructu red  
segregated approach, based on the cell cycle. The re s t of th is d issertation  
is concerned with the development and application of such a model.
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1CHAPTER 3 
A GENERIC CELL CYCLE MODEL
3.1 INTRODUCTION
In Chapter Two the wide range of theoretical and m athem atical concepts 
which have been proposed to  describe the growth of cells have been 
reviewed. It was noted th a t there is a need fo r a generic cell cycle model 
which can encompass all these concepts. This general model would fac ilita te  
the development of a model fo r a specific cell line. Furtherm ore, cell 
cycle models f  or other cell lines could be developed within the same 
fram ework allowing direct comparisons to be made.
In th is chapter, the fea tu res which are  relevant to  a generic cell cycle 
model are  identified. These featu res are  considered in some detail, 
expressed m athem atically and a solution method is proposed.
3.2 FEATURES OF A GENERIC CELL CYCLE MODEL
A generic model of the cell cycle must be flexible enough to  allow radical 
a ltera tions in the in teractions between the cell cycle phases, and between 
the cell population and its  growth medium. The following fea tu res  are 
im portant:
3.2.1 A F lex ib le  Num ber o f Cell Cycle Phases
As well as the four conventional cell cycle phases (Gl, S, G2 and M(11)), 
many researchers have postulated the existence of other phases. The most
common is the proposal of a quiescent s ta te , often re fe rred  to  as the GO
(299)phase (the numerous theories as to the nature of such a phase have
been reviewed in Chapter Two). Other cell cycle phases th a t have been
considered are  a death phase and a phase associated with the recovery from
, (288,289,297,298)a quiescence s ta te  . Other workers have proposed the
sub-division of one or more of the four conventional cell cycle phases into
(277)more defined cytological periods ; th is concept is im portant in the
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development of any in tegrated  cell cycle model. It is clear th a t any 
generic cell cycle model must be able to incorporate any number of such
additional phases as necessary.
3.2.2 Phase D ura tion
Certain cell cycle phases can be assumed to have a fixed duration, while
others definitely have a variable duration (see Section 2.12.2). Therefore, 
a generic model must be able to simulate both types of phase. Furtherm ore, 
d ifferen t theories have been proposed to describe the source of variation
in the variable cell cycle phases (see Section 2.13).
D eterm inistic descriptions rely on the occurrence of some specific event, 
or the meeting of some specific condition, to trigger transition  to  a new 
cell cycle phase. Stochastic descriptions describe the transition  of cells
in term s of a probability distribution; cells of a known age and s ta te  
having a pre-determ ined chance of moving on to a new cell cycle phase. More 
recently, models which rely upon both a determ inistic and a stochastic 
component have been proposed (see Section 2.14). A generic model must be 
capable of defining rules to  describe any of these types of cell cycle 
phase.
3.2.3 Movement o f th e  Cells Between Cell Cycle Phases
Cells which make the transition  between phases, need not necessarily always 
do so in a simple step by step progression from  the end of one phase to  the 
beginning of the next. In certain  circumstances, a cell may be capable of 
leaving a particu la r phase a t any time during its  progress through th a t 
phase. Also, when a cell does leave a phase it  may be capable of 
progressing to  one of several other phases. The exact nature of both of 
these phenomena will be dictated by the prevailing environmental and 
in tra-ce llu la r conditions or by a chance.
An example of departure f  rom within a phase is the in itia tion of the
(299)supposed GO phase . A large proportion of the lite ra tu re  suggests th a t 
mammalian cells may well be able to enter the GO phase from  any point 
w ithin Gl, or from  a number other cell cycle phases (see Section 2.13).
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However, in each case the likelihood of th is transition  occurring is 
dependent upon the s ta te  of the growth medium and the s ta te  of the cells.
An example of cells having alternative phases to  move to  is observed in the 
behaviour of the yeast, Saccharom yces cerevisiae. In th is case, the 
organism reaches a point in the cell cycle term ed START, a t which the cell
(344)may embark on one of four d ifferen t pathways : i) cell cycle initiation 
resu lting  in mitosis; ii) meiosis and sporulation, iii) conjugation; or, 
iv) quiescence. Again, the choice is a reflection of a combination of the
(372 373)cytological s ta te  and the prevalent environmental conditions
In any generic cell cycle model, cells must be able to move from  any cell 
cycle phase to  any other phase and depart from  any point within a phase. 
Furtherm ore, param eters must be included which will determine the relative 
proportion of cells moving between each phase and to  encompass any 
conditional ru les which may regulate these flows.
3.2.4 In te ra c tio n  o f th e  Cell Population  w ith  a M ulti-com ponent Medium
It is c lear from  the above th a t progress around the cell cycle may be 
d ictated  by the physiological s ta te  of a cell and by the prevailing 
environmental conditions. As such, a facility  must be introduced into the 
generic model to  allow any cell, in any cell cycle phase, to be able to 
in te rac t w ith a multi-component medium, independently of all o ther cells. 
These in teractions will influence both the physiology of the cells and the 
cells’ environment. In order to  achieve this, a fac ility  must be 
incorporated in the generic model which will allow the definition of a 
multi-component medium and methods fo r representing cytological s ta te .
3.2.5 The In h ib itio n  o f P rogress around  th e  Cell Cycle
The concept of blocking, or arresting , the progress of cells around the 
cell cycle was mentioned briefly in Chapter Two. However, it  is im portant 
to  note th a t the progress of cells through a cell cycle phase, or from  one 
cell cycle phase to  another, may be inhibited, and as such th is phenomenon 
must also be allowed in any generic cell cycle model.
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3.3 CONCEPTUAL FRAMEWORK OF THE GENERIC MODEL
Various fea tu res  have now been identified which need to  be incorporated 
into the generic cell cycle model; these fea tu res are  now discussed in some 
detail.
3.3.1 The D efin itio n  o f Phases w ith in  th e  G eneric Model
The transla tion  of the concepts of the cell cycle into mathem atics presents 
a number of problems. The most fundamental of these derives from 
contradictions in the biological definitions of cell cycle phases. Consider 
the conventional definitions of the S and Gl phases. The S phase is defined 
as the period of time during which DNA is synthesised; in other words it is 
defined in term s of the time taken to  complete a specific biochemical
process. However, the Gl phase is simply defined as the period a f te r  which
m itosis has finished and before DNA synthesis has s ta rted ; it  is defined by 
the period of time between two biological processes, neither of which are 
directly  associated w ith th a t phase. The successf ul transla tion  of any 
concept into m athem atics requires the form ulation of rigorously defined 
rules. I t is d ifficu lt to define such rules when cell cycle phases are
defined in such vague and contradictory term s. Therefore, an alternative 
definition of a phase is required fo r use within the generic model.
A phase is a s ta te  in which ‘all cells obey the same se t of transition  
rules, share the same form s of in teraction w ith the environment and are 
perform ing the same internal operations and functions.’ As a consequence of 
th is definition, the c rite ria  employed above, in the biological definition 
of the Gl phase fo r example, can no longer apply. Furtherm ore, the 
biological definition may require the sub-division of the Gl phase into a 
number of d iscrete phases in a particu la r model; as defined by specific
cytological or interactive processes. Theref ore, i t  is a necessary 
requirem ent of the generic model th a t any number of phases, Np, may be 
defined, in order to  develop d ifferen t models fo r specific cell lines.
Many param eters are  required to define a phase completely. These include 
param eters which d ic tate  how cells will in te rac t w ith the grow th medium and 
how th e ir cytological s ta te  changes. However, before these fac to rs  can
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considered the principals of how cells move within and between phases will 
be developed.
3.3.2 The Movement o f Cells W ithin and B etw een Phases
In o rder to  describe clearly the behavior of cells within the generic model
a number of term s must be defined. The datum time is some a rb itra ry  time a t
which all of the initial conditions apply, th is is denoted as t  .o
Laboratory tim e is defined as the amount of time elapsed since t  , th is is 
denoted as t.  Biological age is defined as a cells position within a 
specific phase relative to  the s ta r t  of th a t phase and is denoted as
(where X is some a rb itra ry  phase); i t  should be noted th a t biological age 
is independent of laboratory time. The maximum biological age a cell can 
a tta in  in any phase is denoted as T . Flow is defined as the movement of 
cells w ithin a phase. Transition is defined as the progress of cells from  
one phase to  another. The position of all cells, in all phases, a t any 
instan t, is term ed the cell age distribution.
In general, flow will resu lt in cells of a particu la r biological age 
becoming older relative to the s ta r t  of a phase and in rela tion  to the 
passage of laboratory  time. Transition may occur a t any time during a 
phase. The number of individuals, of a specific biological age, leaving a 
phase and th e ir  destination, is determined by the set of transition  rules 
defined fo r th a t phase. The transition  rules may be either stochastic, 
determ inistic or a combination of both.
In the case of stochastic transition  rules, the ra te  a t which cells leave a 
phase, is determined by some pre-defined probability distribution function. 
A number of probability distributions have been incorporated into the 
generic model. For determ inistic transition  rules, cells will not undergo a 
tran sitio n  until one or more specific conditions are  met. Once these 
conditions have been met the cells must progress to another phase. It
should be noted th a t when cells reach an age of Tx they must undergo a 
transition , th is is a particu la r type of determ inistic rule. Rules may also 
ex ist in which transition  is dictated by both a determ inistic and a
stochastic facto r; cells will leave a t some ra te  determined by a
probability distribution, but only a f te r  a determ inistic event (or events)
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has been met. Both stochastic and determ inistic rules may be functions of 
biological age, the s ta te  of the growth medium or the cytological sta te .
In principle there  is no lim it to the number of transition  rules which may
be defined in the transition  rule set fo r a p articu la r phase. Each
transition  ru le may resu lt in d ifferen t cells in itia ting d ifferen t phases.
These fea tu res  fac ilita te  considerable flexibility  in phase definition
within the generic model.
3.3.3 C e llu la r P ro life ra tio n
When cells leave a phase X, to enter another phase Y, a pro lif eration 
fac to r must be specified fo r th is transition; th is is denoted as PJxy f ° r
cells leaving as a resu lt of the Jth transition  rule. This param eter
represen ts the fractional increase in the number of cells in a particu lar 
population. For example, if  the degree of pro liferation  from  phase X to
phase Y is 1.5, one hundred cells leaving phase X would resu lt in one
hundred and f if ty  cells entering phase Y, i.e. f if ty  of the cells which 
le ft phase X have successfully divided. If all the cells undergo binary 
fission then the degree of proliferation is 2. In general, as cells are 
conserved and DNA replication can only yield one new copy a t a time, 1 ^ i
p  ^ 2  
JXY
3.3.4 D efin itio n  o f a  M ulti-com ponent Medium
Typically a grow th medium fo r a cell culture will consist of numerous 
components. These components are  intended to provide a source of nutrition  
and a com fortable biochemical environment in which the cells can grow. A 
typical grow th medium will also contain m aterials which have been secreted 
by the cells, as a resu lt of th e ir metabolic activity. In order to  simplify 
the definition of a growth medium within the generic model, th ree component 
categories have been defined; th is has been introduced to  fac ilita te  a more 
convenient user in terface. The components within each category in te rac t 
with the cells in slightly d ifferen t ways. The categories are  defined as 
follows:
a) nutrients: m aterials which are required by the cells fo r survival
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and growth; usually these components are  consumed by the cells 
(i.e. glucose, fructose, glutamine);
b) metabolites: useful m aterials which are  produced by the cells and 
secreted  into the grow th medium. These are  often m aterials which 
may be recovered from  the growth medium as products, but in general 
they will have no beneficial or detrim ental e ffec t upon cell 
survival and grow th (i.e. antibody); and,
c) toxins: w aste m ateria ls which are  produced by the cells and 
secreted into the grow th medium. They are  generally not useful as 
products and can have a detrim ental e ffec t upon cell growth. In 
essence they are  w aste products from  the cells metabolic activity 
(i.e. ammonia, lactate).
The s ta te  of the multi-component medium is described by the ‘medium state* 
vector C(t), where each element w ithin th is vector represen ts the 
concentration of one of the medium components a t laboratory  time, t. An 
‘inlet medium s ta te ’ vector, C (t), is also used to account fo r the medium 
concentration of each component in any potential feed stream . The ra te  of 
change of the medium s ta te  vector, due to in teractions w ith the cell 
population in any phase X, is determined by the ‘medium ra te ’ vector, Rx - 
Each element of the medium ra te  vector contains a ra te  constant fo r the 
tran sp o rt of the relevant component in to  or out of the cell. This ra te  of 
tran sp o rt may be of any order, th is is defined by vector OR-x -
3.3.5 D efin ition  o f In tra-cellu lar Components
Some account must also be made of the internal make-up and behaviour of 
cells. In the model there  are  four categories of in tra -ce llu lar components, 
these are  the th ree  medium component categories, as defined above 
(nutrients, m etabolites and toxins), and another sets of components which 
shall be re fe rred  to  as the interm ediates category. The interm ediates are  
defined as m aterials not accounted fo r in the other categories, but may 
include m ateria ls which fac ilita te  the transform ation  of nu trien ts into 
m etabolites, toxins, energy or new cellular m aterial. The generic model 
needs to be capable of monitoring the in tra -ce llu lar contents f  or each
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component in each category.
As with the multi-component medium, the cytological s ta te  can be described 
by a vector where each element within th is vector represents the per cell 
concentration of a single in tra-cellu lar component. Clearly, cells in 
d iffe ren t phases and of d iffe ren t ages within a phase will have d ifferen t 
cytological s ta te s  Therefore, a ‘cytological s ta te ’ vector *s
defined. This represen ts the average cytological s ta te  of all cells in 
phase X of biological age t  , a t time t. While the s ta te  of the entire 
culture is represented by the set of all of these vectors in every phase.
The in teractions between the in tra-cellu lar components is described by the 
‘cytological r a te ’ vector, Rc x * This is a m atrix , w ith the row giving the 
original component and the column the final component. For example, 
consider a  model w ith Z in tra -ce llu lar components, the cytological s ta te  
vector may be represented as follows:
Comp 1 ... Comp n ... Comp m ... Comp z  
Comp 1 [ 'j
Comp m | A |
Comp n j B j
Comp z  { J
In th is case the ra te  constant fo r production of component M from  component 
N is B. However, N is also produced from  M w ith a ra te  constant of A. The 
order of each in ter-reac tion  may be se t independently fo r each component. 
This defines another vector fo r each phase ORcx
3.4 MATHEMATICAL MODEL OF THE GENERIC CELL CYCLE
The m athem atical expressions developed below form  the basis of the generic
cell cycle model. This model is subsequently re fe rred  to  as CELCYMUS: Cell 
Cycle Model, University of Surrey.
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3.4.1 D efin ing the Cell Population
Consider a cell cycle w ith Np phases. For any phase X, le t n^ltjT ) be the 
population density function (number of cells per unit volume of bioreactor 
per unit biological age in phase X), and le t n ^ t.x ^ ) dx be the number of 
cells w ith ages between x^ and x^ + dx in phase X, per unit volume, a t time 
t; th is  will be re f  erred  to  as age element x . The number of cells in this 
phase a t  time t, is given by,
N (t) = V(t) n (t,x  ) dx x x (3.1)
where,
3
V(t) is the working volume of the bioreactor a t tim e t  (m ).
Furtherm ore, the to ta l number of cells a t time t, N(t), is given by,
N(t) = V(t) n (t,x  ) dx x x
x= 1
(3.2)
These are  the expressions which define the number of cells in the 
population. The manner in which th is age distribution changes with 
laboratory  tim e must now be considered.
3.4 .2  Describing Changes in the Age Distribution
Consider an individual cell: during an infinitely small in terval of
laboratory  time, dt, one of the following events may occur:
a) the cell gets older (flow);
b) the cell leaves the phase as a resu lt of a ru le in the transition  
set; or,
c) the cell gets washed out of the bioreactor.
These events a re  mutually exclusive; i.e. if a cell undergoes one event it 
may not undergo any of the others. As a resu lt an expression can be w ritten
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fo r  each event in the absence of the other events.
In th is  analysis, it  is now more convenient to  consider a small population
of cells, although the mutual exclusivity s till applies to individuals.
Consider Event a), a t time t  the number of cells in phase X of age x^ to
x + dx is n (t,x  ) d r, and the number of cells in phase X of age x -  dx x x x x
to  x^ is nx(t,xx -  dx) dx. During time interval d t = dx, all cells in age 
element x^ -  dx will a tta in  an age of x^ to x^ + dx, while those in age 
element x^ will go to  the next higher age group. Therefore, the net ra te  of 
depletion of age element x^ as a resu lt of cells aging is given by
V(t) n ( t ,x  ) dx -  V(t) n ( t ,x  -dx) dx
X X — -----   . (3.3)d t
This may be reduced to,
S(n ( t ,x  ))
V (t)------  —~ ~ —  dx. (3.4)ox
For Event b), the fraction  of the population which leaves as a re su lt of 
transition  ru le must be evaluated. For a purely stochastic event th is
frac tion  may be calculated from  a probability distribution, but fo r a 
determ inistic event th is f  raction may be 0 or 1 only, depending upon
w hether the conditions have been met or not. As has been s ta ted  in Section
3.3.2, th is  frac tio n  may be dependent upon biological age, cytological
s ta te , as represented by the cytological s ta te  vector ^  (t,x  ), or the
concentration of any of the components of the medium, as represented by the 
medium s ta te  vector C(t). A general function fo r the evaluation of the
frac tion  of cells of age x^ which leave phase X as a resu lt of single 
transition  rule may be w ritten  as,
0 * F fx ,C (t,x  ),C (t)| == 1. (3.5)x[ X CX x J
As there is no theoretical restric tion  upon the number of d iffe ren t rules 
which may be used to  describe transition  from  a phase (provided they are  
mutually exclusive), the net ra te  of depletion of age element x , as a 
resu lt of all such rules in phase X, is given by,
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Gx
V(t) n (t,x  ) dx ) F x x /  JX
j  = i
Tx,Cc(t,Tx),C(t) (3.6)
where Gx is the number of d ifferen t transition  rules defined fo r phase X.
Finally, assuming a well mixed bioreactor, the net ra te  cells a t which 
cells in age element x a r e  washed out, Event c) is given by,
F(t) n^lt.T^) dx (3.7)
3 -1where F(t) is the outlet flow ra te  (m hr ) a t time t.
The possibility of a non-sterile  f  eed must also be considered in this 
generic approach. In th is case the ra te  a t which cells in age element 
are  introduced into the bioreactor is given by,
Fj(t) dx (3.8)
3 -1where F (t) is the inlet flow ra te  (m hr ) and n (t,x  ) is the inlet
- 3feed concentration of cells of age x to x + dx (cells m ) a t  time t.x x
These assumptions fac ilita te  the simulation of various s tirre d  batch 
bioreactor configurations, i.e. conventional batch, fed-batch, continuous, 
repeated batch.
Combining Equations 3.4, 3.6, 3.7 and 3.8, an expression may be obtained 
fo r  the net ra te  of depletion fo r age element x ,
SV(t)n ( t ,x  )
X X dx = F (t) n (t,x  ) dx -  F(t) n (t,x  ) dxSt i ix ’ x x ’ x
V(t) n (t,x  ) dx ) Fx x /  JX
G
X Sn ( t  ,x  )
x ,C (t,x  ),C(t) ' X X
X C x
-  V (t)  ?—=— —  dx. (3.9)Sx
7=1
Expanding the le ft hand side using the chain rule,
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dn (t ,x ) H vm
V (t)  dx + n (t,x  ) —“jt—  dx = F (t) n (t,x  ) dx -  F(t) n (t,x  ) dxat x x d t i ix x x x
-  V(t) n (t,x  ) dx ) F
x  x  /  , JX
T=i
x ,C (t,x  ),C(t)
X C x
an ( t , x  )
-  V (t) X dr X dx (3.10)
Assuming a constant density,
= F (t) -  F(t).
a t  I
(3.11)
Substituting Equation 3.11 into Equation 3.10 and rearranging, an
expression fo r the ra te  of change of the age distribution in phase X with 
respect to laboratory time,
3n ( t ,x  ) F (t) x x I
at V(t) n (t,x  ) -  n (t,x  )[ ix x x x J
n (t,x  ) \  F x x JX
J = i
x ,C (t,x  ),C(t)
X C x
3n ( t , x  ) x x
3x (3.12)
It should be pointed out th a t th is expression does not apply to  cells of 
age zero.
3.4.3 Boundary Conditions
Cells can leave a phase X, a t any time during the phase, and go to  any 
other phase as a resu lt of d ifferen t transition  rules. Cells always 
en ter a new phase with an age of zero. The to ta l number of cells leaving 
phase X, as a resu lt of the Jth rule, a t time t, is given by,
V(t)
r T f
X f
F
JX
V
J  0
x ,C (t,x  ),C(t) x cx  x n (t,x  ) x x dx (3.13)
where: 0 < x ^ T and 1 < J < G .
x x  x
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If the frac tion  of these cells which move to  phase Y is f  , where
JXY
0 ^ ^ 1 and
JXY
FI
Y= 1
/  =  1. JXY (3.14)
and the degree of prolif eration of these cells is PJxy> where normally 
1^ PJXY -  2, then the to ta l number of these cells joining phase Y, a t time 
t ,  as a resu lt of the Jth rule is given by,
V(t) p  fJXY JXY
r T X
r >
FJX x ,C (t,x  ),C(t) X c XV. J
n (t,x  )X X
J 0 j
dx. (3.15)
Consequently, the to ta l number of cells joining phase Y, a t  time t ,  as a 
resu lt of all tran sition  rules is given by,
V(t) ) p f7 JXY JXY
J = i
rTX r ' -N y
FJX x ,C (t,x  ),C(t) X c X J
n (t,x  )X X
J 0 i. j
dx (3.16)
and the to ta l number of cells joining phase Y as a resu lt of all transition  
ru les in all cell cycle phases, T ^ t), a t time t, is
T (t) = V(t) 
y
N G
p
X= 1
( X nTX
>
r  '
/ p  f/  JXY JXY FJX x ,C (t,x  ),C(t) X c Xk J
n (t,x  )X X dx
/_..»
 ^ J=1 0
j
j
(3.17)
An expression fo r the to ta l number of cells which join a particu la r cell 
cycle ph 
w ritten ,
ase a t time t, the boundary condition value fo r nY(t,0), can now be
n (t,0) = T (t) (3.18)Y Y
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or expanding,
n (t,0) = V(t)
N G
P f  X
L X=1
P fJXY JXY
J = 1
r T f
X /
F
JX V.
J  0 w
V Cc(t' V ' C(t)) nx (t'Tx> dx
(3.19)
3.4.4 Medium Component Mass Balance
Let CK(t) be the medium concentration of medium component K a t time t, 
where C (t) is an element of medium s ta te  vector C(t). Let C (t) be the
K IK
inlet concentration of th is component a t time t, where C^Ct) 1S an element
of the inlet medium s ta te  vector C (t). Finally, le t C (t,x  ) be thei J ckx x
in tra -ce llu la r content of th is component fo r all cells of age r  , in phase
X, a t time t: where C (t,x  ) is an element of the cytological s ta te
ckx x
vector C (t,x  ).
CX X
In principle all the cells in every phase of the cell cycle can either
excrete to  or consume from  the growth medium, any of the medium components. 
These in teractions are  defined through the medium ra te  vector, R^, and the 
vector representing the order of the process, OR-x - Let Pkx be the average 
net tran sp o rt ra te  per cell of component K fo r a cell in phase X. This may 
be determined by using the relevant elements of vectors C(t), C^Ct), Rx  and 
OR^ as follows: fo r consumption,
OR
P = R C (t)
KX KX K
KX R > 0
KX
(3.20)
and fo r production,
OR
P = R C (t)
KX KX CKX
KX R < 0.
KX
(3.21)
Where R is an element of the medium ra te  vector, R , and is the ra te  KX x
constant fo r the tran sp o rt of component K into a cell; and 0RKX is an 
element of vector ORx > aad is the order of the process fo r the tran sp o rt of 
component K in phase X. A mass balance can now be w ritten  fo r component K
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in the medium,
F C (t) = F C (t) + V(t) 
I IK K KX
C (t),C (t,T ),R 
K CKX X KX
X=1
n  (t,T ) d x  X X
dt V(t) CK(t) (3.22)
The accumulation term  can be expanded,
F C (t) = F C (t) + V(t)
I IK K KX
C (t),C (t,T ),R
K CKX X KX
0 < T < T X x
n (t,x  ) dx x x
x=i
dC (t)
+ V(t) -------—  + C (t) dV(t)d t k d t (3.23)
Substituting in Equation 3.11 and rearranging  yields an expression fo r the 
ra te  of change of the concentration of component K,
dC (t) F (t)
K I
dt V(t) c y t )  -  c K(t)
KX
C (t),C (t,x  ),R
K CKX X KX
n (t,x  ) dx X X I
X=1
3.4.5 In tr a -c e llu la r  Component Mass Balance
(3.24)
Consider a system, w ith Z in tra -ce llu lar components. Let PCLX
average net in ternal production ra te  per cell of in tra-ce llu la r component
L. This may be determined by using the relevant elements of vectors Cc (t),
R and OR as follows: cx  cx
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z /■ i Z
OR OR
^  \ _ ^ CKLX \ „ ^ CLKXp = ) R C - > R CCLX / CKLX CKX CLKX CLX
*
J = 1 t. j
I t
J = 1 l J
(3.25)
Where R and R are  elements of vector R , representing the ra teCKLX CLKX CX
constant fo r the conversion of component K to component L and component L
to  component K respectively; C and C are  elements of vector C , K ckx clx c
representing the in tra-ce llu lar concentrations of components K and L;
OR and OR are  elements of vector OR representing the order of the CKLX CLKX CX
conversion from  component K to  component L and from  component L to 
component K, w ith respect to  the in tra-cellu lar concentrations of K and L. 
The ra te  of change of the in tra -ce llu lar concentration of component L can 
now be calculated from  the ra te  of transpo rt of component L and the ra te  of 
in tra -ce llu la r production of component L,
dC ( t ,T  )
clx  x  p
d t LX
3.4.6 Cell C ontents a t  th e  S ta r t  o f a  Phase
C (t),C (t,T ),R 1 + P (c  (t ,x  ),R ] .  (3.26)L CLX X LXJ CLX CX X CXj
All the cells which s ta r t  a particu lar phase a t time t  are  assumed to  be in 
the same s ta te ; th is  is the average of the s ta te s  they had when leaving 
th e ir  previous phases. As such, the average cell contents a t the s ta r t  of 
each phase, CcL(t,0), is given by the sum of the average cell contents of 
the cells which leave all the cell cycle phases divided by the to ta l number 
of cells which join phase X. Therefore,
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If th is is an unacceptable assumption then two or more sim ilar phases can 
be assumed to  operate in parallel.
3.5 THE SOLUTION OF THE MODEL
F irst, consider the generic expression fo r the change in cell concentration 
fo r cells of a p articu la r age (Equation 3.12). This may be rew ritten  as 
f  ollows,
3n ( t ,x  ) 3n ( t , x  ) F 
x  x  x x  I
—  +  -at dx v ( t ) n (t,T ) -  n (t,x  ) IX x  x  x
-  nx( t , r x) £  F jx (Tx,Cc(t,Tx),C(t) (3.28)
i =1
This is a f irs t-o rd e r  quasi-linear hyperbolic p a rtia l d ifferen tial 
equation. Now, consider the to ta l derivative fo r n ^ t.x^ ),
3n ( t ,x  ) 3n ( t ,x  )
. . .  x X X X X ,
“VW = —St-----dt + —Si-------dT (3.29)
rearranging
dn ( t ,x  ) 
x  x
dt
3n ( t ,x  ) 3n ( t , x  ) ,
x  x  x  x  dx
3t + dr d t (3.30)
By comparing Equation 3.28 with Equation 3.30 it  can be deduced th a t,
dx
d t = 1 (3.31)
dn ( t ,x  ) F 
x  x  I
dt V(t) n (t,x  ) -  IX x
n (t,x  ) \  x x JX x C (t,x  ),C(t)X C x (3.32)
i =1
Equation 3.32 is an ordinary d ifferen tial equation which can be solved 
using a simple numerical technique such as Euler integration,
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dn ( t , x  )
n (t+ S t,r +St) = n (t,T ) +  X -y, X Stx x x x d t (3.33)
therefore,
n (t+St,x +5t) = n (t,T ) + x x x x V(t) n (t,x  ) -  n (t,x  ) IX x  x  x
-  "x'W  XJX T ,C (t,T ),C(t) X C x
i = 1
St. (3.34)
The changes in the medium composition and the cytological s ta te  are  also 
given by ordinary d ifferen tia l equations (Equations 3.24 and 3.26). These 
can also be solved by the application of Euler integration.
For the medium composition,
dC (t)
C (t+St) = C (t) + ---- — St
K K d t
(3.35)
th e re f ore,
C (t+St) = C (t) +K K
F _ (t)
m r (ciK(t) - cK(t)]
x = i
/ X
P |C (t),C ( t , r  ),R I n (t,T ) d r
KX[ K CKX X KX J X X
k. J
(
j
) J
(3.36)
For components in the in tra-ce llu lar pool,
dC (t , t  )
C ( t + S t , T  +St) = C ( t , T  ) +  ------ CL- - , , — —  S t
clx x  clx x  d t
(3.37)
th e re f ore,
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C (t+St,T +5t) = C (t,x  ) + 
clx x clx x LX C (t),C (t,x  ),RL CLX X LX
CLX
C (t,x  ),R ]c x cxj St. (3.38)
Although the solution method applied is relatively simple, the number of 
equations to be solved is potentially large and the order in which they 
must be solved is vitally im portant. This is fu rth e r complicated by the 
number of data  which must be stored during any simulation. G reat care has 
been taken to develop a robust, effic ien t algorithm  fo r th is model. A 
prin tout of the program  used in all of the simulations presented in th is
d issertation  may be found in Appendix A2 and a simplified flow sheet is 
presented in Appendix Al.
3.6 CONCLUDING COMMENTS ^
A generic model has been proposed fo r the cell cycle, CELCYMUS. This model 
consists of the concepts developed in Section 3.3, converted into
m athem atics in Section 3.4. The featu res of th is generic model can be 
summarised as follows:
a) the cell population is described in term s of an age distribution;
b) biological age, t ,  describes the cell age within a phase;
c) a phase is defined as a s ta te  in which all cells obey the same set 
of transition  rules, share the same form s of in teraction with the 
environment and are  performing the same internal operations and 
f  unctions;
d) any number of phases, Np, may be defined;
e) changes in the age distribution resu lt from  cells moving through a 
phase (flow) or cells moving to a d ifferen t phase (transition);
f) transition  may occur a t any point during a phase, depending upon 
the natu re of the se t of events which have been defined to control 
transition  from  th a t phase (the transition  rules);
g) any p articu la r set of transition  rules may be determ inistic, 
stochastic or determ inistic and stochastic in nature;
h) any number of transition  rules may be defined fo r each phase;
i) each transition  rule may resu lts  in one or more independent
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population of cells; 
j) all cells must undergo transition  when they reach a maximum age of 
in phase X; this is always the f i r s t  rule in the transition  rule
set;
k) fo r the convenience of the user in terface  the multi-component
medium is defined in term s of th ree  component categories:
nutrien ts, m etabolites and toxins;
1) the concentration of components in the grow th medium is described 
by the medium s ta te  vector C(t); 
m) cells in d ifferen t phases may in te rac t w ith the growth medium
independently of the behaviour of cells in other phases; 
n) the interactions between the cell population and the growth medium 
are  defined by the medium ra te  vector, R , and by vector OR ;
X  X
o) th ree  categories of in tra-ce llu la r components exist, reflecting  the
medium components make-up. A fourth  se t of components,
interm ediates, also ex ist to  account fo r in tra-ce llu lar components
not encountered in the medium;
p) the in tra-ce llu lar concentration of each of the components fo r
cells of biological age t is described by the cytological s ta te
vector C (t,x  ); and,
CX x
q) interactions between the in tra-ce llu la r components are  defined by 
the cytological ra te  vector, Rcx  and by vector, OR-c x -
This fram ework has been transla ted  into a number of basic mathem atical 
expressions which define the s ta te  the cell population. From these 
expressions th ree  ordinary d ifferen tial equations have been derived which 
describe changes in the cell age distribution (Equation 3.32), changes in 
the composition of the growth medium (Equation 3.24) and changes in the 
cytological s ta te  of the population (Equation 3.26). These ordinary 
d iffe ren tia l equations may be solved using a simple numerical technique 
such as Euler integration (Equations 3.34, 3.36, 3.38).
The next th ree  chapters will consider the application of th is CELCYMUS to 
the cell cycle of a hybridoma cell line, mm321. In Chapter Four a specific 
model fo r th is cell line will be proposed using experim ental da ta  obtained 
from  a series of post-synchronisation cultures.
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A SPECIFIC CELL CYCLE MODEL FOR A HYBRIDOMA CELL LINE
4.1 INTRODUCTION
The next two chapters will consider the development of a specific model fo r
a hybridoma cell line (mm321). This will be achieved by using the generic
(15)model, CELCYMUS, proposed in Chapter Three. Data are  available in the
3
form  of a number of batch cultures carried  out in shake flasks and a 1 dm 
ferm enter and fo r a chemostat; some of the batch cultures were synchronised 
before inoculation.
The specific model will be based upon the analysis of the metabolically 
synchronised cultures. These data  will be used to develop the basic cell 
cycle model which will be solved using CELCYMUS. Many of the param eters in 
the specific model will be determined directly  from  the analysis of 
experim ental data. The remaining param eters will be estim ated by
m athem atically fittin g  the model to the experim ental data. In the next 
chapter the model fu rth e r  developed using conventional batch resu lts  and
other data.
4 .2 THE SYNCHRONISATION OF THE MODEL HYBRIDOMA CELL LINE
A synchronised culture consists of a population of cells which have 
equivalent ages since the ir last cell division. Synchronised cells pass 
through the d ifferen t phases of the cell cycle together. As a resu lt, any 
d ifferences in the behaviour of cells a t d ifferen t points within the cycle 
can be identified more easily. Methods of synchronising cell populations 
have been reviewed briefly  in Chapter Two (Section 2.12.2).
4.2.1 The Thym idine Double Block
The cell line used in all of the experimental work described was a
mouse-mouse hybridoma (designated mm321) producing IgG antibody to
paraquat. Synchronisation of these hybridoma cells was accomplished by
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using a thymidine double block technique*15*. High concentrations of 
thymidine inhibit D.N.A. synthesis, th is prevents any cells in the Gl phase 
entering the S phase and a rre s ts  cells already in the S phase. Therefore, 
the f i r s t  block concentrates the cell population a t the end of the Gl phase 
and throughout the S phase. The cells are  then released from  the block fo r 
long enough to  allow all of the cells to complete the S phase, they are  
then blocked again. This second block concentrates the whole cell 
population a t the end of the Gl phase.
4.2.2 Experim ental Procedure
(15)To block the cells Hayter added 2 mM thymidine to  normally passaged 
cells in mid-exponential growth. The cells were arrested  fo r 30 hours, spun 
down, re-suspended in a thymidine free  medium a t a cell density of
5 -12.5x10 cells ml and then incubated fo r 6 hours. A fter incubation the 
cells were again a rres ted  with 2 mM thymidine fo r a fu rth e r 18 hours and 
then re-suspended a t a density of 2.5xl05 cells ml 1 in a thymidine free  
medium. The grow th medium used was RPMI1640 supplemented with 10% newborn 
calf serum.
4.3 ANALYSIS OF POST-SYNCHRONISATION DATA
The resu lts  obtained from  th ree  post-synchronisation cultures are  presented 
in Figures 4.1, 4.2 and 4.3. All th ree sets of data  broadly exhibit the
type kinetics which are  expected from  a synchronised population: a period 
in which no cell division occurs; a short period in which cells divide 
rapidly; a second, shorter period of no division; and finally, the decay of 
the synchronisation into exponential growth.
One experim ent exhibited a very high degree of synchronisation, th is  data  
is presented in Figure 4.1 (no glutamine data  was available fo r th is 
experiment). However, th is  degree of synchronisation was not always 
achieved and the data  presented Figures 4.2 and 4.3 were more typical.
All th ree  se ts of data  were used to develop a consistent model of the cell 
cycle, which would account fo r as much of these data  as possible. Analysis 
of these th ree  data  sets, allowed a number conclusions to  be drawn about
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the s tru c tu re  and nature of the cell cycle fo r the mm321 cell line. From 
th is inform ation a number of assumptions may be made w ith regard  to the 
specific model fo r th is cell line. For convenience the data  presented in 
Figures 4.1, 4.2 and 4.3 will be re fe rred  to  as data  sets SYNC1, SYNC2 and 
SYNC3 respectively.
4.3.1 Basic Cell Cycle Structure fo r  the Specific Cell Cycle Model
The core of the proposed model is based around the four conventional cell
cycle phases: Gl, S, G2 and M(U). Cells progress around the cell cycle
from  Gl to  S, from  S to G2, from  G2 to M and finally from  M to Gl, a f te r  
cytokinesis.
The thymidine double block, should ensure th a t the entire cell population 
is a t the end of the Gl phase when the cells a re  released from  the block. 
This should resu lt in all of the cells simultaneously in itia ting the S 
phase and, due to  the relative lack of variation in the combined duration 
of the S, G2 and M phases, all of the cells should divide together. It is 
clear from  the viable cell concentration data  fo r each experiment (Figures 
4.1a, 4.2a and 4.3a) th a t th is does not occur.
This may be explained by assuming th a t the Gl phase consists of two parts: 
Gla and Gib. The Gla phase may be a period of time associated w ith the
cells recovery from  mitosis, while the Gib phase may be rela ted  to cell
grow th and the initiation of DNA synthesis. I t is assumed th a t the Gla
phase has a fixed duration. However, the Gib phase is assumed to  be of 
variable duration. It is fu rth e r assumed, th a t once a cell en ters the Gib 
phase, it  is immediately capable of in itia ting  the S phase. Theref ore, it 
is proposed th a t the thymidine double block actually prevents the cells 
from  sta rtin g  the Gib phase. From th is i t  can be concluded, th a t the 
distribution of tim es to mitosis during the f i r s t  period of rapid division, 
is a d irect resu lt of this variation within the Gib phase.
This basic cell cycle s truc tu re  is sim ilar to the transition  probability
model proposed by Smith and M artin(300); where the S, G2, M and Gla phases
represen t the ir B s ta te  and Gib phase represents th e ir A sta te . However,
instead of the cells leaving the A s ta te  to en ter the B s ta te  a t a fixed
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ra te , here the ra te  a t  which cells leave the Gib phase appears to  increase 
as cells progress through the Gib phase.
4.3.2 The Addition o f a Quiescent Phase
It can be seen f  rom the viable cell concentration data  f  or the 
synchronisation experim ents (Figures 4.1a, 4.2a and 4.3a), th a t in each
case a proportion of the cell population does not to  divide over the 
duration of the culture. In the case of data  se t SYNC1, 28% of the 
population appear to  fa ll into th is category; fo r data  set SYNC2, 28% and 
fo r data  se t SYNC3, 22%. However, cell viability remained, a t over 95%, 
throughout all of these cultures*15*; th is was also observed in subsequent 
synchronisation experiments*15*. Therefore, i t  is proposed th a t a fu rther, 
quiescent, phase exists (GO), which appears to  la st fo r a t least the 
duration of the post-synchronisation cultures (32 hours). In th is phase the 
cells remain viable, but do not divide. At present, it  is also assumed th a t 
these cells exhibit only a limited degree of metabolic activity  and no
rules have been defined w ith regard  the in teraction  between th is phase and 
the other cell cycle phases.
4.3.3 The Duration o f the Cell Cycle Phases
The thymidine double block is assumed to  ensure th a t all of the cells are 
a rres ted  a t  the boundary between the end of the Gla phase and the s ta r t  of 
the Gib phase. In the case of the data  presented in Figure 4.1a th is seems 
valid. When these cells are  released f  rom the block, a few  of them 
immediately en ter the S phase. From Figure 4.1a, it  can be seen th a t it 
takes 9 hours fo r the f i r s t  cells to  divide, th is  is the time required fo r
the f i r s t  cells to complete the S, G2 and M phases. Previous 
experiments*15* have estim ated the duration of the S phase to  be about
5 hours. Therefore, the combined duration of the G2 and M phases is
estim ated to be 4 hours. These same cells s ta r t  the second mitosis a f te r  
approxim ately 20-21 hours. It is assumed th a t these cells in itia te  the S 
phase immediately upon entering the Gib phase. Therefore, it  can be deduced 
th a t the duration of the Gla phase must be between 2 and 3 hours. 
Therefore, in the specific model the duration of the Gla phase has been set 
a t 2.5 hours.
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4.3 .4  The In itial Age Distribution
The thymidine double block did not always achieve the degree of 
synchronisation apparent in Figure 4.1a; the data  presented in Figures 4.2a 
and 4.3a were more usual. One of the differences is th a t the time until the 
f i r s t  m itosis s ta r ts  is shorter in Figures 4.2a and 4.3a, another is th a t 
the synchronisation is lost more rapidly. It is proposed th a t the shorter 
in itia l lag is due to  some of the cell population being in the S phase when 
the cells were released from  the second block. This assumption accounts 
fo r, and may also explain, the more rapid loss of synchronisation.
From the data  presented in Figures 4.2a and 4.3a, it  can be seen th a t the
f i r s t  cells s ta r t  to  divide a f te r  about 4 hours. As the combined duration
of the G2 and M phases is also 4 hours, th is observation implies th a t these
cells must have been a t the end of the S phase when they were released from
the block. As a resu lt, it  will be assumed th a t a frac tion  of the cell
population is blocked in the S phase bef ore release and th a t this 
population is evenly distributed over the en tire phase. In the case of data 
se t SYNC2 36% of the initial population are  in the S phase, while fo r data
set SYNC3 39% are  in the S phase.
4.3.5 Glutamine Uptake Kinetics
Figures 4.2b, 4.3b, 4.2c and 4.3c show the glutamine concentration data  and 
the specific glutamine uptake ra te s  fo r data  sets SYNC2 and SYNC3. It was 
observed from  these data, th a t the specific glutamine uptake ra te  appears 
to  vary around the cell cycle. The uptake ra te  drops rapidly to  a minimum 
within the f i r s t  6-8 hours in both cultures; th is  corresponds to  a point
where the m ajority  of the cells are  in the S, G2 or M phases of the cell 
cycle. A second minimum occurs a f te r  about 18-20 hours (this is not as 
c lear fo r  data  set SYNC3), again this corresponds to a point where the 
m ajority  of the cells are  in the S, G2 or M phases. However, a t th is second 
minimum some of the synchronisation has been lost and the drop in the 
specific glutamine uptake ra te  is not as pronounced. From these data  it has 
been hypothesised th a t glutamine uptake occurs predominantly during the G1 
phase of the cell cycle. It is therefore proposed th a t in the specific 
model, glutamine is taken up by the cells during the G1 phase (both Gla and
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Gib) only. The magnitude of glutamine uptake ra te  in these phases cannot be 
determined directly  from  the experimental data. Therefore, it  will be 
determined by f ittin g  the specific model to the experim ental data  (Section 
4.5).
It has been observed th a t glutamine degrades due to hydrolysis in cell free  
medium*60*. The following kinetic equation has been used in the model to 
account fo r the consumption of glutamine by hydrolysis.
r  = -8.917xl0"7 C (t) (4.1)h 1
where
r  = ra te  of hydrolysis (mg ml 1 hr X)H ^
C (t) = glutamine concentration in the grow th medium a t time t  (mg ml )
This expression has been deduced f  rom the analysis of the glutamine 
degradation kinetics in a standard medium*401*.
It has been estim ated, th a t the cells which are  trapped in the Gib phase 
during the second block, spent about 13 to  14 hours, on average, in the G1 
phase before release. It is assumed th a t these cells will take up glutamine 
during th is period a t the normal ra te . Therefore, an estim ate of the 
average in itia l glutamine content of these cells can be made from  the ir 
residence tim e within th is phase and the specific glutamine uptake ra te .
Finally, it  should be noted th a t conventional batch cultures fo r th is cell 
line suggest th a t glutamine uptake follows zero order kinetics w ith respect 
to  glutamine concentration (see Chapter Five). Hence, the specific 
glutamine uptake ra te  is constant throughout the culture.
4.3.6 The Desynchronisation of the Cell Population
It has already been assumed th a t once a cell has entered the Gib phase it 
is immediately capable of initiating DNA synthesis. However, it  is clear 
from  the d istribution of mitoses during the periods of rapid  division, th a t 
even though all the cells are  capable of in itia ting  the S phase, they don’t  
all do so a t once. Therefore, it has been proposed th a t the transition  from
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the Gib phase to the S phase is controlled by some random event w ithin Gib.
The transition  probability model*300* assumes th a t progress to the B -state 
is dictated  by a random event, with the magnitude of th is event being 
constant w ith respect to laboratory time (and biological age); i.e. f i r s t  
order kinetics. However, analysis of data  sets SYNC1, SYNC2 and SYNC3 does 
not suggest th a t such a simple relationship ex ists fo r the mm321 cell line. 
In th is case, the ra te  of in itiation of the S phase appears to increase as 
cells trave rse  the Gib phase.
A number of workers*339,355’365 36S* have suggested th a t cell size may also 
influence the ra te  of transition  to the S phase. Currently in CELCYMUS, 
there  is no direct method of accounting fo r  cell size. However, the 
accumulation of the various medium components can be monitored. The main
source of nitrogen in these cultures is glutamine*60*. As nitrogen is an
essential component of biomass, it  will be assumed th a t the cumulative
amount of glutamine consumed is a measure of the average size of the 
individuals w ithin the cell population. As such, it  is proposed th a t the 
ra te  of transition  to  the S phase, is dependent upon the cumulative
glutamine content of the cells in the Gib phase; measured since these cells 
s ta r ted  th a t phase.
A number of possible form s were considered fo r  the relationship between the 
cumulative glutamine content and the fraction  of cells to have in itia ted  
the S phase. The following quadratic form  was found to  be the most 
successful,
[c  (t,T ) -  S I
_  ( ClGlb G i b_______ Max Jn G lt/t , T Glb^ I^ lb'1' ’ C l ' ^ I (4.2)
n  ( t - T  ,0 )  ■ 2
G i b  G i b  S
Max
The denominator on the righ t hand side was derived from  the boundary
condition a t the s ta r t  of the Gib phase, when the fraction  of cells
remaining is one and the cell content f  or Gib is zero; even though
glutamine is consumed in Gla it is not assumed to  influence the transition .
The param eter S represents the maximum cumulative glutamine content a 
Max
cell may obtain in Gib before it has to  in itia te  the S phase.
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Rearranging and d ifferen tia ting  th is expression we obtain,
dn (t ,x  )
G i b  G i b  _  ,, \ I >^iuiu u i u  maA | _ s= 2 n (t-x  ,0)  L- (4.3)
fc (t , t  ) -  S ]
( ClGlb G i b _______ M x J
dC ( t , T  ) G i b  G i b ’ 0  2
C l G l b  Gib S
Max
Substituting into Equation 4.3 fo r the in itia l number of cells from 
Equation 4.2 and rearranging, an expression can be obtained fo r the 
fraction  of cells of any age which leave, given the ir cumulative glutamine 
content,
dn ( t , T  )
Gib Gib
n ( t , r  )
Gib Gib
2 dC ( t , T  ) 
C l G l b  Gib
C ( t , T  ) -  S
C l G l b  Gib  Max
(4.4)
This is the probability distribution function fo r departure from  within the 
Gib phase,
Gib
t ,C (t,x  ),C(t)
Gib CGlb Gib
2 dC ( t ,T )
C l G l b  Gib
C ( t , T  ) -  S
C l G l b  Gib Max
(4.5)
4.3.7 Antibody Production K inetics
Figures 4.1b, 4.2d, 4.3d, 4.1c, 4.2e and 4.3e show the antibody
concentration and the specific antibody production ra te  fo r all th ree  data 
sets. As w ith the glutamine uptake ra te , the antibody production ra te  
appears to vary around the cell cycle. In each case it  fa lls  to a minimum 
between 7 & 9 hours, th is is 2-3 hours la te r than the minimum in glutamine 
uptake ra te . A second minimum can be observed in all th ree data  sets a f te r  
about 25 hours; again th is is about 2-3 hours la te r than a minimum in the 
glutamine consumption ra te . Therefore, it  would appear th a t antibody
production lags behind glutamine consumption by a period of time 
approxim ately equivalent to the duration of the Gla phase. Therefore, it  is 
proposed th a t no antibody is produced during the Gla phase. Furtherm ore, it 
is proposed th a t antibody is not produced while a cell is preparing fo r
m itosis, during G2 and M. Therefore, in the specific model it  is assumed
th a t cells produce antibody a t a constant ra te  during only the Gib and S 
phases of the cell cycle.
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4.4 CELCYMUS EQUATIONS FOR THE SPECIFIC MODEL
The theoretical basis fo r the cell cycle model of the mm321 cell line has 
been established and is presented schematically in Figure 4.4. This 
inform ation must now be w ritten  in term s of CELCYMUS. The equations must 
account fo r  changes in age distribution, the boundary conditions between 
phases, changes in the growth medium composition and changes in the 
cumulative glutamine content in the Gib phase. F irst, some basic param eter 
values and the initial conditions must be defined.
4.4.1 In it ia l  Conditions and P a ram e te r Values
The cell cycle phase durations and the number of probability distributions 
associated w ith each phase must also be defined, these a re  presented in 
Table 4.1.
Gla Gib S G2 M GO
P h a s e  D u r a t io n  (T) 2 .5
*
>32 5 2 2
*
>32
Number of T r a n s i t io n  R u les (G) 1 2 1 1 1 1
* T h e  m a x i m u m  d u r a t i o n  o f  t h e s e  p h a s e s  a r e  u n d e t e r m i n e d  i n  t h i s  m o d e l
TABLE 4.1
P h a se  D u ra tio n s  a n d  th e  N um ber o f T ra n s i t io n  R u le s
The inoculum size and the initial percentage of cells in the Gib, S and GO 
phases are  presented in Table 4.2. Cells blocked a t the Gla-Glb in terface 
are  assumed to  be a t the s ta r t  of the Gib phase, i.e. in age element 
n (0,0) dx. For data  sets SYNC2 and SYNC3 cells in S are  assumed to  be
Gib
evenly d istributed throughout the phase a t densities of 
1.8xl04 cells ml 1 hr 1 and 1.79xl04 cells ml 1 hr \
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D a ta  S e t
Inocu 1 um 
S iz e  
(C e l ls  ml X)
Cell C y c le  P h a se
G ib S GO
SYNC1 2. 5 x 1 0  5 72% 0 28%
SYNC2 2 . 5 x 1 0  5 36% 36% 28%
SYNC3 2 . 3 x 1 0  5 3 9 % 39% 22%
TABLE 4.2
Inoculum  S ize  and In it ia l C ell C ycle D is tr ib u tio n
The grow th media consists of two monitored components: component one (C ) 
is glutamine, which is defined as a nutrient; component two (C^) is 
monoclonal antibody, which is defined as a metabolite; the initial
concentrations of these components fo r data  sets SYNC1, SYNC2 and SYNC3 are 
given in Table 4.3. The only in tra-ce llu lar component to  be monitored is 
the cumulative glutamine content in the Gib phase. When new cells enter
th is phase th is will be set to zero so th a t the accumulation fo r th a t
population can be monitored. However, a t the s ta r t  of the culture, the 
cells in the Gib phase will have been trapped a t the Gl-Glb in terface  fo r 
an average of 13.5 hours. It is assumed th a t these cells will consume 
glutamine a t the normal ra te  during th is period. Hence, the initial
cumulative glutamine content can be estim ated from  the duration and the 
ra te  constant.
D a ta  S e t
G lu t  am in e  
C oncen t  r a t  ion 
(fig m l " 1)
Ant i b ody 
Concen t  r a t io n  
(fig m l 1)
SYNC1 N ot Ava i 1 a b le 0 . 0
SYNC2 182 . 5 3 . 0
SYNC3 170 . 8 1 . 8
TABLE 4.3
N  V
I n it ia l G lutam ine and A ntibody C oncentrations  
fo r  Data Sets SYNC1, SYNC2 and SYNC3
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4.4 .2  Changes in  Age D is trib u tio n
Equation 3.32 is the generic expression fo r the ra te  of change of the age 
distribution. This may be w ritten  independently fo r each of the proposed 
cell cycle phases. The Gla, S, G2, M and GO phases are  all of fixed 
duration and have the same specific expression:
dn ( t ,T  ) x x
dt = -n  (t,x  ) FX X IX t ,C (t,T ),C(t) x cx  x (4.6)
where
IX
IX
t  ,C (t,T ),C(t) 
X cx  X
T ,C (t,T ),C(t) 
X CX X
= 0
= 1
0 — t  < T
X X
T =  T . 
X X
(4.7)
(4.8)
However, fo r the Gib phase,
dn ( t ,T  ) 
Gib Gib
dt
= -  n (t,x  ) F I t  ,C ( t , r  ),C(t)
Gib G i b  lGlb I Gib CGlb Gib
-  n ( t , T  ) F 
Gib G i b  2Glb
T ,C (t,T ),C(t) 
Gib CGlb Gib
(4.9)
where
F \ t  ,C (t,T ),C(t)
lGlb { Gib CGlb Gib
lGlb
T ,C (t,T ),C(t) 
Gib CGlb Gib
= 0
= 1
0 < x < T
Gib Gib
T = T
Gib Gib
(4.10)
(4.11)
2Glb
I t  ,C (t,T ),C(t){ Gib CGlb Gib
2 dC (t , t  )
C l  Gib
C ( t ,T  ) - S 
C l  Gib Max
(4.12)
4 .4 .3  B oundary Conditions f o r  each  Phase
The boundary conditions are  defined as follows. For the Gla phase,
n (t,0) = p f  n (t,T ) F
Gla lMGla lMGla M M 1M
T ,C (t,T ),C(t) 
M CM M
(4.13)
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fo r the Gib phase,
n (t,0) = p f  n ( t ,T  ) F
Gib lG laG lb lG laG lb Gla Gla lGla
T ,C ( t ,T  ),C(t) 
Gla CGla Gla
(4.14)
fo r the S phase,
n (t,0) = p f  n (t,x  ) F
S 2GlbS 2GlbS Gib Gib 2Glb
T ,C ( t ,T  ),C(t) 
Gib CGlb Gib
fo r the G2 phase,
(4.15)
n (t,0) = p f  n (t,x  ) F
G2 1SG2 1SG2 S S IS Ts-Ccs(t>Ts )*C(t) (4.16)
and fo r the M phase,
n (t,0) = p f  n (t,x  ) F 
M 1G2M 1G2M G2 G2 1G2
T ,C ( t ,T  ),C(t) 
G2 CG2 G2 )■
(4.17)
Where p  and f  a re  the degree of pro liferation  and the fraction  of the 
transiting  population in itia ting a phase, respectively. These are  given in 
Table 4.4
p
lMGla
p
lG laG lb
P
2G lbS
P
1SG2
P
1G2M
2 1 1 1 1
f
lMGla
f
lG laG lb
f
2G lbS
f
1SG2
f
1G2M
1 1 1 1 1
TABLE 4 .4
D egree  o f  P r o l i f e r a t io n  (p) an d  F ra c tio n  I n i t i a t in g  a  New P h ase  ( / )
4 .4 .4  Consum ption o f Medium Components
The following expression may be derived from  Equation 3.24 to  account fo r 
the changes glutamine concentration (component 1),
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dC (t) F _ (t)
dt w  ( c n (t) -  c i ( t ) )
-  P
lG la
C (t),C (t,T ),R
1 CIGla Gla lGla
n (t,T ) dr  
Gla Gla Gla
P C (t),C (t,T ),R
lGlb 1 ClGlb Gib lGlb
n (t,T ) dx 
Gib Gib Gib
(4.18)
As glutamine is only consumed and not produced,
P C (t),C (t,x  ),R
lG la l 1 CIGla Gla lGla
OR
= R C (t)
lG la 1
lG la (4.19)
and
lGlb
C (t),C (t,x  ),R
1 ClGlb Gib lGlb
OR
= R C (t)
lGlb 1
lGlb (4.20)
It is assumed th a t the ra te  of glutamine consumption is independent of the 
bulk concentration (OR and OR are equal to  zero) and th a t glutamine
lG la lGlb n
is consumed a t a constant ra te  throughout the G1 phase. Therefore, , and
P = R and P = R
lG la lG la lGlb lGlb
(4.21)
and
R = R = R
lG la lGlb Glut
(4.22)
R is used fo r  ease of notation through the re s t of the tex t.
Glut
Changes in antibody concentration are  given by component two,
dC (t) F (t)
2 I
dt V(t) C (t) -  C (t) 12  2
-  P
2Glb
C (t),C (t,x  ),R
2 C2Glb Gib 2Glb
n (t,T ) dx
Gib Gib Gib
-  P
2S
C (t),C (t,x  ),R
2 C2S S 2S
n (t,x  ) dx s s s (4.23)
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It is assumed th a t the antibody production ra te  ra te  is also zero order and 
constant throughout the Gib and S phases. Therefore,
R = R = R (4.24)
2Glb 2S Anti
Again, R is fo r ease of notation.
Anti
4.4.5 Cumulative Cell Contents
The average cumulative glutamine content of individual cells in the Gib 
phase must be accounted for. The ra te  of glutamine accumulation is given 
by,
dC (t , t  )
C lG lb Gib _  p
d t ~ lGlb C (t),C ( t ,T  ),R 1 ClGlb Gib lGlb (4.25)
th e re f ore
dC ( t , T  )
ciGib Gib _ R # (4.26)
d t Glut'
As the probability distribution employed to account fo r Glb-S transition  is 
only dependent on the glutamine accumulated in Gib, the boundary condition 
is,
C (t,0) = G (4.27)
ClGlb
4.4.6 Prelim inary Simulation
Before fittin g  the model to  experimental data  it  was im portant to  establish 
th a t the model would exhibit quantitatively correct behaviour. A simulation 
was conducted w ith a a rb itra ry  set of param eter values; in th is simulation 
the en tire  cell population is assumed to  be a t the Gla-Glb in terface. The 
viable cell concentration data  generated fo r th is simulation are  presented 
in Figure 4.5. It is clear th a t over the simulation period of 50 hours, the 
f  our d istinct periods typical of a post-synchronisation culture are 
present: a period during which no cell division occurs; a period during
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which cells divide rapidly; a second, shorter period of no division; and 
finally, the decay of the synchronisation into exponential growth.
The glutamine and antibody concentration data  (not shown) also exhibit the 
kinetics expected of post-synchronous growth. In the early  p a rt of the 
culture the specific consumption (or production) ra te  varies markedly. 
However, as the culture progresses and the degree of synchronisation 
decreases, th is variation reduces dram atically until, during exponential 
growth, the specific ra te  a tta in  constant average values.
These data  suggest th a t the specific model built from  CELCYMUS is capable 
of describing quantitatively the kinetics of data  sets SYNC1, SYNC2 and 
SYNC3. Furtherm ore, the model may be f itte d  to  the experim ental data  in 
order to determine the remaining unknown param eters values.
4.5 OPTIMISATION OF THE REMAINING MODEL PARAMETERS
Many of the param eters in the specific model have been obtained from  the 
d irect analysis of the growth of the post synchronisation cultures. 
However, it  was not possible to  estim ate all of the param eters in th is way. 
Three param eters have been identified in the specific model, which must be 
obtained by f ittin g  the model to the post synchronisation data. These 
param eters are  the specific glutamine uptake ra te , ^ G1 t » ^ e specific 
monoclonal antibody production ra te , R and the maximum amount of 
glutamine a cell can consume during the Gib phase, before i t  has to  proceed 
to the S phase, S
Max
These param eters have been determined by minimising a  general sum of the 
e rro rs  squared function, $, Equation 4.25. This function has been optimised
(402)using a NAG library  minimisation routine, E04CCF (folding polygon 
method).
$ =  —
a =  1
/  Ba
EXP -  MODEL
(a ,b )  (a ,b )
\
2
B )  
a L - J
b =1V.
EXP
( a , b )
j
(4.28)
This general expression will determine the sum of the e rro rs  squared fo r
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any number of data  sets, A, each containing any number of data  points, B .
a
4.5.1 Optimising R and S
Glut Max
For data  se ts SYNC2 and SYNC3, the specific glutamine uptake ra te , R ,
Glut
and the maximum amount of glutamine any cell can consume before i t  must 
leave the Gib phase, , were optimised simultaneously by f ittin g  the
model to  both viable cell concentration and glutamine concentration. For 
data  se t SYNC1, R and S were optimised by fittin g  the model to  the
Glut Max
viable cell concentration data only (no glutamine data  were available fo r 
th is experiment). The optimised values of these param eters and the value of 
the sum of the e rro rs  squared function fo r th is optimisation, $ , are  
presented in Table 4.5.
It is clear th a t there is some variation in the optimised values of R
^  Glut
and S between each data set. However, the values are  of the same
Max
magnitude.
D a ta  Set R G l u t
( m g  c e l l  1 h r  *)
S
M ax  
( m g  c e l l  )
$ l
(No u n i t s )
SYNC1
001OiXo00 3 .2 7 1  x lO -7 3 . 0 8 0 x l0 -4
SYNC2 1 .550x10  8 2 . 7 6 3 x l0 -7 2 . 199xl0~ 4
SYNC3 l.O lO x lO "8 1 .644x1O '7 3 .0 3 1 xlO -4
TABLE 4.5
The O ptim ised  V alues o f R and S fo r  Data S ets SYNC1, SYNC2
--------------- ------------------------------------------------ G lu t---------------M ax--------------------------------------------------- --------------------
and SYNC3 and th e Value o f th e  Error F u n ction , $  ; - 1
4.5.2 Optimising R
Anti
The specific antibody production ra te , R , has been determined by
Anti
f ittin g  the antibody concentration predicted by the model to  the
experim ental antibody concentration data only. In each case the previously
determined values of R and S were used in the simulations. The
Glut Max
resu lts  of th is fittin g  exercise fo r data se ts SYNC1, SYNC2 and SYNC3 are 
presented in Table 4.6 together with the values of the sum of the e rro rs
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squared function,
D a ta  Set RA n t i
(mg ce 11 1 h r *)
$ 2
(No u n i ts )
SYNC1
SYNC2
SYNC3
1. 7 2 3 x l 0 -8
1 . 0 8 1 x l 0 " 8 
1. 16 8 x l 0 ~ 8
9 . 9 4 8 x l0 " 4 
2 . 3 6 6 x l 0 -4 
1 . 7 0 7 x l 0 -3
TABLE 4.6
The O ptim ised  V alues o f  R fo r  Data D ets SYNC1, SYNC2 and  
--------------- L ---------------------------------------------- A n t i---------------------------------------------------- :------------------------------
SYNC3 and th e  Value o f th e  Error F u n ction , $ --------------------------------------------------------------------------- :— 2
In th is case the values of R determined fo r data  sets SYNC2 and SYNC3
Anti
are  very close. However, the value obtained fo r data  se t SYNC1 is 
considerably higher, although it  is of the same magnitude.
4.5.3 Optimisation Results
Figures 4.6, 4.7 and 4.8 show the experim ental data  fo r data  sets SYNC1, 
SYNC2 and SYNC3, together w ith the predictions generated by the specific 
cell cycle model as a resu lt of the fittin g  exercise. In each case the 
model has successfully simulated the initial lag phase, the period of rapid 
growth, the interm ediate period of no growth and the subsequent 
desynchronisation in the viable cell concentration (Figures 4.6a, 4.7a and 
4.8a). The simulations of glutamine concentration (for data  se ts SYNC2 and 
SYNC3, Figures 4.7b and 4.8b) have failed to  account fo r a period of 
apparent glutamine production which was observed during the f i r s t  10 hours 
of each culture. However, both simulations yield approximately the righ t 
final glutamine concentration, but do fa il to account fo r the magnitude of 
the variation in glutamine consumption ra te  around the cell cycle. In the 
case of the antibody data  (Figure 4.6b, 4.7d and 4.8d), all th ree
simulations predict a distinct drop in antibody production ra te  a f te r  about 
10 hours (Figures 4.6b, 4.7d and 4.8d).
The f i ts  to  data  se t SYNC2, fo r viable cell concentration, glutamine 
concentration and antibody concentration are  sa tisfac to ry  (Figures 4.7a,
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4.7b and 4.7d). The f i t  to  data set SYNC3 fo r cell concentration and 
antibody concentration is also sa tisfac to ry  (Figures 4.8a and 4.8d).
however, the f i ts  to  the cell concentration and antibody concentration data 
fo r data  se t SYNC1 are  less so (Figure 4.6a and 4.6b); in both cases there 
is considerable disagreem ent tow ards the end of the culture. The f i t  to  the
glutamine concentration fo r data  set SYNC3 is the least sa tisfac to ry  of the
f i ts  (Figure 4.8b).
The antibody production ra te  and glutamine consumption ra te s  predicted by 
the model have also been compared to  the experim ental ra te  data. The 
experim ental ra te  data  have been estim ated by the numerical d ifferen tiation  
of the concentration data. It should be pointed out th a t numerical
d ifferen tia tion  is a d ifficu lt and inaccurate procedure, however it  is
useful in identifying d istinct trends.
In the case of glutamine consumption ra te , the comparison between the 
numerically d ifferen tia ted  data  and the predicted data  is unsatisfacto ry  
(Figures 4.7c and 4.8c). In both cases the numerically d ifferen tia ted  data  
suggests th a t glutamine is produced early in each experiment; the cu rren t 
model is not capable of predicting th is behaviour. It is also clear th a t
the magnitude of the variation in the consumption ra te  is f a r  more marked 
in the d iffe ren tia ted  data.
The antibody production ra te  data  compares much more favourably (Figures 
4.6c, 4.7e and 4.8e). In the case of data sets SYNC2 and SYNC3 the position 
and magnitude of the maxima and minima have been predicted sa tisfac to rily  
(Figures 4.7e and 4.8e). For data  set SYNC1 the comparison is not as good, 
however the f i r s t  minimum is in the righ t place.
A quantitative measure of each f i t  is given by the values of the sum of the
erro rs  squared, S^and $2 (see Tables 4.5 and 4.6). The sm allest values of
$ and $ w ere obtained fo r the f i t  to  data se t SYNC2. In the case of data  
1 2
set SYNC3 the value of $ is 37.8% larger, while the value of $ is over
1 2
7.2 tim es larger. For data set SYNC1, ^  is 40% larger, while $2 is 4.2 
tim es larger. Both, the qualitative and quantitative evidence suggests th a t 
the f i t  the da ta  se t SYNC2 is the most successful. The f i t  to  da ta  se t 
SYNC3 being less successful and the f i t  to data  se t SYNC1 being the least
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successful.
4.5.4 C onfidence C ontours
Confidence contours have been generated fo r the simultaneous optimisation 
of R and S fo r  each data set. These contours have been generated by
Glut Max
evaluating the e rro r  function, ^  over a range of values fo r R  ^ and
S . A contour is placed on th is grid fo r values of $ which correspond to 
Max 1
the 95% and 99% confidence limits. The values of $ which correspond to 
these levels of confidence have been estim ated from  the following 
expression (see fo r example Draper and Smith(403)),
$ = $ [ l +  E  F (p ,n -p ,l-q ) ] (4.29)q m  ^ n -  p J
where,
$ = the value of the e rro r  function a t a confidence level of 100(l-q)%;
q
$ = the minimum value of the e rro r function;m
p = the number of param eters;
n  = the number of observations; and,
(404)F = the F -distribution as tabulated in s ta tis tic a l tables
The confidence contours corresponding to the 95% and 99% confidence lim its 
are  presented fo r each f i t  in Figure 4.9. The m ajor axis of the 95% and 99% 
contours fo r data  se t SYNC1 both lie a t an angle of 45° to  the y-axis 
(Figure 4.9a); these contours appear to be unbounded along th is axis. For 
data  se t SYNC2 the m ajor axis of each contour lies a t an angle of about 10° 
to  the y -ax is (Figure 4.9b). It is clear th a t the value of R has been
J Glut
found more accurately than th a t of S ; a t a confidence level of 99% the
J  Max
value of R has been found to  within +8% and -7%, while fo r  the same
Glut
confidence level S has been determined to  within +24% and -17%. The
Max
contours fo r data  se t SYNC3 lie a t an angle of 30% to  the y-axis. As with
data  se t SYNC2, R has been determined to  a g rea te r degree of accuracy
Glut
than S ; a t a confidence level of 99% R has been determined to within
Max Glut
+10% and -8% and S to within +25% and -6%.
Max
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4.6 SENSITIVITY ANALYSIS ON THE MODEL PARAMETERS
A sensitivity  analysis was carried  out on the model param eters. This
identifies the param eters which have the most significant e ffec t upon the
e rro r  functions, $ and $2> and hence the param eters which may have to  be 
optimised by m athem atically fittin g  them to the experim ental data. The
sensitivity  of the model to variations in integration step length has also
been investigated.
4.6.1 Sensitiv ity  Analysis on the a ll o f the Model Parameters
A sensitivity  analysis has been conducted on all of the model param eters. 
Each param eter is varied by ±10% and the resu ltan t values of $ and $2 are 
compared w ith th a t a t the 90% confidence lim it (see Table 4.7), th is will 
highlight other param eter which may require optimisation; a t 90% confidence 
the value of $ is 16% g rea te r than a t the minimum, while $2 19% greater.
The most significant variation in $ is observed when the in itial inoculum
level or glutamine concentration is varied. However, as these initial 
values are  taken directly  from  the experim ental data  these represent the 
best guess fo r these param eters, as such these param eters will not be 
optimised. The next most significant e ffec t is when p  , the degree of
lMGla
proliferation , is reduced by 10%. A sim ilar resu lt would also be observed
if it  were rea lis tic  to increase p  by 10%. There is no evidence to
lMGla J
suggest th a t a significant proportion of the cells fa ils  to  divide 
successfully. Therefore, it  is not proposed th a t P M(J shall be optimised.
As expected, variation in R  ^ resu lts  in a significant change in $ .
However, the model appears relatively insensitive to  S . The relationship
Max
between the proportions of cells which s ta r t  in phases Gib, S and GO has 
also been investigated; in order to  m aintain an initial inoculum of 100% 
these param eters had to be varied in combination. These data suggests th a t 
the model is sensitive to the. ra tio  of the proportion of cells which are 
cycling (i.e. s ta r t  in Gib or S) to those which are  not (i.e. GO cells). 
Increasing the duration of the S phase also appears to  have a significant 
e ffect, while reducing th is phase has a much sm aller e ffec t (regardless of 
the change in age distribution). Therefore, the re  may be some scope fo r
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P a ra m e te r V a r ia t io n
f *  1
- L - i
 ^ i  ;
xioo f *  12 -1  xlOO 
 ^ 2
Comments
R
Glut
+107o +43% + 14%
-10% +47% -11%
s Max
+10% +6% -24%
-10% + 11% +52%
R
Anti
+10% 0% + 174%
-10% 0% + 173%
T G la
+10% +4% -5%
-10% -4% +37%
T
G i b
+10% -6% +7%
-10% + 1% +3%
T
S
+10% +29% -34% N o C h a n g e  
i n t h e  
I n  i t  i a l  
C e l l  Di  s t .
-10% + 11% +53%
T s
+10% +38% -44% I n  1 t  1 a 1 
C e l l  D i s t .  
A 1 t  e r e d-10% + 13% +85%
T
G 2
+10% +4% -5%
-10% -1% +21%
T
M
+10% +4% -5%
-10% -1% +21%
T
GO
+10% 0% 0%
-10% 0% 0%
2
P  2 3
-10% +69% +4% p 2 =£2 
2 3
c °
c
+10% +3% +23%
-10% 0% +21%
T ab le  4.7: Continued overleaf
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T able 4.7: Continued
P a ra m e  t e r V a r ia t io n
f $ 1
1 -i
*°l
xlOO
$
2 -1  xlOO
$° 
v 2
Comments
% G 1b/S
+10 7o + 27. +267.
-10% + 1% +24%
%G1b/GO
+10% + 5% +277.
-10% + 21% +517.
% S / G l b
+10% + 2% +247.
-10% + 1% +267.
7oS/G0
+10% + 12% +537.
-10% +28% +287.
7oG 0/G lb
+10% + 14% +317.
-10% + 2% + 137.
7oGO/S
+10% + 18% +137.
-10% + 6% +337.
I n i t i a l  
I n n o  c u m l  u m  
D e n s  i t  y
+10% + 141% + 1757.
-10% +2037. +1747.
I n i t i a l
G l u t a m i n e
C o n e .
+10% +3777. 07.
-10% +293% 07.
I n i t i a l  
A n t i  b o d y  
C o n e .
+10% 07. -47.
-107. 07. +487.
TABLE 4.7
A Sum mary o f th e  S e n s it iv ity  A n a ly sis  Conducted on 
a ll o f  th e  Param eters in  th e S p e c if ic  C ell C ycle Model
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fu rth e r  optim isation of these param eters.
The most significant variation in $ is observed when R or the initial
& 2 A n t i
inoculum is varied. However, the variation due to the initial inoculum
change is simply a side effec t of increasing the size of the cell
population. The only param eters in the model which will d irectly  influence
the antibody concentration independently are  R and the durations of the
Anti
Gib and S phases. It is clear from  Table 4.7 th a t R does have a
^  Anti
significant effect. The duration of the Gib phase has very little  effect,
however the duration of the S phase does have a significant effect.
4.6.2 Sensitiv ity  o f the Model to Variations in the Integration Step Length
Experiments w ere conducted on the model in order to  establish the optimum 
d iscrete time interval or step length, St. As St decreases the accuracy of 
the model increases, however the demand on the CPU (central processing 
unit) also increases, as does the potential fo r  e rro rs  in floating point 
arithm etic. Therefore, an optimum step length ex ists which provides a 
suitable degree of accuracy, while utilising a reasonable amount of CPU 
time.
To determine the optimum St, R and S have been simultaneously
^  Glut Max J
optimised over a range of values of St using data  se t SYNC2. These 
experim ents will also determine how sensitive the optimised value of each 
param eter is to  variations in St.
The resu lts  obtained in these experiments are  presented in Table 4.8. The 
value of St was varied from  60 minutes to  1 minute; w ith the interval 
between subsequent S t’s being reduced as St got smaller. It is clear th a t 
both R and S get sm aller as St decreases. Furtherm ore, the optimised
Glut Max
value of the e rro r  function, $ , also decreases w ith St. However, the re  isl
a substantial increase in the CPU demand per hour of simulation time as St 
decreases, particu larly  below a St value of 6 minutes. As a resu lt of these 
simulations a step length of 6 minutes was selected fo r all subsequent 
simulations presented in th is dissertation.
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St
(Hours)
R
G l u t
(ml c e l  1 1 hr *)
S
M ax
(mg c e l  1 )
E r r o r
F u n c t i o n
( $ x )
CPU Ti me  ( s ) /  
Hour Sim.  
Ti me
1 . 0 0 1. 6 0 3 x l 0 -8 3 . 3 8 4 x l 0 -7 7 . 8 9 0 x l 0 -3 0 .  1 6 3 7
0 .  5 0 1 . 5 5 9 x l 0 -8 2 .  9 8 8 x l 0 -7 7 . 7 6 7 x l 0 -3 0.  2 0 3 1
0 . 3 3 1 . 5 6 9 x l 0 -8 2 .  969x10 -7 7 . 4 0 1 x l 0 -3 0 . 2 1 2 2
0 .  25 1 . 5 5 3 x l 0 -8 2 . 5 8 8 x 1 0 -7 7 . 5 5 9 x l 0 -3 0.  2 4 5 4
0.  2 0 1 . 5 5 8 x l 0 -8 2 .  8 6 4 x l 0 -7 7 . 3 9 2 x l 0 -3 0 .  2 8 7 9
0 .  10 1 . 5 5 0 x l 0 -8 2 .  763x10 -7 7 . 4 7 6 x l 0 -3 0 .  3 4 2 4
0 . 0 5 1. 5 5 0 x l 0 -8 2 . 7 6 3 x l 0 -7 7 . 4 5 5 x l 0 -3 0 . 5 3 9 4
0.  0 3 3 1. 5 4 9 x l 0 -8 2 . 7 4 1 x l 0 -7 7 . 4 5 0 x l 0 -3 1. 6 2 4 1
0 . 0 1 7 1. 5 5 0 x l 0 -8 2 .  735x10 -7 7 . 4 4 3 x l 0 -3 3 .  3 4 8 0
TABLE 4.8
The E ffe c t  o f In tegration  Step Length on th e  O ptim ised  
V alues o f  R and S and on th e  CPU Tim e R equirem ent
— — — — —  G lu t-------------- Max 1 ■ 1 '■
4.7 DISCUSSION
This discussion is divided into two parts , the validity of the models
assumptions and the perform ance of the model.
4.7.1 The Model’s Assumptions
The division of the G1 phase into two distinct periods, in th is case Gla 
and Gib, has been employed in many other cell cycle models; most notably in 
the transition  probability model of Smith and Martin*300*. The idea of an 
approxim ately constant period of time a f te r  mitosis, during which a cell 
can recover from  th is process, is intuitively appealing. Indeed, th is point
(207 208)has been highlighted by a number of researchers ’ . However, there  is
also a certain  amount of circum stantial evidence which can be used to
support th is  theory. Despite the inherent variability  in the G1 
phase*220-237,248 254), there are very few documented cases (outside the 
study of embryo’s) of mammalian cells which can immediately in itia te  DNA
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synthesis a f te r  mitosis. It should also be emphasised th a t there  is a
d istinct, and relatively constant, period of time which is required to
fac ilita te  the process of mitosis; th is period commences sometime in G2 and 
encompasses the whole of M. Therefore, it  may reasonable to assume th a t 
there  is sim ilar period of time which is required to  dismantle the
(207)machinery of mitosis and reo rien ta te  the cell
An im portant fea tu re  of the proposed specific model is the nature of the 
random transition  from  the Gib phase to  the S phase. There is much evidence 
in the lite ra tu re , to support the theory th a t the regulation of progress
around the cell cycle, is controlled by a random event in the G1
phase(299,300,325_330); th is subject has been reviewed in Chapter Two
(Section 2.13.4). In the proposed model, th is concept has been modified by 
re la ting  the magnitude of the probability of th is  event occurring to cell 
size; cell size being measured in term s of the cumulative amount of
glutamine consumed by individual cells since entering the Gib phase, by
virtue of the role of glutamine as the m ajor nitrogen source.
The reason fo r  the modification to  the transition  probability approach, is
th a t fo r th is cell line, the ra te  of transition  from  Gib to  S appears to 
increase as cells progress through the Gib phase. A number of 
workers*339’355,365 368) have concluded th a t cell size is an im portant
param eter in the transition  from  G1 to  S and th a t cells can only in itia te  
th is  transition  once they have attained a minimum size. It has also been
proposed th a t i t  is a critica l protein content th a t governs th is control 
point(369,370). As sta ted  above, glutamine, as well as being a m ajor energy 
source, is also the m ajor source of nitrogen fo r  these hybridoma cells;
nitrogen is an essential constituent of new biomass, in p articu la r new
protein. Therefore, it seems reasonable to  assume th a t the cumulative 
amount of glutamine consumed by the cells is d irectly  rela ted  to  the ir 
average protein content. If th is is the case there  must also be a 
relationship between the amount of glutamine consumed and the ra te  of 
transition; th is is the assumption made in the model. The nature of the
relationship between the probability of the random event and the cumulative 
glutamine content has been arrived a t empirically. At present there  is no 
theoretical basis underlying the proposed relationship.
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The addition of a quiescent phase to account fo r the cells which did not
divide is also contentious issue. Even though the existence of
non-d ifferen tiated  cellular s ta tes , external to  the cell cycle, has been
(302)established, the ir tru e  physiological nature s till rem ains unclear . It
is apparent from  the data  under consideration th a t in each case a certain  
frac tion  of the cell population did not divide (between 20% and 30%) during 
the course of each culture. There is some evidence from  the fittin g
exercise th a t the model underestim ates the viable cell concentration in the 
la st few  hours of each culture. This evidence is circum stantial, however it 
does point to  the existence of a non-prolif erating, but viable cell
population, which is slowly re-en tering  the cell cycle. If th is  is the 
case, and cells are  re-en tering  in the Gib phase, then the minimum recovery 
period from  th is s ta te  is between 18 and 22 hours.
It is evident from  the experimental data  available (Figures 4.2c and 4.3c) 
th a t the glutamine consumption ra te  does vary around the cell cycle. It is 
accepted th a t glutamine consumption is likely to  occur in all cell cycle 
phases, however the available evidence suggests th a t it  occurs mainly 
during the G1 phase. It has also been suggested above, th a t glutamine plays 
a key role in determining the protein content of the cells and hence th a t 
ra te  of transition  from  G1 to S. This assumption presupposes a m ajor role 
fo r glutamine in the cell cycle regulation of th is cell line. On this 
basis, i t  has been assumed in the model th a t glutamine is only consumed
during the G1 phase of the cell cycle. The kinetics of the consumption have 
been determined from  conventional batch culture (see Chapter Five). This is 
indicates zero order kinetics w ith respect to  glutamine concentration and 
f i r s t  order w ith respect to cell concentration, i.e. the specific glutamine 
uptake ra te  is constant.
The experim ental data  also suggest th a t antibody is produced predominantly 
in the la te  G1 and S phases of the cell cycle and in the proposed model 
la te  G1 is assumed to  be the Gib phase. This correlates fa irly  well with
other experim ental data. Work on other cells lines suggests th a t antibody
synthesis occurs predominantly in the G1 phase(12,13,17) and th a t secretion
. , (13,14,16) . -(12,13,17) , . . .  . .,(1 2 ,1 7 )occurs in la te  G1 , in S and possibly in G2+M . It
is apparent th a t antibody accumulates in the cell before it  is
(12 13 17)secreted * ’ . This may explain the lag between glutamine consumption,
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in Gla and Gib, and antibody secretion, in Gib and S, assumed in the model.
There is some evidence which suggests th a t antibody secretion may also 
occur in G2 and be less pronounced in la te Gl. Compare the predicted and 
experim ental antibody production ra te  data (Figure 4.6c, 4.7e and 4.8e). 
Although not as apparent in Figure 4.6c, in Figures 4.7e and 4.8e there  is 
a d istinct o ff-se t between the maxima and minima a f te r  the f i r s t  doubling. 
It is apparent th a t the model predicts maxima and minima about two hours 
before they are  observed experimentally. However, in all th ree cases the 
f i r s t  minima is predicted correctly. A possible explanation fo r th is is 
th a t during the thymidine block antibody accumulates to  a level which 
fac ilita te s  secretion while the cells are held in Gl. Upon release th is 
antibody is secreted suggesting a high production ra te  during Gib and S. 
However, in the next cycle new antibody has to be synthesised once more, 
th is occurs in Gl and the antibody is secreted la te r  than previously in S 
and G2. Due to  the inherent e rro rs  of numerical d ifferen tiation  i t  is only 
possible to  speculate on th is as a possibility. Clearly the model has been 
f itte d  very well to  the experimental data with the cu rren t assumptions and 
these are  broadly supported by other experimental data. F urther experiments
would be required to  prove th is supposition.
4.7.2 The Model’s Performance
The most significant discrepancy between the behaviour of the model and the 
experim ental data  is observed in the glutamine concentration over the f i r s t  
10 hours. This discrepancy is apparent fo r both data  se ts SYNC2 and SYNC3. 
The experim ental data  suggests th a t glutamine is initially  consumed by the 
cells, in the case of data  set SYNC2 a t a very high ra te , and is 
subsequently released back into the medium. This over-consumption may be a 
consequence of the thymidine block. One possible explanation f  or th is 
phenomenon may be as follows: once the cells are  released from  the block 
they will consume glutamine rapidly, but because they have continued to 
consume glutamine during the a rre s t period they will now steadily
accumulate an excess of in tra-cellu lar glutamine. This excess is 
subsequently released back into the medium unmetabolised. At present, th is 
release phenomenon is not accounted fo r within the specific model; what
e ffec t the neglect of th is phenomenon has had on the optimised values of
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R and S will be assessed in the light of subsequent simulations. 
Glut Max
However, i t  should be noted th a t the prediction of the glutamine 
concentration in the la tte r  p a rt of the post-synchronisation culture is 
sa tis f  actory.
The perform ance of the model in predicting viable cell concentrations fo r 
post-synchronisation cultures has been very good. The model is capable of 
reproducing all of the key featu res identified in post-synchronisation 
culture: a period in which no cell division occurs; a short period of rapid 
cell division; a second period of no cell division; and, the decay of the 
synchronisation into exponential growth. However, some discrepancy is 
apparent in the f i ts  to  all th ree data  se ts tow ards the end of each 
culture; the prediction fo r viable cell concentration appears to  be 
slightly too low, th is is particu larly  apparent in data  set SYNC1. As 
mentioned earlier, th is may be due to cells trapped in the GO phase
sta rtin g  to  en ter the main cell cycle; as yet no account is taken of th is 
behaviour.
There is a considerable variation in the values of the optimised param eters 
between the th ree  data  sets. However, in both qualitative and quantitative 
term s the f i t  to  data  set SYNC2 is the most successful. Analysis of the 
confidence contours derived fo r each fittin g  exercise reveals more
inform ation about the param eter values.
In the case of data  set SYNC1 the m ajor axis of the 95% and 99% confidence
contours lie a t angle of 45° to the y -ax is and also they appear to  be
unbounded along th is axis. This suggests a significant amount of
co-variance between the param eters R and S . Indeed, closer
Glut Max
inspection of the values of $ along th is axis reveal th a t they are  all the
_7
same, 7.888x10 . This explains the unbounded nature of these contours and 
fu rtherm ore i t  means th a t the optimised values of R and S are
Glut Max
unreliable. However, fo r the f i t  to data  se ts SYNC2 both confidence
contours lie a t an angle of 10° to the y-axis, respectively; th is  suggests
very little  co-variance between R and S . While the contours fo r data
Glut Max
set SYNC3 lie a t 30°, indicating some co-variance but not as much as th a t 
apparent from  data  se t SYNC1. Furtherm ore, fo r da ta  sets SYNC2 and SYNC3, 
the contours indicate th a t both param eters have been determined to  w ithin
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reasonable limits.
The only difference in the fittin g  exercise between data  sets SYNC2 and
SYNC3 as compared to data  se t SYNC1, is th a t in the case of data  set SYNC1 
the model was f itted  to viable cell concentration data only (no glutamine 
data  was available). While fo r data  sets SYNC2 and SYNC3 the model was 
simultaneously f itted  to  both viable cell and glutamine concentration data. 
It would appear th a t the simultaneous f i t  to  both viable cell and glutamine 
concentration uncouples the co-variant behaviour of R and S . The
Glut Max
quality of the glutamine data  may also be an im portant facto r. There is 
significantly less variation in the glutamine da ta  fo r  SYNC2 than fo r
SYNC3. Less noise would appear to  reduce the amount of co-variance and lead 
to more accurate determ ination of the param eters.
The evidence presented above means th a t the values of R and S
^ Glut Max
obtained from  data  sets SYNC1 can be discarded. However, there  is s till a 
significant difference in the optimised values obtained from  data  sets 
SYNC2 and SYNC3. For R the value obtained from  SYNC3 is 65.2% of th a t
Glut
obtained fo r SYNC2, while fo r S it  is 59.5%. Even a t a confidence level
Max
of 99% the contours do not overlap. This suggests th a t the values of R  ^
and S are  actually d ifferen t fo r each experiment. This may be explained
Max
w ith reference to  the observed glutamine production a t the s ta r t  of each
culture; th is has been discussed above. It would appear from  the glutamine 
data  obtained fo r data  set SYNC3, th a t th is  release of glutamine actually
increases the concentration to a level above th a t observed the s ta r t  of the 
culture; th is occurs a f te r  9 hours. This is not the case fo r data  set 
SYNC2. As a resu lt, there  is a significant discrepancy between the model 
and da ta  se t SYNC3 over the period from  9 to 20 hours. Over th is period it 
is apparent th a t the actual glutamine consumption ra te  is higher than th a t 
predicted by the model. This indicates th a t the optimised value of RQ1 t 
may be too low fo r data  set SYNC3. It would be pure speculation to  increase 
the initial glutamine concentration fo r data  set SYNC3 to  obtain a b e tte r 
fit; although th is is indeed possible and does yield values of R and
Glut
S much closer to those obtained fo r SYNC2.
Max
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4.8  CONCLUDING COMMENTS
A specific cell cycle model has been developed fo r a hybridoma cell line. 
This model has been developed f  rom the analysis of a series of 
post-synchronisation cultures. The main fea tu res of the proposed cell cycle 
model can be summarised as follows:
a) the basic model consists of the four conventional cell cycle 
phases: Gl, S, G2 and M(11);
b) the Gl phase is divided into two distinct periods, denoted Gla and
and Gib;
c) the Gla, S, G2 and M phases of the cell cycle are  of fixed duration 
(2.5, 5, 2 and 2 hours respectively);
d) a quiescent phase exists, GO; e) glutamine is consumed a t a fixed
ra te  during the Gla and Gib phases only;
f) the consumption of glutamine by chemical hydrolysis is also taken 
into account;
g) the in itia tion of the S phase is controlled by a random event, the 
probability of th is event is dependent upon the cumulative 
glutamine content of the cells in the Gib phase;
h) the relationship between the probability of the random event and
the cumulative glutamine content is a quadratic form; and,
i) antibody is produced a t a fixed ra te  during the Gib and S phases
only.
Most of the param eters in th is model have been determined directly from  the 
analysis of the experim ental data. However, th ree param eters, the specific 
glutamine consumption ra te , R , the maximum cumulative glutamine 
content, S , and the specific antibody production ra te , R , have been
Max Anti
estim ated by m athematically fittin g  the models predictions to  the 
experim ental data.
The sensitivity of the model has been tested  with respect to the model 
param eters. It has been confirmed th a t the model is sensitive to  the 
f it te d  param eters R , S and R . However, w ith the exception of the
^  Glut Max Anti r
in itia l inoculum level, glutamine and antibody concentrations, the model 
does not appear to  be sensitive to any of the other model param eters.
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Furtherm ore, it  has been shown th a t the integration step length chosen fo r 
the sim ulations and the mathematical f ittin g  exercise gives a reasonable 
degree of accuracy w ithout excessive CPU requirem ents.
The evidence presented in th is chapter suggest th a t the values of RG t and 
S obtained from  data  se t SYNC2 are the most accurate. These param eters
Max
values will now be used in the next chapter fo r fu rth e r  development of this 
model in order to predict behaviour in conventional batch culture and 
continuous culture. A death rule will be developed fo r th is cell line and 
the in teractions of other medium components, glucose, ammonia and lactate, 
will also be considered.
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CHAPTER 5
MODEL PREDICTIONS AND FURTHER MODEL DEVELOPMENT 
5.1 INTRODUCTION
The objectives of th is chapter are: to develop fu rth e r the specific cell 
cycle model proposed in Chapter Four, to dem onstrate the capability of this 
model in describing growth under a variety  of d ifferen t conditions and to 
dem onstrate how th is model may be used in the in terpreta tion  of 
experim ental data. The specific model will be used to simulate the kinetics 
of a number of other sets of experimental data  obtained fo r the cell line 
investigated previously. The experiments which will be studied are:
a) a series of 100 ml s tirred  flask  cultures w ith d ifferen t in itial 
glutamine concentrations;
b) a s ta tic  flask  culture and a s tirred  batch culture conducted in a
3
1 dm ferm enter; and,
3c) a 1 dm chem ostat culture.
For each series of experiments a b rief experim ental outline will be given;
(15)full details are  given by Hayter . This will be followed by a 
description of any modification or additions which must be made to  the 
model or its  param eters before any predictions can be made. A series of 
prelim inary predictions will then be generated and any f  u rther 
m odifications will be considered. Revised predictions will then be made and 
the resu lts  discussed.
5.2 STIRRED FLASK CULTURES
Data was obtained fo r a series of s tirred  flask cu ltu res(15). Each 
experim ent was conducted with a d ifferen t in itia l glutamine concentration. 
The glutamine concentrations used w ere 300 pg ml \  200 pg ml \
100 pg ml 1 and 50 pg ml 1; from  this point these shall be re fe rred  to  as 
data  se ts STIR1, STIR2, STIR3 and STIR4 respectively.
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5.2.1 Experim ental Outline
Four s tirred  batch cultures w ith d ifferen t initial glutamine concentrations
were conducted in parallel. The 100 ml cultures were inoculated a t a 
5 -1density of 1x10 cells ml in 250 ml Duran bottles and agitated using a 
magnetic follow er a t 100 rpm. Cell number and viability were evaluated 
daily and samples fo r monoclonal antibody, glucose, lactate , glutamine and
ammonia determ inations were taken simultaneously and stored a t -20 °C fo r 
la te r  analysis.
5.2.2 Accounting fo r  the In itial Lag Phase
During the exponential growth period the doubling time was about 20 hours. 
However, the time fo r the f i r s t  complete doubling of the population was
30 hours. A lag period a t the beginning of mammalian cell culture and
microbial ferm entation is a frequently observed phenomenon and must be 
accounted fo r w ithin the model.
It was evident from  the experimental data fo r these cultures th a t there is
very little  cell division during th is lag period, very little  glutamine or
glucose is consumed and very little  antibody, ammonia or lac ta te  is
produced. This lag period can be accounted fo r by introducing a new phase, 
/
designated Gl , in which cells do not in terac t w ith the medium components 
considered by the model, and from  which cells enter the Gib phase. 
Initially, cells are  assumed to be evenly d istributed throughout the Gl7 
phase and using the model it  is estim ated th a t the maximum duration of th is 
phase is 14 hours.
5.2.3 Prelim inary Predictions
Incorporating the lag period and the initial age distribution into the 
specific model, predictions can be made fo r the growth kinetics of the four 
s tirred  flask  cultures. The kinetics of cell death could not be obtained 
from  the post synchronisation data; th is is simply because the experiments 
did not continue into the death phase. As a resu lt there is no account of 
cell death within the current model. Therefore, prelim inary predictions fo r 
cell growth are  generated to the point where glutamine is exhausted, which
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coincides w ith the onset of cell death.
Prelim inary predictions f  or viable cell concentration, glutamine 
concentration and monoclonal antibody concentration w ere made (data not 
presented). Satisfactory  predictions were made fo r  data  sets STIR2, STIR3 
and STIR4. The predicted antibody concentration fo r data  se t STIR1 was also 
sa tisfac to ry . However, the predictions fo r viable cell concentration and 
glutamine concentration fo r data  set STIR1 was less satisfactory . With the 
exception of th is data  se t the model has perform ed well. Therefore, the 
introduction of a suitable death rule into the specific model may now be
considered.
5.2.4 Further M odifications to the Specific Model
5.2.4.1 Cell death
The following observations have been made with regard  to  cell death in 
these cultures:
a) the onset of cell death coincides w ith the exhaustion of glutamine;
b) there was no stationary  period between grow th and death in these 
cultures;
c) the death ra te  appears to be a function of the number of viable 
cells remaining; and,
d) the ra te  of cell death was significantly lower in cultures with
lower in itia l glutamine concentrations.
In the cu rren t model, once all of the glutamine has been assim ilated, any 
cells subsequently entering the Gib phase will be incapable of in itiating 
the S phase; they will be trapped in the Gib phase. It is proposed th a t 
these cells can only remain within th is phase fo r a certain  maximum 
duration, a f te r  which they must en ter a death phase, D. It is fu rth e r 
proposed th a t th is maximum duration fo r Gib also applies fo r cells even 
when glutamine is present. In the D phase cells are  not dead (i.e. they do 
not stain  w ith Trypan Blue), however they are  approaching death.
Experiments on the model have estim ated th a t the maximum duration of the
Gib phase is about 10 hours. However, th is assumption alone is not
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suffic ien t to account fo r the apparent lack of a s ta tionary  period. 
Therefore, it  is fu rth e r proposed th a t in a glutamine free  environment, 
cells which have ju s t completed mitosis are  incapable of in itia ting the Gla 
phase and en ter the D phase immediately.
To sa tisfy  observation c) it  is also proposed th a t once a population of 
cells has entered the D phase, the cells are  assumed to  die w ith f ir s t  
order kinetics. Therefore,
Observation d) suggests th a t the death ra te  constant is a function of the 
prevalent environmental conditions. A prelim inary analysis of the 
experim ental data  suggests th a t the death ra te  constant, k, may be function 
of the ammonia concentration; ammonia is a d irect product of glutamine 
metabolism. The relationship does not appear to be linear, the ra te  of 
death increases fa s te r  than the prevalent ammonia concentration. However, 
in the case of a second order relationship the increase in the death ra te  
is too fas t. The lack of data during the decline period would make 
mathem atical f ittin g  a d ifficu lt and questionable exercise. Therefore, it 
will be assumed th a t the death ra te  constant is a function of ammonia I
concentration raised to  the power 1.5.
.TD
n ( t , T  ) dx 
D D
(5.1)
where:
T
r
k
D
D
the ra te  of cell death (cells ml 1 hr *);
the death ra te  constant (hr 1); and,
the maximum duration of the D phase (hrs).
k = k  [NH ]L5
4
(5.2)
where:
k
[NH^] = ammonia concentration (pg ml ).
a constant, estim ated to  be 5.56x10 3 ml1'5 pg 1,5 h r 1; and,
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Theref ore,
rTD
r = k  [NH ]1,5 n(t,x) dr. (5.3)
D 4
oJ
This expression will be used in the specific model in order to estim ate the 
ra te  of cell death throughout the course of an en tire culture. However, it  
is clear th a t to use th is expression provision must be made f  or the 
production of ammonia within the specific model.
Finally, i t  should also be noted th a t it  may also be possible fo r cells to
leave th is death phase and re -en te r the cell cycle if the environmental 
conditions improve. However, as yet there is no experimental evidence to
substantiate  th is possibility.
5.2.4.2 Accounting fo r  other medium components
Analysis of the s tirred  flask  culture data  suggests th a t the specific ra te
of glucose uptake decreases as glucose concentration decreases. Therefore,
it  is proposed th a t the specific uptake ra te  of glucose is proportional to
its  concentration in the growth medium. It is d ifficu lt to  deduce from  the
available data  the cell cycle phases in which glucose assim ilation is
likely to  occur. Therefore, it is assumed th a t glucose will be assim ilated
throughout the cell cycle except during mitosis. Experiments on the model
—8 —1 —1have yielded a ra te  constant of 3.6x10 ml cell h r .
The build up of lactic acid in the grow th medium is a d irect resu lt of
(6B)glucose metabolism . Therefore, it is proposed th a t lac ta te  is produced 
throughout the cell cycle as a resu lt of glucose metabolism. A simple 
average mass balance over all of the s tirred  flask  cultures may now be used 
to  estim ate the yield of lactic acid per unit mass of glucose consumed. The 
specific ra te  constant fo r lactic acid production was estim ated to  be 
3.4x10 8 ml cell 1 hr \
It will be assumed th a t the accumulation of ammonia in the growth medium is 
a d irect resu lt of glutamine metabolism. Analysis of the ammonia 
concentration data  fo r the stirred  flask  culture resu lts  indicates th a t
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overall each mole of glutamine produces 0.81 moles of ammonia (0.1 mg 
ammonia per mg glutamine). It is assumed th a t the ammonia is produced in 
the same cell cycle phases as glutamine is assimilated. Therefore, the
ammonia production ra te  can be estim ated from  the glutamine assimilation
ra te  constant. From th is analysis an ammonia production ra te  of
—8  —1 —i1.5x10 mg cell h r during the Gla and Gib phases only will be used.
5.2.5 Revised P red ic tio n s
A schematic of the revised model in presented in Figure 5.0. The 
incorporation of the assumptions to account fo r cell death in the specific 
model will a ffec t the optimised values of R , S and R . Therefore,
Glut Max Anti
these param eters have been re-optim ised by fittin g  the revised model to
data  se t SYNC2. The new values of these param eters are  presented in Table
5.1, together w ith the ir percentage change from  the previously optimised
values. It is noticeable th a t the value of has changed considerably
more than th a t of R or R . A s  the f itte d  data  should be close to
Glut Anti
th a t obtained previously, only very small changes in R and R would
Glut Anti
be expected. The new assumptions regarding death will only d irectly  a ffec t 
cell concentration and th is is directly reflected  in the change in S
Max
These param eters are  now used in the updated model to  make the revised 
predictions fo r the s tirred  flask cultures.
R
G l u t
(mg ce 11 1 h r 1)
S
Ma x
(mg ce 1 1 )
R
A n t  i
(mg c e l l  1 h r 1)
1 .5 4 4 x 1 0~8 2 . 588x10"7 1 .0 7 9 x 1 O-8
0.4% 6.8% 0.2%
TABLE 5.1
R e -o p tim ise d  v a lu es  f o r  R , S an d  R
G lu t M ax---------------Anti
The predictions made by the updated model fo r the series of s tirred  flask 
cultures are  presented in Figures 5.1 to  5.4, together w ith the 
corresponding experimental data. These figures show the predictions fo r 
viable cell, glutamine, glucose, monoclonal antibody, ammonia and lacta te
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concentrations and the percentage of cells in each cell cycle phase during 
the course of the culture.
It can be seen th a t sa tisfac to ry  predictions have been made fo r  the viable
cell concentrations fo r data  sets STIR2, STIR3 and STIR4 (Figures 5.2a,
5.3a and 5.4a). However, fo r data  se t STIR1 (Figure 5.1a) the predicted
grow th ra te  a f te r  about 60 hours is g rea te r than th a t actually observed,
resu lting  in a cell concentration 30% g rea te r than th a t observed a fte r
82 hours. Satisfactory  predictions fo r cell death have also been made for
all fou r experiments. The predictions fo r cell viability (not shown)
throughout all four s tirred  batch experiments are  consistently g rea te r than
90%; until the onset of cell death shortly a f te r  glutamine exhaustion. This
is slightly lower than th a t observed experimentally, where viabilities
(15)above 95% were more typical
Satisfacto ry  predictions have been made fo r glutamine concentration fo r 
da ta  se ts STIR2, STIR3 and STIR4 (Figures 5.2b to  5.4b). However, the 
predictions fo r data  set STIR1 (Figure 5.1b) are  less sa tisfac to ry . The 
experim ental data  suggests th a t glutamine is consumed a t a ra te  which is 
considerably less than th a t predicted during the early  p a rt of th is culture 
and a t a higher ra te  tow ards the end. However, i t  should be emphasised th a t 
the predicted point of glutamine exhaustion appears to be correct.
The experim ental data  and model predictions fo r glucose concentration are 
presented in Figures 5.1c to 5.4c. The predictions generated fo r data  sets 
STIR1, STIR2 and STIR4 (Figures 5.1c, 5.2c and 5.4c) are  satisfacto ry .
However, fo r data  set STIR3 (Figure 5.3c) the model under-estim ates the 
glucose usage tow ards the end of th is culture. As a resu lt, the final 
predicted glucose concentration is 51% g rea te r than th a t observed 
experimentally.
Figures 5. Id to  5.4d show the predicted and experim ental monoclonal 
antibody concentration data. In each case sa tis f  actory predictions of 
antibody concentration have been made during the growth period, however 
during the decline period some discrepancies are  observed. For da ta  sets 
STIR1 and STIR2 (Figures 5 .Id and 5.2d) the model predicts higher antibody 
production ra te s  during the decline phase. This resu lts  in a final
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predicted antibody concentration which is 30% g rea te r than th a t observed 
fo r data  set STIR1, although fo r data  se t STIR2 the final concentration is 
predicted correctly. In the case of data  se t STIR3 (Figure 5.3d) one data 
point stands out significantly; th is suggests a ra th e r low prediction fo r 
antibody concentration in mid-decline phase. However, in th is case the 
final predicted antibody concentration is only 13% too large. Finally, fo r 
data  se t STIR4 (Figure 5.4d) the final concentration is 92% g rea te r than 
th a t observed experimentally.
Overall, the predictions of ammonia concentration (Figures 5.1e to  5.4e) 
f  or all f  our data  sets are  less than sa tisf  actory. As with the antibody 
data  significant deviations are most prominent during the decline period of 
the culture. In the case of data  sets STIR3 and STIR4 (Figures 5.3e and 
5.4e) less ammonia was actually produced than th a t predicted, 35% and 190% 
less respectively; while fo r data  set STIR1 (Figure 5.1e) the model 
under-estim ates the experimental data throughout the culture. The 
prediction fo r data  se t STIR2 (Figure 5.2e) yielded the only sa tisfac to ry  
re su lt fo r ammonia concentration.
S atisfactory  predictions have been made fo r lac ta te  concentration fo r data 
sets STIR1 and STIR3 (Figures 5 .If and 5.3f). However, the predictions fo r 
data  se ts STIR2 and STIR4 (Figures 5.2f and 5.4f) both underestim ate the 
lac ta te  concentration, especially tow ards the end of the culture. The final 
predicted concentrations being 6.5% and 7.4% less than those observed.
Figures 5.1g to  5.4g show the distribution of viable cells in each cell 
cycle phase. Once the cells have entered the exponential grow th period, 
a f te r  about 30 hours, the cell age distribution becomes relatively constant 
w ith about 50% of the cells in the Gl phase (~20% in Gla and ~30% in Gib), 
23% of the cells in S, 8% in G2, 8% in M and 11% in D. Once glutamine is 
exhausted, the percentage of cells in the D phase increases rapidly.
5.2.6 Discussion o f M odifications to the Model
Lag phases are  common in almost every type of cell culture. In animal cell
(405)culture they vary from  2 to 24 hours in duration . They are  regarded as 
periods of adaption fo r the cell population(406 408). The duration of the
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lag phase is dependent upon two crite ria , the size of the inoculum*118’407* 
and the physiological s ta te  or age of the inoculum*118’407’408*. A large 
inoculum of cells taken from  a culture in the early or mid-exponential 
period will have a relatively short lag period.
It should be pointed out th a t very little  work has been conducted with
regard  to  cell age distributions during the lag period. However, two
phenomena characterise  th is period, no cell division and low metabolic
activity. These are  also characteristic  of cells in a s ta te  of cellular
quiescence. Therefore, it  has been assumed in the model, th a t the entire
cell population s ta r t  in a quiescent phase designated G l '. At the s ta r t  of
each simulation the en tire cell population is assumed to be evenly
distribu ted  throughout th is phase. Cells near the end of th is phase rapidly
en ter Gib and progress around the cell cycle. Thus, the actual lag period
(with no cell division) is determined by the minimum time to  m itosis from
entering Gib which is 9 hours. The effec t of the duration of th is phase
/
must also be considered. If the Gl phase has a short duration a partia lly
synchronised population resu lts. As such, despite the in itial lag period,
the f i r s t  population doubling is as rapid (shorter than during typical
exponential growth) and a stepped growth curve resu lts  (data not shown). If
the duration of th is phase is increased the f i r s t  doubling time is extended
/
and the grow th curve becomes smooth. The duration of the Gl was increased
until an in itia l doubling time of 30 hours was achieved (this was typical
/
fo r these cultures). This gave a duration fo r Gl of 14 hours and a very 
smooth grow th curve.
The reason fo r designating th is phase G l' is th a t its  tru e  natu re is 
undetermined. In order to induce a true  quiescent s ta te , the cell 
population must generally by subjected to  s tress  fo r a reasonable period of 
time. When cells are  simply spun down and resuspended the s tress  involved 
is not normally considered sufficient. It is commonly accepted th a t the lag 
period is due to the change in medium. If there  is a significant change the 
cell metabolism may have to a lter, th is will require the m anufacture of new 
enzymes and cofactors*118*. Furtherm ore, if a small inoculum is used many 
sm aller molecules (cofactors, ions, vitamins) may diffuse out of the cells 
due to  concentration or ionic imbalances*118’408*. Therefore, it  is most 
likely th a t most cells get trapped in a prolonged Gl phase (hence the
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designation Gl7) while they m anufacture these components; a 
pseudo-quiescent sta te . A few cells which are  already committed to cell 
division may divide, but the ra te  of pro liferation  will be very low. In 
conclusion, despite the empirical nature of the assumptions regarding the
observed lag period, they account fo r it  very well. However, it  is accepted 
th a t the tru e  biological nature of th is period, w ith regard  to the cell 
cycle, rem ains to  be determined.
The ru les which have been introduced with regard  to cell death were based
on observations made from  the experimental data. It should be pointed out
th a t little  work has been conducted with regard  to  the mechanism of cell 
death in term s of the cell cycle. In the model, it  is proposed th a t there 
is a maximum duration fo r the Gib phase. If cells fa il to  in itia te  the S 
phase before the end of Gib they enter a death phase, D. When glutamine is 
available i t  must be assumed th a t the protein accumulation
requirement*369,370* can be met. Therefore, some other fac to r must be
responsible fo r  a fa ilu re  to  in itia te  S. If glutamine is unavailable, then
the cells will be unable to  meet the protein accumulation requirem ent and 
th is leads to  cells being trapped in Gib. The idea th a t a cell which is 
unable to  in itia te  the S phase, fo r some reason other than the fac t it  is
metabolically blocked, will only remain in the Gib phase fo r a certain
period of time seems reasonable. It is likely th a t a cell will try  to 
remain viable, while waiting fo r conditions to  improve and fac ilita te  
transition . While waiting, the metabolic ra te  will be reducing, ultim ately 
to  the point where the cell can no longer function. The maximum duration 
suggested fo r the Gib phase simply implies th a t there  is a point when the 
metabolic activity  no longer constitutes th a t of a Gib cell.
The assumption regarding a cell’s entry to the death phase immediately 
a f te r  m itosis in a glutamine free  environment is harder to justify . It 
implies th a t there is some process very early in the Gl phase which is 
glutamine dependent, fa ilu re  to complete th is process resu lts  in the cell 
entering the D phase. It is clear th a t th is cell line is highly sensitive 
to glutamine deficiency, th is can be concluded from  the lack of a 
significant sta tionary  period between cell growth and cell death. This may 
be evidence of the existence of a highly glutamine dependant event 
somewhere early in the cell cycle.
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The final assumption made with respect to  the death kinetics is th a t the 
ra te  of cell death is a f  unction of ammonia concentration. The limited 
amount work conducted on the death kinetics of hybridoma cells would 
suggest th a t neither ammonia or lac ta te  are  capable of triggering cell 
death(40); th is  also seems to  be true  fo r some other mammalian cells(73). 
However, i t  is clear from  the s tirred  flask  data  th a t the ra te  of cell 
death is increased in the cultures w ith a higher initial glutamine 
concentration. This in itse lf suggests th a t the ra te  of death is re la ted  to 
the amount of glutamine which is assim ilated, or a product of glutamine 
metabolism, i.e. ammonia.
Glucose is the other m ajor source of carbon and energy in hybridoma 
cultures*6 .^ It has been suggested th a t in hybridoma cell lines glutamine 
is the m ajor source of energy(60,61), while glucose is the m ajor biomass
(38)source . If th is is the case, it  may be possible th a t glucose is also 
consumed predominantly in the Gl phase. However, i t  is not possible to 
conclude th is from  the data available. Therefore, i t  is currently  assumed 
the glucose is assim ilated throughout the cell cycle with the exception of 
the M phase. However, th is  assumption may be reviewed in the light of new 
evidence. The experimental data  suggests th a t glucose assim ilation is a 
function of glucose concentration, and the predictions made by the model 
would appear to confirm this. Other workers have also reported a 
relationship between glucose concentration and assim ilation ra te (66).
The assumptions made with regard to lac ta te  and ammonia production are 
necessarily simplistic; as with glucose concentration, the only data 
available fo r lac ta te  and ammonia are  from  conventional batch cultures. As 
a resu lt, very little  inform ation can be obtained with respect to  the 
expression of these components as a function of the cell cycle. It has 
already been pointed out th a t these components are  products of glucose and 
glutamine metabolism respectively. Furtherm ore, if the turnover ra te  of 
glutamine and glucose is considered to be rapid, it  is reasonable to  assume 
th a t ammonia and lac ta te  are  produced in the same cell cycle phase in which 
glucose and glutamine are  consumed. The assumptions have been introduced as 
convenient and simplistic descriptions of the in teractions between these 
components; it  is accepted th a t the true  in teractions are  likely to be more 
complex.
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Ce 1 1 
L i n e
D o u b 1 ing 
T i me  ( h r s )
7.
Gl
7.
S
7o
G2+M Comment s
R ef e r  ence 
N um ber
Mode 1 2 0 . 0
*
5 3 .0
*
2 6 . 0 21.  0* N. A.
S3  HeLa 2 0 .  1 50 . 9 27 . 6 21.  5 2 3 9
CHO 1 2 . 4 4 6 . 0 31 . 7 22 .  3 241
B a l b  3T3 A31
1 6 . 0 5 0 . 9 24.1 25 .  0 8% S e r u m
2 7 6
1 6 . 0 48 . 6 28 . 9 22.  5 10% S e r u m
1 6 . 0 42 . 8 3 1 . 0 26.  2 16% S e r u m
1 6 . 0 38 . 6 3 8 . 2 23 .  2 20 % S e r u m
SV40 
T r a n s f  o r m e d  
Ba 1 b 3T3 A31
1 6 . 0 4 9 . 0 27 . 5 23 .  5 8 % S e r u m
1 6 . 0 5 0 . 0 24 . 7 25 .  3 1 0  % S e r u m
1 6 . 0 46 . 8 27.1 26 .  1 1 6 % S e r  u m
HTC N. A. 5 1 . 0 3 6 . 0 1 3 . 0 1 6 % S e r  u m 4 0 9
Sw i s s 3T3
2 3 .  3 66 . 8 14.7 18.  5 5 % S e r  u m
4 1 0
2 0 . 2 54 . 5 25 . 6 19.  9 7 % S e r  u m
1 7 . 5 4 9 . 2 28 . 0 22 .  8 10% S e r u m
1 5 . 3 3 7 . 9 33 . 4 28 .  7 20 % S e r  u m
Me a n 1 7 . 0 48 . 8 28 . 5 22 .  7
* A v e r a g e  c e l l  a g e  d i s t r i b u t i o n  d u r i n g  e x p o n e n t i a l  p e r i o d  f o r  S T I R 1 - 4
TABLE 5.2
C ell Age D is tr ib u tio n s  R eported in  th e  L iterature
Measurements of the cell age distributions of the cell population during
these cultures were not made. However, the cell age distributions predicted
by the model can be compared to those measured fo r other mammalian cells
lines (Table 5.2). Typically, cell age distributions are  measured using
flow cytometry. This technique will give an estim ate of the number of cells
w ith one copy of DNA (indicative of G1/G0 phase cells), those w ith two
copies of DNA (G2/M phase cells) and those in the process of producing a
new DNA (S phase cells). The data presented in Figures 5.1g to 5.4g show
/
the percentage of cells in the Gl (both Gla and Gib), S, G2, M, Gl and D
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phases separately. In order to  compare the data from  the present model with
/
other cell age distributions the cells in Gl and D must be accounted for. 
It is clear th a t flow cytometry would assume th a t both these populations of 
cells would appear to  be G1/G0 cells. Therefore, the model predicts th a t 
61% of the population would appear to be G1/G0 cells during exponential 
growth. Furtherm ore, the percentage of G2/M cells is 16%. Comparing these 
values to those presented in Table 5.2 it  is clear th a t the model predicts 
a sim ilar distribution to  th a t which would be expected fo r a mammalian cell 
line. This is fu rth e r  circum stantial, but independent, evidence th a t the 
predictions made by the model are  a reasonable reflection of reality .
5.2.7 Discussion o f Predictions made fo r  the Stirred Flask Cultures
It is clear from  the predictions made fo r these experiments (Figures 5.1 to 
5.4) th a t the model is able to  describe the kinetics of th is cell line 
sa tisfac to rily  during the exponential growth period. Significant 
disagreem ents between the models predictions and the experim ental data  only 
occur during the decline period; these being most evident in the antibody 
and ammonia predictions. However, there is some disagreement between the 
model and the experim ental data during the growth period in data  se t STIR1.
It appears th a t during the la tte r  p a rt of the grow th period, the predicted 
grow th ra te  fo r data  set STIR1 is somewhat g rea te r than the observed growth 
ra te  (see Figure 5.1a). One possibility is th a t the accumulation or absence 
of some component in the growth medium may be s ta rtin g  to  influence the 
grow th kinetics. There is also significant disagreement between the model 
and the glutamine concentration fo r data  se t STIR1. In th is case the 
in itia l consumption ra te  appears to  be ra th e r less than th a t predicted, 
while the final ra te  appears to be g reater. The low initial ra te  may be due 
glutamine inhibition (data set STIR1 had the highest in itia l glutamine
concentration) however th is is not reflected  in a reduced in itia l growth 
ra te  which would be expected f  or conventional inhibition. However, the 
apparent increase in glutamine consumption ra te  tow ards the end of the
culture is associated with the reduction in growth ra te  mentioned above.
This phenomenon can be explained in cell cycle term s. If the duration of 
the Gl phase were increased, a g rea ter percentage of the cells would be in 
the Gl phase. The growth ra te  would slow down and the overall specific
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glutamine uptake ra te  would increase. This is due to a higher percentage of 
the cells being in the glutamine consuming phases of the cell cycle. There 
is also some evidence from  the model’s predictions th a t the assim ilation 
ra te  of glutamine in data  se t STIR2 is also enhanced tow ards the end of the 
culture (see Figure 5.2b). However, there  is no evidence of a decrease in 
growth ra te  fo r th is data set.
As has been pointed out above, there  are  a number of disagreements between 
the model’s predictions and the experimental data  during the decline 
period. The predictions fo r the cell death kinetics appear reasonable 
(Figure 5.1a to  5.4a), however there are  some significant discrepancies in 
the predictions fo r glucose (Figures 5.1c to 5.4c), antibody (Figures 5.1d 
to 5.4d), ammonia (Figures 5.1e to  5.4e) and lac ta te  (Figures 5 .If to 5.4f) 
concentrations during th is period. One possibility is th a t there is some 
interaction between cells in the D phase and the growth medium, resulting 
in these discrepancies.
The model suggests th a t more antibody is produced during the decline period 
than is actually observed. In the model, all cells which are  in the Gl 
phase when glutamine becomes exhausted are  committed to completing it  
before they enter the D phase. These cells will continue to produce 
antibody in the second p a rt (Gib) of th is phase. The experim ental data 
would suggest th a t antibody production is reduced during the Gib phase 
under glutamine free  conditions, thus resulting in lower production ra te s  
and lower final yields fo r antibody.
All of the predictions of glucose concentration are  sa tisf  actory except f  or
those made fo r data  set STIR3 (Figure 5.3c). In th is case, the experimental 
data  suggest th a t there is a g rea te r consumption of glucose during the
decline period. The predicted antibody and lac ta te  concentrations are  also 
significantly g rea te r in the mid-decline period than those observed.
However, the final concentrations fo r these components are  sa tisfac to rily  
predicted.
The ammonia predictions would appear to be to most varied. The only
sa tisf  actory prediction is obtained f  or data  se t STIR2. The evidence f  rom 
the other data  suggests th a t the yield of ammonia from  glutamine decreases
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significantly as the in itia l glutamine concentration decreases.
5.3 PREDICTIONS FOR OTHER BATCH CULTURES
5.3.1 A Typical Static Batch Culture
A typical s ta tic  batch culture will now be considered; in th is case the 
experimental data  will be re fe rred  to  as data  se t STATI.
5.3.1.1 Experim ental Outline
This s ta tic  batch culture was conducted by H ayter(15)with an initial
glutamine concentration of 230 pg ml \  100 ml cultures of RPMI 1640
supplemented w ith 10% new born calf serum were inoculated a t a density of
5 - 1  22x10 cells ml in 150 cm tissue culture flasks. Cells were cultured a t
37 °C w ith 5% CO^/95% air. Cell number and viability were evaluated daily
and samples fo r monoclonal antibody, glucose, lactate , glutamine and
ammonia determ inations were taken simultaneously and stored  a t -2 0 0 C for
la te r analysis.
5.3.1.2 Prelim inary Predictions
Prelim inary predictions have been made fo r a s ta tic  batch culture; these
have been compared with typical experimental data  (predictions not shown). 
For these predictions glutamine and ammonia concentrations were predicted 
satisfac to rily . However, both the predictions fo r  antibody and the lac ta te
concentrations were too high; as was the glucose concentration during the
decline period. The model sa tisfac to rily  predicted the viable cell 
concentration during growth and the onset of cell death, but it was clear 
th a t the death kinetics were substantially d ifferent.
5.3.1.3 M odifications and Revised Predictions
A new value f  or the constant which re la tes  death ra te  to ammonia 
concentration, k, has been determined fo r data  se t STATI in order to
resolve the discrepancy in the death kinetics. The new value fo r k  fo r  th is
data se t has been estim ated to be 5.0 x 10 4 ml1'5 mg 1,5 h r \  Figure 5.5
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shows the revised predictions fo r data set STATI. It is clear th a t the 
adjustm ent in k  has had the desired effec t and a sa tisfac to ry  prediction of 
the death kinetics has been made. The altera tion  of th is param eters does 
have a minor a ffec t upon the viable cell concentration during the growth 
phase (Figure 5.5a); the growth ra te  tow ards the end of the exponential 
period appears g rea te r than th a t observed. However, the glutamine (Figure 
5.5b) and ammonia (Figure 5.5e) concentrations are  s till predicted 
sa tisfac to rily . While the predictions fo r glucose (Figure 5.5c), antibody 
(Figure 5.5d) and lac ta te  (Figure 5.5f) concentration are  s till too high.
5.3.2 A Typical Stirred Batch Fermentation
3
Experiments were also conducted on this cell line in a 1 dm ferm enter. 
Data fo r a typical s tirred  batch ferm entation will now be considered; these 
data  will be re fe rred  to as data set STIR5.
5.3.2.1 Experim ental outline
Stirred  batch ferm entations were conducted by H ayter(15) in a 1 dm3 
Gallenkamp ferm enter. Headspace aeration was provided by a 5% C02/95% a ir 
m ixture a t a flow ra te  of 50 ml min \  Agitator speed was 100 rpm and the
5 -1working volume 500 ml. Cells were inoculated a t 2x10 cells ml in 500 ml 
RPMI 1640 supplemented with 10% new born calf serum. Cell number and 
viability were evaluated daily and samples f  or monoclonal antibody, 
glucose, lactate , glutamine and ammonia determ inations were taken 
simultaneously and stored a t -2 0 °C fo r la te r analysis.
5.3.2.2 Prelim inary Predictions
Prelim inary predictions fo r a typical s tirred  batch ferm entation were made 
(prediction not shown). It was clear th a t the predictions fo r the viable 
cell and antibody concentration data were unsatisfactory . However, the 
predictions fo r glutamine, glucose, ammonia and lac ta te  concentrations were 
reasonable.
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5.3.2.3 M odifications and Revised Predictions
There w ere two problems with the prelim inary predictions fo r data  set
STIR5, i) the predicted initial growth ra te  is less than th a t observed and, 
ii) the ra te  of cell death is g rea te r than th a t observed. Upon inspection 
of the experim ental data  fo r th is culture, it  is clear th a t there was no 
significant lag period. Therefore, it is probable th a t the initial
population is more typical of th a t encountered during the exponential
grow th period. In order to  account fo r this, a typical batch experiment can 
be simulated to a point when the cell population is in the exponential
grow th period, a t th is point the age distribution can be stored. Using this 
age distribution as the initial age distribution f  or th is  culture a new
prediction can be made. This significantly improves the prediction fo r the 
grow th period fo r th is culture.
It has already been dem onstrated th a t modification of the death ra te
re la ted  constant k  may improve the prediction of the death kinetics. A new
value fo r k may be estim ated fo r th is culture; th is has been determined as
0  _ . _ - 4  .1.5 -1.5 , -18.3 x 10 ml mg hr .
Incorporation of these two modifications into the existing model yielded 
the predictions presented in Figure 5.6. There has been a dram atic
improvement in the prediction of the viable cell concentration data  (Figure 
5.6a), w ith both the growth and death phases now being predicted 
satisfac to rily . The prediction fo r the glutamine concentration (Figure 
5.6b) is somewhat less satisfactory . However, the point of glutamine 
exhaustion has been predicted correctly. The glucose (Figure 5.6c), ammonia 
(Figure 5.6e) and lacta te  (Figure 5.6f) concentrations have again been
predicted sa tisfacto rily . However, the prediction fo r antibody 
concentration (Figure 5.6d) is still unsatisfactory.
5.3.3 Discussion o f M odifications made to the Specific Model
t
The assumption regarding the Gl phase has been modified in order to 
account fo r data set STIR5. Although the inoculum size employed fo r data  
set STIR5 was g rea te r than th a t used fo r data  sets STIR1 to STIR4, it  was 
the same as th a t used fo r data set STAT1 and th is data  se t did exhibit a
105
Further D evelopment
lag period. This would appear to eliminate increased inoculum size as an 
explanation. For data  se t STIRS, it  has been assumed th a t the age 
distribution of the inoculum is typical of a population of cells in the 
mid-exponential period. This adequately describes the data  and implies th a t 
the inoculum fo r th is culture was taken in the early - to  mid- exponential 
period, while th a t fo r the other cultures may have been taken la ter.
The assumptions made with regard  to the kinetics of cell death have
perform ed well in the predictions fo r data sets STAT1 and STIR5; these have
been discussed in some detail in Section 5.3.2.3 However, th ree d ifferen t
values of the death ra te  rela ted  constant, k , have had to  be used in order
to predict the death kinetics of the batch cultures: a value of
5.6x10 3 ml1*5 mg 1,5 hr 1 fo r the s tirred  flask  cultures, 
- 4  1 5  - 1 5  -18.3x10 ml ‘ mg hr fo r a typical s tirred  ferm enter, and
- 4  1 5 - 1 5 - 15x10 ml ' mg ' h r  fo r the s ta tic  batch culture. It should be noted 
th a t k  decreases as working volume increases and increases when the culture 
is agitated. This suggests th a t the param eter k  may well be a function of 
ag ita to r speed, and may also be rela ted  to  e ither scale-up or the geometry
of the grow th environment.
5.3.4 Discussion o f Predictions made for  other Batch Cultures.
There is a definite discrepancy between the model’s predictions and the
experim ental data  a t the higher cell concentrations. In the case of data
sets STIR1 and STAT1 the predicted growth ra te  is higher th a t th a t observed
tow ards the end of the growth period, a t cell concentrations over 0.7xl06
cells ml however, this does not appear to  be the case fo r data  set
STIR5. A number of researchers have reported th a t low serum concentrations
(35—38)can detrim entally a ffec t the growth of hybridoma cells . It is also 
possible th a t the accumulated lacta te  or ammonia may a ffec t the grow th 
kinetics. Reports have been published stating  th a t both 
ammonia(42,68,7°’71) and lac ta te (71,74) can reduce growth ra te s. If either 
of these possibilities is responsible fo r th is apparent reduction in grow th 
ra te , i t  would seem th a t the effect upon the cell cycle is to increase the 
duration of the Gl phase. It has already been pointed out th a t th is 
increase may resu lt in an apparent increase in the specific glutamine 
assim ilation ra te , and indeed the glutamine predictions fo r data  se ts STIR1
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and STIR5 may suggest such an increase in the la tte r  stages of the growth 
period.
A consistent observation (confirmed in the predictions fo r data  sets STAT1 
and STIR5) has been the prediction of antibody concentrations higher than 
those observed, mainly during the decline period. It has been suggested 
above (Section 5.2.7) th a t the ra te  of antibody expression during the Gib 
phase, in a glutamine free  environment, is reduced. This supposition is 
supported by predictions made fo r STAT1 and STIR5. However, the evidence 
also suggest th a t antibody is produced well into the decline period, even 
when all of the cells have entered the D phase. The accumulation of 
antibody during a stationary  and decline period has been 
reported (32,41,75,77,81). In the curren t model, cells do not produce 
antibody during the D phase. However, those cells committed to completing 
the Gib period do. The evidence available from  all the simulations suggests 
th a t the ra te  of antibody production in the Gib phase is reduced and th a t 
antibody production does occur during the D phase. The reduction in the 
antibody production ra te  in Gib may be due to the absence of glutamine or 
the build up of some other metabolite.
The existence of two distinct populations of hybridoma cells, those
exhibiting high secretion ra te s  and those exhibiting low secretion ra te s
(82)has been postulated . It is possible th a t these researchers may have 
observed cells in the D phase; s till metabolically active (therefore 
appearing viable), characteristic  of Gl cells, in term s of DNA content, and 
yet exhibiting a low specific antibody production ra te .
The predictions fo r glucose concentration fo r data  se t STATI (Figure 5.5c) 
are  too high during the la te exponential and the decline periods. However, 
in th is case there does not appear to be any significant over-production of 
antibody or lac ta te  (Figure 5.5d and 5.5f), as observed in data  se ts STIR3. 
In each case, it  may be possible th a t the cells are  attem pting to  ad just to 
a glutamine free  environment by using glucose as an alternative nu trien t 
source. If th is  is the case, the reasons why th is phenomenon is observed in 
two cultures only requires fu rth er investigation.
Predictions fo r data  sets STAT1 and STIR5 fo r ammonia concentration are
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both sa tis f  actory. This is in agreement with the predictions made f  or the 
s tirred  flask  cultures. The only sa tisfac to ry  prediction made fo r those 
cultures was f  or data set STIR2 which had an initial glutamine 
concentration of 200 fig ml \  The initial concentrations fo r data  sets 
STAT1 and STIR5 are  235 fig ml 1 and 213 fig ml \
5.4 PREDICTIONS FOR A CONTINUOUS CHEMOSTAT CULTURE
The continuous culture of mammalian cells has been reviewed briefly  in 
Chapter Two (Section 2.5) as has the potential of such propagation 
techniques to  improve the yield of marketable products. It is essential 
th a t any robust model, whether specific or generalised, be able to predict 
both the steady s ta te  and transien t kinetics of chemostat operation.
5.4.1 Experim ental Outline
H ayter(15) used a 1 dm3 glass reac to r with a working volume of 500 ml fo r 
the chem ostat culture. The medium used was RPMI 1640 supplemented with 
2 mg ml 1 sodium hydrogen carbonate and 10% new born calf serum, with 
glutamine as the growth limiting nutrient. As with the batch cultures 
considered previously, cell numbers and viability were determined daily and 
samples were taken fo r glutamine, monoclonal antibody, glucose, lac ta te  and 
ammonia determination.
The chem ostat was inoculated a t a density of 2xl05 cells ml 1 and grown as 
a batch culture fo r 24 hours to allow the cells to  reach the exponential 
growth phase. Continuous operation was then commenced and a series of 
■experiments was conducted.
Steady s ta te  was achieved a t a dilution ra te  of 0.042 hr 1 and a glutamine 
feed concentration of 100 pg ml \  A fter 96 hours the glutamine feed 
concentration was increased to 146 pg ml \  This increase did not re su lt in 
a change in the steady sta te , thereby suggesting th a t the culture was not 
glutamine limited. A fter 180 hours the dilution ra te  was reduced to 
0.024 h r \  The chem ostat reached a new steady s ta te  a f te r  a fu rth e r  
120 hours (total elapsed time 300 hours). To confirm the fa c t th a t 
glutamine was now limiting a glutamine pulse of 0.26 mM was introduced.
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This resulted  in an increase in cell number, which then reverted to  the 
previous steady s ta te  level.
Once a glutamine limited steady s ta te  had been achieved a number of other 
experim ents w ere conducted. The change in steady s ta te  was investigated a t
d iffe ren t dilution ra te s  0.024 hr \  0.033 hr 1 and 0.042 hr \  Finally,
the washout kinetics were also investigated by increasing the dilution ra te  
to  0.05 h r \
5.4.2 Prelim inary predictions
Initial attem pts to  simulate the steady s ta te  levels achieved
experimentally, were made using the same param eters values as those used 
fo r the s tirred  flask  cultures; these simulations proved to be
unsuccessful. Washout always occurred a t a dilution ra te  below 0.035 h r-1, 
and even though steady s ta te  was achieved a t a dilution ra te  of 0.024 h r-1, 
the steady s ta te  levels fo r cell concentration and antibody concentration 
w ere below those observed experimentally. Upon evaluation of the possible 
causes fo r  th is discrepancy, it was decided th a t differences in the death 
kinetics between the s tirred  flask  cultures and the chem ostat may be
responsible. The chem ostat culture was conducted in a vessel of working
volume 500 ml, which was the same specification as fo r the Gallenkamp 
ferm enter used fo r the s tirred  batch ferm entation. Therefore, these
predictions may be improved by using the value of the death ra te  constant 
which was used to  predict data  set STIR5.
5.4.3 Revised Predictions
5.4.3.1 Achieving steady state w ith  the model
A 24 hour conventional batch culture was simulated using an in itia l
glutamine concentration of 292 pg ml \  The cell age distribution was then 
stored and reloaded under the initial chemostat conditions used in the 
above experiment.
The model proved incapable of achieving steady s ta te  a t a dilution ra te  of 
0.042 hr 1; the model suggested washout. However, steady s ta te  could be
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achieved a t a dilution ra te  of 0.024 hr \  Figure 5.7a shows the viable
cell concentration reaching a steady s ta te  level of 0.56xl06 cells ml-1 
a f te r  150 hours. The cell concentration peaked a t 0.66xl06 cells ml 1 a f te r  
66 hours. The glutamine concentration (not shown) remained very low during 
th is simulation «0.1 pg ml 1), and the antibody concentration has almost 
reached a steady s ta te  value of about 133 pg ml 1 a f te r  300 hours (Figure
5.7b). This compares favourably with th a t obtained experimentally,
128 pg ml 1 ±3.8. The cell age distribution (Figure 5.7c) a t steady s ta te  
gives a population of cells with 49% in the Gl phase, 19% in S, 7% in M, 7% 
in G2 and 18% in D, or 67% G1/G0 cells, 19% S and 14% G2/M.
5.4.3.2 The response to a glutamine pulse
The response of the model to a glutamine pulse is presented in Figure 5.8, 
along w ith the experimental response. It is clear th a t the simulated cells 
are  glutamine limited; the introduction of a pulse of glutamine resu lts  in 
an increase in the viable cell concentration and a subsequent
re-establishm ent of the steady s ta te  (see Figure 5.8a). The increase peaks 
35 hours a f te r  the pulse a t a cell concentration of 0.67xl06 cells ml-1. 
The model then gradually re tu rn s to its  previous steady s ta te  level. The 
corresponding glutamine data  are  presented in Figure 5.8b. The glutamine 
concentration fa lls  steadily from  its  in itial peak concentration to  a 
residual level over a period of 27 hours following the glutamine pulse.
Subsequently, the glutamine concentration remains a t th is  residual level. 
Finally, the prediction fo r antibody concentration (Figure 5.8c, no
experim ental data  available) shows a peak 45 hours a f te r  the pulse a t 
147 pg ml 1.
This prediction fo r viable cell concentration during the recovery period is 
sa tisfac to ry , as is the prediction fo r glutamine concentration. However, 
the in itia l response of the viable cell concentration to  the pulse is
unsatisf actory.
The cell age distribution is presented in Figure 5.8d. It is clear th a t the
pulse immediately changes th is distribution, resulting in a peak in Gl 
cells corresponding to  the peak in viable cell concentration. However, th is 
d istribution re tu rns to  its  previous steady s ta te  value about 80 hours
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a f te r  the pulse.
5.4.3.3 The response to a change in dilution rate
The model was also used to simulate a change in dilution ra te  f  rom 
0.024 hr 1 to  0.033 hr \  The resu lts  of th is simulation are  presented
together w ith the experimental data  in Figure 5.9. It is clear th a t the 
model under estim ates the steady s ta te  viable cell concentration a t this 
dilution ra te  by about 9% (Figure 5.9a). While the steady s ta te  antibody 
concentration is about 22% g rea te r than th a t observed (Figure 5.9c). The 
prediction fo r glutamine (Figure 5.9b, no data  available) indicates a
residual glutamine concentration of 27 pg ml \  Finally, the cell age 
d istribution (Figure 5.9d) predicts a slight change from  the previous
steady s ta te , with 23% of the cells now in the S phase (previously 19%) and
13% in the D phase (previously 18%).
5.4.3.4 The washout k inetics
The predictions fo r the washout kinetics are  presented in Figure 5.10. In
th is case an unsatisf actory prediction f  or the viable cell concentration
data has been obtained. The cell concentration drops more rapidly than in 
the rea l case. Furtherm ore, the recovery from  potential washout takes 
significantly longer. Predictions fo r glutamine and antibody concentration 
(Figures 5.10b and 5.10c, no experimental data  available) indicate a 
dram atic increase and decrease respectively. The glutamine concentration 
peaks a t 115 pg ml \  while the antibody concentration fa lls  to  a minimum 
of 24 pg ml \
5.4.4 A Discussion o f the Chemostat Predictions
The in itia l fa ilu re  to  achieve any steady s ta te  values approaching those 
observed were solved by the adjustm ent of the death ra te  constant, k. The 
value of k  was reduced to  the same value as th a t used in the simulation of
the s tirre d  batch ferm enter culture, data  se t STIR5. The reason th is value
3
was chosen is th a t in both cases 1 dm s tirred  vessels w ith a working 
volume of 500 ml were used. Upon adjustm ent of k, the model is able to 
achieve viable cell, glutamine and antibody concentrations a t steady s ta te
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comparable w ith those observed a t a dilution ra te  of 0.024 hr \  This is 
f  u rth er circum stantial evidence to  suggest th a t k  may be rela ted  to 
agitation ra te  and working volume as proposed in Section 5.3.3.
Even w ith th is modification the model remains incapable of being able to 
achieve any steady s ta te  a t a dilution ra te  of 0.042 h r \  The reason fo r 
th is fa ilu re  is simply due to the fa c t th a t within the curren t model the 
maximum growth ra te  attainable is about 0.035 h r \  therefo re  the cells can 
never grow fa s t enough fo r higher dilution ra tes. This is a lim itation of 
the cu rren t model a must be addressed in fu tu re  work.
In all of the batch cultures, including the post-synchronisation 
experim ents, the medium was so arranged th a t glutamine was always growth 
limiting. It is clear from  the s tirred  flask  cultures th a t glutamine is 
grow th lim iting but not growth ra te  limiting. This may be concluded because
the grow th ra te  is the same in each culture, th a t glutamine assim ilation
appears to be zero order and th a t the onset of cell death is coincidental
with the exhaustion of glutamine. Furtherm ore, in the cu rren t model, i t  is
the availability of glutamine which limits the grow th ra te  by controlling 
the ra te  of transition  from  the Gib phase to the S phase. As a resu lt, in 
any situation in which glutamine is in excess the model will predict th a t 
the cells will grow a t the maximum growth ra te  (=0.035 h r X). However, it  
may be possible th a t under d ifferen t conditions some other component may be 
able to  supplement the requirem ent f  or glutamine and allow cells to  
progress around the cell cycle fa s te r; glucose could fu lfil th is role.
An alternative explanation may be th a t the critica l protein requirem ent, 
and hence glutamine requirement, is reduced. It has been reported*62,63* 
th a t th is  requirem ent can a lte r due to changes in the environmental 
conditions. As th is requirem ent is d irectly  rela ted  to  cell size, th is 
would imply a reduction in cell size if th is were responsible.
Predictions have also been made fo r three other experiments conducted in 
the chemostat. The transien t kinetics resulting from  a pulse of glutamine 
were predicted well during the recovery period, but not so well w ith 
respect to  the immediate response. However, the nature of the response was 
predicted correctly; th is supports the assumption th a t cell grow th in the
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model is glutamine limited. Analysis of the cell age distribution data 
(Figure 5.8d) indicates th a t the culture responds immediately to  the 
increase in glutamine concentration, as witnessed by the decrease in the 
percentage of cells in the G1 phase and the increase of the percentage in
the S phase. 20 hours a f te r  the pulse the cell age distribution appears to
have re-estab lished  its  steady sta te . The percentage of cells in the G1
phase is the same as th a t observed previously, approximately 49%. However, 
the percentage in the S phase has increased to 24% from  19%, while the
percentage in the D phase has decreased from  18% to 12%. This is because a 
higher ra te  of transition  from  Gib to S can be maintained due to  the 
availability of glutamine and hence less cells reach the ‘end’ of Gib and 
en ter D. As soon as the glutamine is exhausted a f te r  about 27 hours, the 
percentage of cells in G1 increases dram atically which subsequently resu lts  
in an increase in the number of cells in the D phase. It should be noted
th a t the response of the age distribution to the glutamine pulse is
complex, although the observed response in the viable cell, glutamine and
antibody concentration is straightforw ard .
The predictions made fo r the response to  a change in dilution ra te  yield an 
under-estim ation of the steady s ta te  cell concentration, and an
over-estim ation of the steady s ta te  antibody concentration. However, a t the 
new steady s ta te  level, glutamine is in excess, and it  is possible th a t the 
culture is no longer glutamine limited; as discussed above.
Analysis of the experimental data obtained f  rom the chem ostat culture
suggests th a t the specific production ra te  of antibody is lower a t higher
(15)
dilution ra te s  . Hayter reports a specific production ra te  of
5.4 pg cell 1 h r 1 a t a dilution ra te  of 0.024 hr 1 and 4.6 pg cell 1 hr 1
a t 0.033 h r \  This phenomenon has also been reported  by a number of other 
workers. However, the model predicts a specific antibody production ra te  of 
5.6 pg cell 1 h r 1 a t  0.024 hr 1 and 5.8 pg cell 1 h r 1 a t 0.033 h r \  The
reasons fo r th is apparent increase can be a ttribu ted  to a change in the 
cell age distribution (see Figure 5.9d). The percentage of cells in the 
antibody producing phases, Gib and S, is 52% a t a dilution ra te  of 
0.024 hr 1 and 54% a t 0.033 hr \  Therefore, the specific production
appears to be higher.
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A number of possible explanations have been proposed fo r  the phenomenon
observed in the experim ental data, these include: i) capacity fo r
m acro-m olecular synthesis being diverted fo r new biomass production a t high 
grow th ra te s , ii) repression or inhibition of antibody synthesis by 
m etabolites, iii) changes in the cell age distribution. It is clear th a t
the cell age distribution can a ffec t the apparent antibody production ra te .
However, in the case of these predictions th is e ffec t has generated an
increase in the production ra te  ra th e r than a decrease.
Further analysis of the predicted cell age distributions obtained a t steady 
s ta te  fo r these two dilution ra te s  reveals th a t there  is also a significant 
difference in the percentage of cells in the D phase. At a dilution ra te  of
0.024 h r 1 18% of the population are  in the D phase, while a t 0.033 h r 1
only 13% of the cells reside in th is phase. It has already been suggested
(see Section 5.3.4) th a t antibody production may be occurring in the D 
phase. If th is  is the case less cells would then be in the antibody 
producing phases a t a dilution ra te  of 0.033 h r \  th is would cause a 
reduction in the observed antibody production ra te .
The predictions fo r the washout kinetics are  very poor. The model perform s 
in a manner which is significantly d ifferen t from  the experimental data. 
This is most probably due to the potential changes in param eters governing
the maximum grow th discussed above, i.e. supplementary m aterials fo r
glutamine, or changes in the cell size distribution.
5.5 CONCLUDING COMMENTS
The following modifications were made to the specific cell cycle model in 
order to  sim ulate the s tirred  flask cultures:
a) a new cell cycle phase, designated G l ', was added, the duration of 
which was estim ated to be 14 hours;
b) a phase in which cells approach death was introduced, designated D;
c) in a glutamine free  environment, cells will only remain within the 
Gib phase fo r a maximum duration of 10 hours, they will then enter 
the D phase;
d) cells are  assumed to be incapable of in itia ting  the Gla phase a f te r
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m itosis in a glutamine free  environment, instead they enter the 
death phase;
e) cells leave the D phase to become non-viable a t a ra te  which is 
dictated  by the concentration of ammonia in the medium;
f) glucose is assim ilated a t a ra te  which is proportional to  the 
glucose concentration in the medium in phases Gla, Gib, S and G2;
g) lac ta te  is produced a t a ra te  which is proportional to  the ra te  of 
assim ilation of glucose in the Gla, Gib, S and G2 phases; and,
h) ammonia is produced a t a ra te  which is proportional to  the ra te  of 
uptake of glutamine in the Gla and Gib phases.
The param eters R , S and R were re-optim ised using th is revised
Glut Max Anti
model; these new param eter values were very sim ilar to those obtained 
previously. Using these new param eter values, th is model was able to 
predict the data  fo r a series of s tirred  flask cultures. These predictions
suggested th a t the modifications made to the model were good w ith respect 
to  sim ulating the lag period and the kinetics of cell death. However, 
discrepancies were identified fo r glucose, antibody, ammonia and lactate  
concentration during the decline period.
Further predictions were made fo r a typical s ta tic  batch culture and a 
s tirred  batch culture conducted in a 11 ferm enter. In both cases it  proved 
necessary to  ad just the value of the constant, k  (constant re la ted  to  cell 
death) in order to  successfully describe cell death. In the case of the
s tirre d  batch culture i t  also proved necessary to a lte r  assumptions 
concerning in itia l age distribution.
This revised model was used to predict the behaviour of th is cell line in a 
chem ostat. It is not designed to  predict the kinetics of th is system a t
high dilution ra te s  where glutamine was not growth limiting. As such, the 
predictions fo r  the washout kinetics fo r th is cell line were 
unsatisfactory . However, in the cases where glutamine was grow th limiting 
the model perform ed well. The steady s ta te  concentrations a t a dilution 
ra te  of 0.024 hr 1 were successfully predicted. Satisfactory  predictions 
were also made w ith respect to the transien t kinetics resulting  from  a
glutamine pulse and a change in dilution rate .
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A specific cell cycle model now exists which can predict successfully the 
kinetics of a particu la r hybridoma cell line under a variety of d ifferen t 
grow th conditions. The following conclusions have been drawn from  these 
simulations;
a) the param eter k  appears to be function of the agitation ra te , and 
also may be rela ted  to scale-up;
b) upon inoculation cells spend a period of time in a phase sim ilar to 
Gl, designated Gl7. In th is phase cells m anufacture a number of 
components missing from  the growth medium;
c) the duration of the Gl7 phase is re la ted  to  the size of the 
inoculum and the presence of agitation;
d) a t cells concentration above 0.7xl06 cells ml 1 the cell growth 
ra te  is reduced due to  a increase in the duration of the Gl phase;
e) in a glutamine free  environment, antibody production is reduced in 
the Gib phase, however antibody appears to  be produced a t th is  low 
ra te  in the D phase;
f) the efficiency of glutamine utilisation increases w ith decreasing 
glutamine concentration;
g) the perform ance of the model deterio rates when describing grow th 
which is not glutamine limited; and,
h) changes in the cell age distribution can influence the apparent 
specific production ra te  of antibody.
The next chapter will consider the application of th is model to 
repeated-batch  culture and the periodic perturbation of continuous culture.
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CHAPTER 6 
NOVEL APPLICATIONS OF CELL CYCLE MODELS
6.1 INTRODUCTION
In Chapters Four and Five a structured, segregated model of a hybridoma 
cell line (mm321) has been developed. This model is capable of simulating
the growth, consumption and production kinetics of th is  cell line under a 
variety  of d iffe ren t culture conditions, and its  validity has been
confirmed by comparison with experimental data. So f a r  th is  model has been 
used to investigate only conventional batch and chem ostat culture. Many
other propagation stra teg ies  ex ist which have been studied on either a 
theoretical or an experimental basis: f  ed-batch(411-416), repeated
, , ( 417-423)  (416,424)  . (425- 434)  ,batch , repeated f  ed-batch , semi-continuous and
periodic perturbation  of continuous culture*433 4485. In th is chapter the 
response of th is model to repeated-batch propagation s tra teg ies and 
periodic perturbations of continuous culture will be considered.
6.2 AN INVESTIGATION OF THE KINETICS OF REPEATED-BATCH OPERATION
6.2.1 Background
Repeated-batch culture techniques have been investigated by a number of 
workers as an alternative to  f  ed-batch and continuous cultures. Studies 
have been conducted on yeasts, Saccharom yces cerev is’iae*417,419,420* and 
Candida brassicaeiA16\  insect cells, Bom byx m o ri* 21\  and other animal
(422 423)cells ’ . The principal of repeated-batch operation is to  grow a
batch culture in the conventional manner fo r a fixed period of time. A
known frac tion  of the liquor (including cells) is then harvested and the
remaining liquor is diluted with fresh  medium; th is process is then
repeated. Generally, the fraction  of liquor harvested is kept constant and
the process is repeated a t regular time intervals*416’422,423* (the
dilution cycle time). However, other c r ite r ia  may also be used to determine
(419)the dilution point: a desired product or cell concentration, when a
particu la r nu trien t is depleted*417*, when gas evolution ceases*420* or
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when the culture en ters its  stationary  phase*421*.
In principle, there  is no reason why th is process may not be repeated 
indefinitely. As a  resu lt, dram atic improvements in overall productivity 
have been reported when using these methods as opposed to  conventional 
batch, f  ed-batch or continuous operation*416’417’419’420*; th is is in p a rt
due to  the reduction of bioreactor down time, but also due to overall 
improvements in specific productivity and product yields. Repeated-batch 
operation has also been used successfully as an interm ediate step between
(421)batch and continuous culture fo r kinetic studies
Despite these studies, only a limited amount of work has been conducted on 
the e ffec t of the various process param eters; harvest fraction , cycle time, 
dilution c rite ria , etc, and as a resu lt little  atten tion  has been paid to
(413)the optim isation of th is propagation method . There are  a number of
reasons fo r th is omission, not least being the time scale involved in these
types of experiments and the ir more complex kinetics. In attem pts to
address th is problem a number of kinetic descriptions of th is type of
(416 418 419 424)process have been proposed ’ ’ . However, these models are
based on simple, unstructured, distributed descriptions of growth, and
th e ir predictive capabilities are  limited. A fa r  more robust and detailed
m athem atical model is required to investigate th is method of operation more 
thoroughly and aid in process optimisation. Such a detailed m athem atical 
description has been developed fo r a hybridoma cell line w ithin CELCYMUS in 
the previous th ree chapters. This model may be used to  investigate the 
potential of th is method fo r enhancing antibody production and to  study the 
e ffec t of the various process param eters.
6.2.2 S im ulating  R epeated-B atch  C u ltu res w ith  CELCYMUS
6.2.2.1 P re lim in a ry  S im ulations
An a rb itra ry  experimental data se t was chosen f  rom those discussed in
Chapter Five (data set STIR3). In th is data  set, the viable cell 
concentration reached a peak of 5xl06 cells ml 1 a f te r  60 hours, w ith an 
in itia l glutamine concentration of 0.1 mg ml \  On the basis of th is 
inform ation a dilution cycle time of 55 hours and a harvest frac tion  of 80%
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were selected. The cycle time was selected to attem pt to ensure th a t the
culture would not enter its  death phase. The harvest frac tion  was selected 
so as to  m aintain approximately the same cell concentration a t the s ta r t  of 
each cycle. The growth of the culture was then simulated over 20 cycles 
(i.e. 19 dilutions).
The resu lting  viable cell concentration and cell viability data, together 
with the glutamine and antibody concentration data  fo r th is simulation are 
presented in Figure 6.1. In all of the data presented fo r the
repeated-batch  simulations, only the initial and final data  points fo r each
cycle are  shown, i.e. the concentrations immediately prio r to  harvest and
those immediately a f te r  dilution.
It is c lear from  the viable cell concentration data  (Figure 6.1a) th a t the
operational param eters selected are  inappropriate. A fter the second cycle 
the final viable cell concentration is less than 3xl06 cells ml-1 and the 
viability has dropped to 48%. During the th ird  cycle the number of viable
5 - 1  5 - 1cells actually fa lls  from  5x10 cells ml to 4x10 cells ml , w ith the
viability dropping even fu rth e r to 27%. In subsequent cycles the viability
recovers to above 90%, however it  s till takes 14 cycles fo r the final cell
concentration to  reach the initial peak of 4xl06 cells ml 1. Furtherm ore,
the final cell concentration only remains a t th is level fo r two cycles
before there  is another significant drop in viability, down to 65%, and a 
subsequent fa ilu re  to  grow.
These catastrophic f  ailures and subsequent long recovery periods are
reflected  in the glutamine (Figure 6.1b) and antibody (Figure 6.1c) 
concentration data. High final antibody concentrations and effective use of 
glutamine are  only observed when high viable cell concentrations resu lt,
i.e. a t the end of the 1st, 2nd, 16th and 17th cycles; during the recovery
period, significant amounts of glutamine remain in the medium and low 
antibody concentrations are  observed. Over the 20 cycle period 45% of the 
glutamine is w asted and although the true  yield fac to r of antibody from  
glutamine is 0.46 g g 1 (mass of antibody produced per unit mass of
glutamine consumed), the effective yield is only 0.25 g g 1 (mass of
antibody produced per unit mass of glutamine fed). As a resu lt the actual 
amount of antibody which would be recovered from  a one litre  vessel over
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th is 20 cycle culture, if  th is  s tra teg y  were applied, would only be 506 mg.
A second simulation was conducted with the same harvest fraction, but with 
a cycle time of- 50 hours; data fo r th is simulation are  presented in 
Figure 6.2. It is immediately clear from  these data  th a t a more stable 
response is obtained with th is cycle period. The final cell concentration
only varies between 3.5xl06 cells ml 1 and 4.5xl06 cells m l 1, while the 
viability is even more stable, fluctuating between only 80% and 85% (Figure 
6.2a). In almost every cycle, glutamine was exhausted (Figure 6.2b) and the
final antibody concentration (Figure 6.2c) varies between only 68 and
85 pg ml 1 (with the exception of the initial cycle). In th is case, over 
the 20 cycles, less than 2% of the glutamine is w asted and the true  
antibody yield is 0.62 g g \  with an effective yield is 0.61 g g 1.
These resu lts  will be discussed in more detail in Section 6.2.3. However, a
number of points should be highlighted: i) i t  is clear th a t the CELCYMUS is
capable of successfully simulating repeated batch propagation strateg ies; 
ii) these simulations have yielded responses typical of those encountered
by other researchers, albeit with d ifferen t types of cells; and iii) the
simulations predict potentially high levels of variability  between batches 
and periodic catastrophic failu res in the growth of cell populations; both
(423)of these phenomena have been observed in industry , although little  
work has been published with respect to them.
6.2.2.2 The E ffe c t o f V arying th e  D ilu tion  Cycle Time
The resu lts  presented above indicate th a t the dilution cycle time has a 
significant e ffec t upon the response obtained in th is method of culture. In 
order to  investigate th is more thoroughly, a number of simulations have 
been conducted with d ifferen t dilution cycle times. A constant harvest 
frac tion  of 80% has been used with cycle times of 45, 52 and 53 hours; th is 
harvest frac tion  was selected so th a t these data  may be compared directly
with those already obtained fo r 50 and 55 hours. The viable cell 
concentration and viability data fo r these new simulations are  presented in 
Figure 6.3.
A dilution cycle time of 45 hours yields a very stable response. The final
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viable cell concentration remains constant a t 3xl06 cells ml \  w ith a 
viability of 90% (Figure 6.3a). However, although stable, the final 
antibody concentration is quite low a t 51 pg ml 1 (not shown) and there  is 
a significant residual glutamine concentration, 20 pg ml \  (not shown) a t 
the end of each cycle. The response with a cycle time of 52 hours is more 
unstable. A fter the f i r s t  two cycles the final viable cell concentration 
drops to  2.8xl06 cells ml 1 and the viability fa lls  to  80% (Figure 6.3b). 
Subsequently, the behavior is very sim ilar to th a t observed a t a cycle time 
of 50 hours. The viable cell concentration fluctuates between 
3.5xl06 cells ml 1 and 4.5xl06 cells ml 1 and the viability fluctuates
Cy c 1 e 
T im e 
(Hou r s )
P e rc e n  ta g e  
G lu ta m in e  
U se d
T rue  
A nt ibody 
Y i e l d  
(g g " 1)
E f f  e c t  iv e  
Ant  ibody 
Y i e l d  
(g  g 1 )
55 54.  8% 0 . 4 6 0 . 2 5
53 89.  2% 0 . 6 0 0 . 5 4
5 2 97.  4% 0 . 6 3 0 .61
50 98.  7% 0 . 6 2 0 .6 1
45 76.  3% 0 . 5 2 0 . 4 0
Cy c le  
T ime 
(H o u r s )
T o t a l  
A n t  ibody 
P r  oduced 
(20 c y c l e s )
Ave ra g e  
A nt i body 
T i t  r  e 
(p g  m l - 1 )
Maximum P e r c e n t a g e  
V a r i a t i o n s  a r o u n d  
t h e  A v e ra g e
55 506 31 . 6 - 9 1 . 3 %  t o  +198%
53 1075 67 . 2 - 5 1 . 1 %  t o  +36.3%
5 2 1224 76 . 5 - 2 9 . 3 %  t o  +14.8%
50 1228 76 . 7 - 1 1 . 5 %  t o  +10.5%
45 799 50 . 5 - 0  . 9% t o  +0.8%
TABLE 6.1
A Sum mary o f th e  E ffe c t  o f V arying D ilu tio n  C ycle Tim e
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between 80% and 88%. Furtherm ore, the antibody concentration only varies 
between 70 pg ml 1 and 90 pg ml 1 (not shown), while the residual glutamine
concentrations are  mostly zero (not shown).
The data  fo r a dilution cycle time of 53 hours are  presented in Figure 
6.3c. At th is cycle time there is a fa ll in final viable cell
concentration, to  2.5xl06 cells ml 1, on the th ird  cycle, w ith a
corresponding drop in viability to 70%. In th is case it  takes five cycles 
fo r the culture to recover, however the response is s till very unstable and 
significant fa lls  in final cell yield are  observed on the 13th and 18th
cycles, w ith corresponding fa lls  in cell viability. This is also reflected
in the resu ltan t antibody concentration, which has a maximum value of
92 pg ml 1, but a minimum of 33 pg ml 1 (not shown); and the residual 
glutamine concentration (not shown) fluctuates between zero and 25 pg ml \
As mentioned above, the glutamine and antibody responses are  not shown, 
however a  summary of the analysis of these data, over a 20 cycle process, 
in term s of glutamine usage, antibody yields, to ta l antibody produced and
percentage maximum variation about the average antibody concentration, is
presented in Table 6.1.
6.2.2.3 The E ffect o f Varying the Harvest Fraction
The e ffec t of harvest fraction  in repeated batch culture has also been 
investigated a t a constant dilution cycle time. A 45 hour cycle time was 
selected because it produced a very stable response with an 80% harvest 
fraction. Corresponding additional simulations have have been conducted 
with the following harvest fractions: 70%, 75%, 77.5%, 85% and 90%. Viable 
cell concentration and cell viability data  f  or these simulation are
presented in Figure 6.4. A summary of the analysis of the glutamine and
antibody data  is presented in Table 6.2.
When the harvested fraction  is increased to  85% a washout type phenomenon 
is observed. The growth ra te  of the culture is not suffic ien t to  generate
enough new cells to  compensate fo r those removed when the culture is 
harvested. The viable cell concentration data  and cell viability da ta  fo r 
th is simulation are  presented in Figure 6.4d. At th is harvest fraction , the
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cells are  effectively washed out of the bioreactor within 10 cycles, while 
a t a harvest frac tion  of 90% (Figure 6.4e) th is is reduced to  5 cycles.
When the harvest fraction  is reduced to  77.5% the perform ance of the 
culture improves dram atically. During the f i r s t  four cycles the final cell 
concentration (Figure 6.4c) and the final antibody concentration increase 
consistently (not shown), while the amount of residual glutamine (not
shown) and the cell viability both fall. Subsequently, the final cell
concentration rem ains fa irly  steady a t approximately 4.1xl06 cells ml-1
w ith a viability of 85%, the final antibody concentration steadily
H a r v e s t
F r a c t i o n
P e r c e n t a g e  
G l u t a m i n e  
Us e d
True 
Ant ibody 
Y ie ld  
(g g " 1)
E f  f  e c t  i ve 
A nt ibody  
Y i e l d  
( g  g ' 1 )
0 . 7 67. 2% 0 .5 4 0 . 3 6
0 .7 5 94.  1% 0.61 0 . 5 8
0 .7 7 5 97. 8% 0.61 0 . 5 9
0 . 8 76.  3% 0 .5 2 0.  40
0 .8 5 34 . 4% 0 .23 0 . 0 8
H a r v e s t  
F r a c t  ion
T o ta l  
A n t  ibody 
P roduced  
(20  cyc les )
Ave r  age  
Ant i b o d y  
Ti  t  r  e 
( pg ml 1 )
M ax im um  P e r c e n t a g e  
V ar  i a t  i on s  a r o u n d  
t h e  A verage
0 . 7 721 45 . 0 - 8 2  . 6 %  t o  +114%
0 .7 5 1154 73 . 9 - 1 7 . 6 %  t o  +23. 1%
0 .775 1187 77 . 9 - 7  . 9% to  +6.5%
0 . 8 799 50 . 5 - 0  . 9% t o  +0.8%
0 .8 5 155 N/A due t o  w a s h o u t
TABLE 6.2
A Sum mary o f th e  E ffe c t  o f V arying H arvest Fraction
123
Novel A pplications
increases from  75 pg ml 1 to  82 pg ml 1 and the residual glutamine 
concentration fa lls  to  zero.
Decreasing the harvest frac tion  to  75% introduces some variability  into the 
response. The final cell concentration varies between 3xl06 cells ml 1 and 
4.5xl06 cells ml 1 (Figure 6.4b), while cell viability varies between 70% 
and 87%; ignoring the f ir s t  two cycles. Antibody concentration (not shown) 
varies between 60 pg ml 1 and 90 pg ml \  with the exception of the f ir s t  
cycle, and the residual glutamine concentration (not shown) varies between 
0 pg ml 1 and 26 pg ml \
Reducing the harvest fraction  s till fu rth e r generates a very unstable 
response; Figure 6.4a shows data fo r a harvest frac tion  of 70%. During the 
f i r s t  four cycles the viability drops dram atically to 45% and there is 
almost no growth during the fourth  cycle. In the next five cycles a 
recovery is observed, however the viability then drops rapidly again, th is 
tim e to  20%, and the culture takes ten cycles to recover. This resu lts  in a 
large fluctuation in the antibody concentration, which varies between 
10 pg ml 1 and 97 pg ml 1 (not shown), and the residual glutamine 
concentration varies between 0 pg ml 1 and 85 pg ml 1 (not shown).
6.2.3 Discussion o f Repeated-Batch Simulation R esults
Similar responses to those observed in experim ental
( 416, 417, 419, 421, 422, 423)  , , , , . , „ , ,  , .systems have been obtained from  the model.
Furtherm ore, the model has indicated high levels of variability  w ith 
respect to  final cell and product concentration, as observed by Nishizawa 
e t a l (417) and Stavroulakis e t a l (421), as well the periodic, sudden and 
catastrophic fa ilu res of a cultures, as observed by G riff ith s(422) and
C1 . ( 423)Slater
As with the experimental systems, the media make-up may be eliminated as a 
possible cause of these phenomena. In all of the simulations a substantial 
amount of fresh  media is added a t the beginning of each cycle. As a resu lt 
the in itia l glutamine concentration is always between 80 pg ml 1 and 
100 pg ml 1 (the glucose is also replenished) and any residual ammonia, 
lactate , and antibody are diluted. No other medium components are
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considered in th is model and the e ffec t of batch to  batch variation and 
contamination of media do not apply. As a resu lt, the media a t the s ta r t  of 
each cycle may be considered to be almost the same in each case and
furtherm ore th a t some other fac to r must be responsible fo r the observed 
variab ility  and growth failures. This conclusion can be confirmed by
conducting simulations in which the cells are completely resuspended in 
fresh  media. Clearly th is would be d ifficu lt to achieve in practice,
however i t  is relatively simple to  simulate within CELCYMUS. A number of
sim ulations have been conducted and the same phenomena are observed, thus
confirming the above supposition.
An analysis of cell age distributions obtained from  the model a t the s ta r t  
and the end of each cycle reveal the true  cause of the variability  and
periodic grow th failures. The more heterogeneous the age distribution a t 
the end of a cycle the more successful the growth in the subsequent cycle. 
However, if  as a resu lt the cell population grows too fa s t  and the 
glutamine becomes completely depleted, cells will s ta r t  to  accumulate in 
the Gl phase of the cell cycle and subsequently enter the D phase. This 
will resu lt in a poor initial age distribution fo r the next cycle and a 
subsequent drop in performance. So, any variations in in itia l age 
distribution will simply resu lt in acceptable variations from  cycle to  
cycle, provided the dilution cycle time is selected so th a t resuspension
occurs well before the peak in cell concentration observed in batch culture 
and the harvest frac tion  is selected so th a t i t  will leave approxim ately 
the same inoculum size a t the s ta r t  of each cycle.
At a dilution cycle time of 45 hours and a harvest frac tion  of 80% almost 
no variability  is observed a f te r  the f ir s t  th ree cycles. Cells are  always 
resuspended when they are  in mid-exponential grow th and when th e re  is 
plenty of nu trien t le ft available. This resu lts  in a good age distribution 
fo r the subsequent cycle. The harvest frac tion  leaves an inoculum size 
almost the same as the previous inoculum size and hence the cell population 
always grows to  the same final concentration. However, as the cycle time 
increases the amount of variation from  cycle to  cycle increases (Figures
6.1a, 6.2a & 6.3). This is a d irect resu lt of variations in the in itia l age 
distribution. Ultimately, these variations become catastrophic and lead to 
periodic growth fa ilu res when cycle times of 53 (Figure 6.3c) and 55 hours
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(Figure 6.1a) are  applied.
Considering these simulations in more detail: in both cases the initial
cycle produces a final population with a low percentage of cells in Gl and 
D. During the second cycle of each culture these populations grow rapidly, 
consume all the available nu trien t and pass th e ir peak before the dilution 
cycle tim e is reached. This resu lts  in a loss of viability and poor or 
non-existent growth in the subsequent cycle. As the harvest frac tion  is the 
same in both cases, a longer cycle time also yields a higher inoculum fo r 
the second cycle and hence exasperates the problem. As the cycle period is 
reduced the time fo r accumulation in the Gl and D phases is reduced and 
eventually the possibility of the cell population consuming all the 
available nu trien t and passing its  peak is eliminated altogether. As a 
resu lt, the possibility of producing a ‘poorly’ d istributed population
becomes less likely.
As has already been s ta ted  there  is very little  variability  a t a dilution 
cycle time of 45 hours with a  harvest frac tion  of 80%. Increasing the 
harvest fraction  will decrease the subsequent inoculum size. As a resu lt, 
the cell population will be even less capable of consuming the available 
nu trien t so the variability  will not be affected. Furtherm ore, if  the
harvest frac tion  is increased too much, a ‘w ash-out’ type phenomenon may be 
observed (Figure 6.4e). If the harvest fraction  is decreased, the 
subsequent inoculum sizes will become larger, thus resulting  in higher cell 
concentrations and the possibility of consuming all of the available 
nutrient. This will inevitably increase the variability  in the culture by
the same mechanism th a t is discussed above. This can be seen in Figure 6.4
as the harvest frac tion  is decreased from  90% to  70%.
It is clear from  the above discussion th a t both dilution cycle tim e and 
harvest frac tion  a ffec t the cycle to  cycle variability  by causing changes
in the in itia l age distribution. Increasing the dilution cycle time or 
decreasing the harvest fraction  will resu lt in an increase in variability.
However, these changes will also resu lt in an increase in productivity; 
higher cell concentrations can be achieved, yielding g rea te r product 
concentrations and utilising more of the available nutrient. In process
engineering term s, a balance must be drawn between an acceptable level of
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variability  and a suitable level of productivity. Therefore, the effec t of 
both of these operational param eters upon efficiency and productivity of 
must now be considered and compared to  conventional batch culture.
In the equivalent batch culture (data se t STIR3), the final antibody 
concentration, a f te r  70 hours, was 85 pg ml \  All of the glutamine was 
consumed and the yield of antibody on glutamine was 0.85; in th is case the 
effective yield and the true  yield are  the same. It is clear from  Tables
6.1 and 6.2 th a t repeated batch cultures perform  less efficiently  than the 
^equivalent batch culture with respect to  product yield. In every simulation 
some glutamine is wasted, although th is is reduced to less than 3% in a 
number of cases. However, in every case the effective yield is
significantly lower than th a t observed in batch culture, and even when the 
w asted glutamine is ignored and the true  yields are  compared, there  is 
s till a significant reduction in efficiency. Furtherm ore, even though in 
certain  cases the final antibody concentration does exceed th a t obtained in 
batch culture, the average final antibody concentration fo r each simulation 
is lower in the final harvest.
The differences in product yield, although very significant, may be
somewhat misleading with regard  to  overall production ra te . As has been 
pointed out in Chapter Five, a significant amount of antibody production 
occurs during the decline period of a batch culture; the decline period is 
the main fea tu re  of the growth curve which th is propagation method is 
designed to  eliminate. In order to  compare the batch and repeated batch 
methods in process engineering term s the overall antibody production ra te  
(antibody produced per unit time per unit volume) shall be considered. 
These have been evaluated fo r each repeated batch simulation and fo r the 
batch culture (Table 6.3).
In the case of the batch culture the to ta l amount of antibody produced per 
litre  (85 mg 1 *) has been divided by the time required to  reach the final 
concentration (70 hours), plus an additional period to  allow fo r the tu rn  
around of the vessel (downtime); th is is assumed to  be 40% of the batch
time. This gives a to ta l batch time fo r a batch culture of 118 hours and
yields an overall antibody production ra te  of 0.72 mg 1 1 hr \  For the 
repeated batch culture data, the to ta l amount of antibody produced per
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li tre  over 20 cycles (see Tables 6.1 and 6.2) has been divided by the to ta l 
production time (i.e. fo r a 45 hours cycle period th is is 900 hours), plus 
the same downtime as th a t applied to a batch culture (48 hours).
It can be seen from  Table 6.3 th a t in term s of overall antibody production 
ra te  a repeated batch propagation strategy  perform s very well, in the best 
case (cycle time 45 hours, harvest fraction  77.5%) the overall productivity 
is 1.25 mg 1 1 hr \  a 73.6% increase when compared to conventional batch 
culture. Even simulations which on f ir s t  inspection would appear to  have 
perform ed poorly, fo r instance cycle time 45 hours, harvest frac tion  70% 
(Table 6.2), have a higher overall production ra te  than the conventional
Di l u t  io n  
C y c l e  Time 
( H o u r s )
H a r v e s t  
F r a c t  ion
O v e r a l 1 
P r o d u c t  ion 
Ra te  
(mg 1 1 h r  *)
55 0 . 8 0 .44
53 0 . 8 0 .9 7
52 0 . 8 1. 13
50 0 . 8 1. 17
45 0 . 8 0 .84
45 0 . 7 0 .76
45 0 .7 5 1.22
45 0 .775 1.25
45 0 .85 0.  16
Batch 0 .7 2
45 0.775
*
1.32
Batch
*
1.21
* N o  D o w n t i m e
TABLE 6.3
A C om parison B etw een O verall A ntibody P roduction  R ates O btained fo r  
V arious R epeated  F ed-batch  C ultures and a C onventional Batch C ulture
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batch culture. If downtime is ignored, it is apparent th a t i t  is the 
reduction of th is period th a t is largely responsible fo r the improvement in 
overall production ra te . However, even when downtime is ignored the best
production ra te  in repeated batch culture is 1.32 mg 1 1 hr 1, which is
9.1% g rea te r than in conventional batch culture.
Finally, even though the overall production ra te  is generally enhanced, in 
a complete process f  actors such as antibody concentration in the 
supernatan t and its  variability  cannot be ignored. In the best simulation
(cycle tim e 45 hours, fraction  77.5%) the average antibody concentration is 
77.9 pg m l 1, th is  is only 9% lower than th a t obtained in batch culture. 
Furtherm ore, th is  concentration only varies between +6.5% and -7.9% of this 
mean; well w ithin the bounds of typical batch to batch variation in
conventional culture. Considering these fac to rs  in a sim plistic
m anufacturing strategy , the same overall production ra te  could be 
maintained w ith a minimal increase in the capacity on the downstream side 
(if thought necessary), but with a 45% reduction in the capacity of the
upstream  process.
6.3 NOVEL CHEMOSTAT FEEDING STRATEGIES
6.3.1 Background
A number of workers have investigated the occurrence of oscillatory
responses in chem ostat culture. Such oscillations may be induced by
periodically varying one of the feed stream  param eters, typically dilution
ra te  or nu trien t concentration. Much of the early work considered the
effec ts  of sinusoidal variations in dilution ra te  on cultures of
Saccharom yces c e rev is ia e^36\  The effec t of square wave variations in
(438)dilution ra te  has been studied fo r th is organism by Vairo e t al , while
(439)Borzani e t al investigated square wave variations in nutrien t 
concentration. Other workers have studied the effects  of variations in 
nu trien t concentration in cultures of E.coli. Sundstrom e t a l (436) applied 
sinusoidal variations in nutrien t concentration, while P ickett e t
( 440 442)al ’ studied the effect of square wave perturbations in nutrien t 
concentration.
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These studies suggest th a t improvements in productivity and overall
perform ance may be possible(440), however, the time consuming nature of
these studies, especially w ith respect to mammalian cells, is hindering
th e ir fu rth e r  development. A suitably robust and detailed model may be used 
fo r the fu rth e r  investigation of these phenomena. Using the model developed 
in Chapters Three, Four and Five fo r the mm321 hybridoma cell line a b rief 
study of these phenomena will be presented.
6.3.2 Sim ple O n /O ff Feeding S tra teg y
The sim plest alternative f  eeding strategy, which may be applied to a
continuous bioreactor, is to switch the growth limiting nutrien t
concentration in the feed stream  on and o ff a t regular intervals.
Simulations have been carried  out over a range of perturbation cycle times,
up to  20 hours, a t a dilution ra te  of 0.024 hr \  In order to  make these 
data  directly  comparable w ith th a t obtained f  rom the s teady -sta te
predictions presented in Chapter Five, the glutamine feed concentration has 
been doubled fo r the periods of time when it  is on. As a resu lt, the
overall glutamine feed ra te  to  the bioreactor is the same as when glutamine
is fed continuously.
The viable cell, glutamine and antibody concentration responses to 
perturbation  cycle tim es of 8, 12, 16 and 20 hours a re  presented in Figure 
6.5. In each case, a well defined oscillatory response is obtained. With a 
cycle time of 8 hours, the viable cell response (Figure 6.5a) is almost saw
5 -1tooth in nature; the maximum cell concentration being 5.7x10 cells ml
5 - Iand the minimum being 5.4x10 cells ml . At 12 hours, th is saw tooth 
response becomes more defined, however both the maximum and minimum cell 
concentrations are  lower, a t 5.6xl05 cells ml 1 and 5.2xl05 cells ml 1
respectively. A cycle time of 16 hours yields a fa r  more symmetrical 
response and the maximum and minimum cell concentrations are  considerably 
increased, to  6.8xl05 cells ml 1 and 5.7xl05 cells ml 1 respectively. 
However, a t 20 hours the maximum cell concentration is reduced to
5 - 1  5 - 15.6x10 cells ml and the minimum to 4.9x10 cells ml . This cycle time
also yields a response with a double peak, the second peak being lower a t a
5 - 1  ^cell concentration of 5.5x10 cells ml .
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The response in the bulk glutamine concentration (Figure 6.5b) is f a r  more 
consistent. For cycle tim es of 8, 12 and 20 hours a symmetrical triangular 
wave resu lts, each peak being interspersed with a short period during which 
the glutamine concentration is almost zero. The bulk glutamine 
concentration increases steadily while the concentration in the feed stream  
is on and fa lls  steadily when it  is switched off. The only exception to 
th is  is the response to a cycle time of 16 hours, where the glutamine 
concentration s ta r ts  to  increase once it  is switched on, however when it 
reaches a level of 0.8 pg ml 1 it  remains constant fo r about 3 hours and 
then resumes the steady increase.
The antibody concentration response is presented in Figure 6.5c. This is 
very smooth when compared to the viable cell and glutamine responses, with 
no sharp changes in concentration. The response a t cycle times of 12 and
16 hours is almost sinusoidal, with the amplitude of the response a t 
16 hours being almost five times g rea ter than th a t obtained a t 12 hours. At 
16 hours the concentration varies between 150 pg ml 1 and 159 pg ml \  
while a t 12 hours i t  varies between 126 pg ml 1 and 128 pg ml \  At cycle
tim es of 8 and 20 hours the sinusoidal wave is skewed to the right. The
response is very f la t  a t 8 hours, with the antibody concentration only 
varying between 132 pg ml 1 and 133 pg ml \  While a t 20 hours it  varies 
between 125 pg ml 1 and 129 pg ml \
The overall e ffec t of cycle time on the maximum and minimum viable cell and 
antibody concentration is summarised in Figure 6.6a. In th is Figure the
maxima and minima are  plotted as percentage variations from  the steady 
s ta te  concentrations obtained a t the same dilution ra te . The maximum viable 
cell concentration is marginally enhanced a t low cycle times, up to 
8 hours, by 2% fo r a cycle time of 4 hours. Above 8 hours the maximum cell 
concentration rem ains less than th a t obtained a t steady s ta te , until a 
cycle time is 12.5 hours is applied; the minimum being 2% below the steady 
s ta te  value a t 10 hours. Between cycle times of 12.5 and 16 hours the 
maximum cell concentration increases rapidly, reaching a peak 19% above the 
steady s ta te  value, it  then declines back to its  steady s ta te  
concentration. Above a cycle time of 19 hours the maximum cell 
concentration continues to decline, falling to  a  level of 1% below the 
steady s ta te  value a t 20 hours. The minimum cell concentration fa lls  by
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8.3% a t a cycle time of 10.5 hours. It then increases to  a peak of 0.5% a t 
16 hours, falling away again to  a value 13% lower than th a t achieved a t 
steady s ta te  fo r a cycle time of 20 hours.
A very sim ilar trend  as th a t obtained fo r viable cell concentration is 
obtained fo r antibody concentration as cycle time is varied. There is a 
small enhancement in both maximum and minimum antibody concentration a t low 
cycle times, below 5 hours. However, between cycle times of 5 and 14 hours 
both the maximum and minimum concentrations are  less than th a t obtained a t 
steady sta te ; the maximum falling by 5.4% fo r a cycle time of 11 hours and 
the minimum falling  by 7% a t 11.5 hours. Above 14 hours the maximum and 
minimum concentrations increase sharply, both increasing by 17% and 11% 
respectively fo r  cycle time of 16 hours. These then decline rapidly, 
falling  by 3.5% and 7.5% of the steady s ta te  value a t  20 hours.
The e ffec t of cycle time on the overall production ra te  (antibody produced 
per unit volume per unit time) is presented in Figure 6.6b. Not 
surprisingly, the variation in overall production ra te  f  ollows the same 
trend  as th a t observed fo r the maximum and minimum antibody concentration. 
At cycle tim es below 4 hours the overall production ra te  is. fractionally  
enhanced, however between 5 and 14 hours it  is reduced, by up to 6.2% fo r a 
cycle time of 10.5 hours. Between 14 and 16 hours the overall production 
ra te  is enhanced considerably, exhibiting a peak fo r a cycle time of 
16 hours; a t th is  cycle time there is a 14% increase in overall production 
ra te  as compared to  the steady s ta te  value. Above 18 hours the overall 
production ra te  fa lls  by 5.4% fo r a cycle time of 20 hours.
The variations in tru e  and effective product yields w ith cycle tim e are  
presented in Figure 6.6c. The effective yield follows exactly the same 
trend  as th a t predicted f  or the overall production ra te . There is a 
minimum, 5.6% below the steady sta te , fo r a cycle time of 10.5 hours and a 
maximum, 13.5% above the steady sta te , a t 16 hours, the yield then
decreases by 5.6% a t a cycle time of 20 hours. However, the tru e  yield 
exhibits a slightly d ifferen t response. This is actually higher than  th a t
obtained a t steady s ta te  over most of the range of cycle tim es considered.
It is only detrim entally affected  between cycle tim es of 9 and 11 hours,
falling by 2.2% a t 10.5 hours. The peak in true  yield is also a t a cycle
132
Novel Applications
time of 16 hours, however the true  yield is enhanced by almost 17%. There 
is also a maximum fo r a cycle time of 4 hours of 2.7%. It should also be 
noted th a t the divergence between the true  yield and the effective yield is 
increased significantly a t cycle times g reater than 16 hours.
6.3.3 The E ffec t o f Varying the Amplitude o f the Square Wave
Switching the nu trien t concentration on and off imposes a square-wave
forcing function upon the system. The effect of varying the amplitude of
th is square-w ave forcing function has also been investigated. As with the
on /o ff feeding strategy , the maximum and minimum concentrations may be 
arranged so th a t the overall feed ra te  of glutamine to  the b ioreactor is
the same as th a t used to  obtain the steady-sta te  a t a dilution ra te  of 
0.024 h r 1. Applying th is principle means th a t the simple on /o ff feeding 
strategy , investigated above, represents the maximum possible amplitude of 
the square-w ave and a fixed feed concentration of 146 pg ml 1 represents 
the minimum amplitude of zero. Simulations have been conducted over this 
range of amplitudes w ith a fixed cycle time of 16 hours.
In each case the responses only d iffered in term s of amplitude and not 
shape. In Figure 6.7a the maximum and minimum viable cell and antibody
concentrations over th is amplitude range are plotted as percentage
variations from  the steady s ta te  values. As the amplitude increases, the 
maximum cell concentration and the maximum and minimum antibody
concentrations all increase f  rom the steady s ta te  values in a broadly 
linear fashion. The minimum cell concentration decreases by 1.5% a t 30% of 
the maximum amplitude, and then steadily increases, surpassing its  steady 
s ta te  value a t 80%.
The a ffec t of amplitude on overall antibody production ra te  and the product 
yields are  presented in Figures 6.7b and 6.7c. Above an amplitude of 30% of 
the maximum, both overall production ra te  and effective yield give a
s tra ig h t line. Up to  an amplitude of 40% the tru e  and effective yields are 
the same. However, a t th is point they diverge, the true  yield becoming a 
linear function above 60%.
133
Novel A pplications
6.3.4 The E ffect o f Varying the Duration o f the O n/O ff Ratio
The effec t of varying the ra tio  between the percentage of time the nutrient 
concentration is on and the percentage of time it  is o ff has also been 
studied. In all of the simulations considered so fa r , the concentration of 
nu trien t in the feed stream  was set a t its  maximum value fo r 50% of the 
tim e and a t its  minimum fo r 50% of the time; an o n /o ff ra tio  of 1:1. The 
fraction  of time during which the nutrient concentration is switched on has 
been varied between 0% and 100%; the concentration of glutamine in the feed 
stream  has also been varied so as to maintain the same overall feed ra te  of 
glutamine to  the bioreactor.
/
The e ffec t of varying the on /o ff ra tio , on the maximum and minimum viable 
cell and antibody concentrations, a t a cycle time of 16 hours, is presented 
in Figure 6.8a. As the percentage of time during which the glutamine is 
switched on is reduced, the maximum viable cell and antibody concentrations 
increase steadily. They reach peaks a t 19.5% and 18% above the steady s ta te  
values a t an o n /o ff ra tio  of 4.8:5.2 (48% on) and subsequently decline 
steadily. The minimum antibody concentration remains a t its  steady s ta te  
value until the o n /o ff ra tio  fa lls  to 9:1 (90% on), i t  then increases
steadily. It reaches a peak a t an on /o ff ra tio  of 1:1 (50% on) and then
fa lls  away. In the case of the minimum cell concentration, th is  fa lls  to  1% 
below the steady s ta te  value a t an on /o ff ra tio  of 4:1 (80% on) and then
increases. It reaches a peak of 0.5% a t an o n /o ff ra tio  of 1:1 (50% on) and
then fa lls  steadily. When the percentage of time during which the glutamine
is on is reduced to zero and the feed concentration is infinite , the
glutamine is added as an instantaneous pulse of ‘zero’ duration. This
periodic pulsing yields a maximum and minimum viable cell concentration 12% 
above and 7% below the steady s ta te  values, and a maximum and minimum
antibody concentration of 9% above and 3% above.
In Figures 6.8b and 6.8c, the variation in overall production ra te  and 
product yields w ith on /o ff ra tio  are  presented. Both the overall production 
ra te  and the effective yield follow the same trend  as th a t observed fo r 
antibody concentration, reaching a peak a t an on /o ff ra tio  ju s t below 1:1 
(50% on). The tru e  yield however responds differently . At o n /o ff ra tio s  
below 1:1 the tru e  yield continues to increase to  an asym ptotic value of
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1.07 g g"1.
6.3.5 D iscussion
The imposition of square-wave perturbations in glutamine f  eed 
concentration, has yielded an extremely complex and varied set of predicted 
responses in bulk viable cell, glutamine and antibody concentration fo r a 
continuously fed bioreactor. In this discussion, some of the aspects of
these responses will be considered in detail: specifically the nature of
the oscillations in term s of the cell cycle and the e ffec t of cycle period, 
amplitude and o n /o ff ra tio  on the overall productivity and bioreactor 
efficiency. Finally, these resu lts  will be compared briefly  to  those 
available in the lite ra tu re .
6.3.5.1 N atu re  o f th e  o sc illa to ry  response
The cause of the oscillatory phenomena may best be understood by
considering the changes in the cell age distributions. In Figure 6.9 the
cell age distribution fo r an on /o ff feeding stra tegy  w ith a cycle tim e of 
16 hours and an o n /o ff ra tio  of 1:1 is presented. The variation in the 
response between d ifferen t phases is quite significant. The Gl phase 
exhibits a sinusoidal type response, the difference between the minimum and 
maximum being 44.7%. The S phase exhibits a sim ilar response, however in 
th is case the difference is only 34.8%. The G2 and M phase responses are 
almost identical w ith a significant skew to the le ft. The differences 
between the minimum and maximum are 14.4% and 12.5% respectively. Finally, 
the response fo r the D phase has a fla ttened  peak and is also
non-symmetrical; in th is case the difference between the minimum and 
maximum is 5.8%.
Consider a single cycle s ta rtin g  a t the peak in the Gl response. At time
zero the percentage of cells in the Gl phase is a t its  maximum of 69.1%.
The maxima in the percentage of cells in the S, G2, M and D phases occur a t
7, 9, 11 and 9 hours with values of 35.7%, 14.4%, 12.5% and 17.7%
respectively. The minimum value fo r the percentage of cells in the Gl phase 
occurs a f te r  8 hours and is 24.4%. While, the minima fo r the S, G2, M and D 
phases are  0.91%, 0%, 0% and 11.9% occurring a t 13, 2, 4 and 4 hours. The
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behavior is indicative of a partia lly  synchronised population of cells.
The mechanism by which the cell population is forced into, and maintained 
in, p a rtia l synchronisation is as follows: when the glutamine is switched 
off cells s ta r t  to  accumulate in the G1 phase of the cell cycle; th is is 
because in itia tion of the S phase is dependent upon the cumulative amount 
of glutamine consumed in the Gib phase. As a resu lt the percentage of 
cells, in the S phase initially  and subsequently in the G2 and M phases is 
depleted. When the glutamine is switched back on, cells trapped in G1 can 
now s ta r t  to  accumulate glutamine and enter the S phase. The G1 percentage 
reaches a maximum and s ta r ts  to  decline, the S percentage increases and 
th is is reflected  5 hours la te r in the G2 phase (the duration of S) and 7 
hours la te r  in the M phase (the combined duration of S and M). If the 
glutamine concentration were now le ft on, th is p artia l synchronisation 
would be lost quickly due to the stochastic element associated w ith the 
in itia tion of the S phase. However, because the glutamine is switched on
and o ff periodically, th is partia l synchronisation is reinforced until a 
constant oscillatory response is obtained.
Generally, all of the oscillations predicted in the simulations as a resu lt 
of periodic perturbations in glutamine f  eed concentration, may be 
a ttrib u ted  to the imposition of varying degrees of p a rtia l synchronisation 
in the cell population.
6.3.5.2 The e f fe c t  o f perturbation parameters on viable cell and antibody 
concentration
The response of the viable cell and antibody concentrations to  variations 
in cycle time are  presented in Figure 6.6a. It is clear from  th is Figure
th a t both viable cell and antibody concentration may be enhanced by 
imposing periodic perturbations in glutamine feed concentration. 
Furtherm ore, the optimum cycle time would appear to be 16 hours fo r an 
o n /o ff ra tio  of 1:1. It is also evident from  Figure 6.6a th a t the amplitude 
of the oscillations increases with cycle time up to  the optimum cycle time 
of 16 hours and then decreases.
The reason fo r  the enhancement in viable cell concentration is re la ted  to
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glutamine availability fo r cells in the Gib phase. At steady s ta te , the 
residual glutamine concentration is almost zero. Glutamine is fed a t a ra te  
which is equivalent to  the requirem ents of the cells in Gla and Gib phases; 
in the model, cells are  assumed to  consume glutamine during these phases 
only. However, cells only require glutamine to complete the transition  from 
Gib to  S, they do not need it to complete Gla. When perturbations in 
glutamine f  eed concentration are imposed upon the culture, glutamine 
availability fluctuates. When glutamine is unavailable, cells in the Gla 
phase are  unaffected, however it  is less likely or even impossible fo r 
cells in Gib to in itia te  the S phase. The peak which is observed a t a cycle 
time of 16 hours is because the glutamine in the feed is switched o ff while 
the m ajority  cells are  in the Gla phase, or are  in the other cell cycle
phases, and it  is switched on when they are  in the Gib phase. As a result, 
more of the glutamine is available when the cells require it  to  progress
around the cell cycle. This resu lts  in a more effic ien t use of the 
glutamine with respect to cell cycle kinetics and as a  resu lt the viable
cell concentration is enhanced. At higher and lower cycle tim es the 
glutamine availability is out of step with the requirem ents of the cell 
population, glutamine is thus used less efficiently  with respect to  cell 
cycle kinetics. Indeed, a t cycle times between 5 and 14 hours and above 
17 hours the glutamine is used less efficiently  than during steady s ta te
resu lting  in lower viable cell concentrations.
As cycle time varies the maximum and minimum antibody concentrations follow 
the same trend  as th e ir respective viable cell concentrations. However, 
there  are  two differences, i) the amplitude of the oscillations is 
significantly less and, ii) the percentage increase in the average antibody 
concentrations is g rea te r than th a t observed in the average viable cell 
concentrations. The reason fo r the reduction in the amplitude of the 
oscillations is th a t antibody is produced over a large proportion of the 
cell cycle while the event controlling the ra te  of cell division, the Gl-S 
transition , occurs a t one point in the cell cycle. As a resu lt the e ffec t 
of the p artia l synchronisation is significantly ‘dam ped-out’ in the case of 
the antibody response.
The g rea te r percentage increase in the average antibody concentration 
implies an increase in the specific antibody production ra te . This may only
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occur if  cells spend a g rea te r proportion of the ir time in the antibody 
producing phases of the cell cycle; Gib and S. As the S phase is of fixed 
duration i t  must be concluded tha t, on average, cells must spend longer in 
the Gib phase and hence the average doubling time should increase. This is 
despite the fa c t th a t glutamine is more readily available fo r cells in the
Gib phase to complete the transition  to  the S phase. At a cycle time of 
16 hours the glutamine is switched off fo r long enough to  allow the cells
to s ta r t  to accumulate in Gib. However, it  is switched back on well before
the maximum duration of 10 hours, th is affo rds plenty of time fo r these
cells to accumulate glutamine and in itia te  the S phase. A consequence of 
th is behaviour is th a t the average ra te  a t which cells en ter the D phase is 
reduced; th is is reflected  in a low average percentage of cells in the D
phase fo r a cycle tim e of 16 hours. As a resu lt, more cells remain in the 
main p a rt of the cell cycle and are thus capable of division, hence the 
cell concentration is enhanced.
The effec ts  of both amplitude and on /o ff ra tio  have been studied a t the
optimum cycle time of 16 hours. Their effects upon viable cell and antibody 
concentration are  presented in Figures 6.7a and 6.8a. The average cell 
concentration and the amplitude of the oscillations increases as the
amplitude of the imposed perturbation increases. This is simply a resu lt of 
glutamine being supplied more efficiently  in term s of cell cycle
progression a t higher amplitudes; more is available when required fo r Gib
and less is being fed, and hence wasted, when the m ajority of cells are
elsewhere in the cell cycle. Therefore, higher amplitudes impose a g rea te r
degree of synchronisation on the cell population.
A very sim ilar resu lt to  th a t described above, and fo r the same reason, is 
obtained as the o n /o ff ra tio  is reduced to 1:1 (50% on). However, below
this ra tio , the values of the maximum and minimum viable cell
concentrations fa ll, but the height of the oscillation rem ains the
constant. As the period of time during which the glutamine is f  ed is
reduced more glutamine is washed out, th is is because the cells are  unable 
to  assim ilate the glutamine a t a fa s t enough ra te . However, the height of 
the oscillations remains constant suggesting th a t the degree of
synchronisation rem ains constant. It may be concluded th a t a t o n /o ff ra tio s  
below 1:1, fu rth e r  reductions in the period of time over which glutamine is
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fed does not increase the degree of synchronisation, however it  does allow 
more tim e f  or glutamine to be washed out, hence the f  all in cell
concentration. The responses in the antibody concentration are  broadly 
sim ilar to  those observed in the viable cell concentration. The only
significant difference is th a t the amplitude of the response is much 
smaller; as discussed above.
6.3.5.3 The e f fe c t  o f perturbation parameters on bioreactor perform ance
Bioreactor perform ance may be measured in a number of ways. In th is case 
changes in the overall productivity, the true  product yield and the 
effective product yield have been considered. These are  the same param eters 
used fo r  the repeated-batch  simulations considered in Section 6.2. As there 
is no change in dilution ra te , the overall productivity is directly rela ted  
to  the average antibody concentration. The maximum increase in overall 
productivity is obtained fo r a cycle time of 16 hours, a t maximum amplitude 
and a t an o n /o ff ra tio  fractionally  under 1:1. I t is also clear from  Figure 
6.6b th a t there  is only a narrow  range of cycle tim es during which overall 
productivity is enhanced. At cycle times between 4 and 14 hours and g rea ter
than 18 hours the overall productivity is reduced. Below 4 hours it  is only
enhanced very slightly, however between cycle tim es of 14 and 18 hours 
productivity may be enhanced by up to 14%, from  a level of 3.21 mg 1 1 h r 1 
to 3.65 mg 1 1 h r \
The effective yield gives broadly the same resu lts  over the range of cycle 
times, amplitude and on /o ff ra tio  considered as those obtained fo r overall 
productivity. This is because the overall glutamine f  eed ra te  to  the 
b ioreactor is the same fo r each simulation. Therefore, the effective yield 
is also a d irec t function of the average antibody concentration. Hence, the 
maximum effective yield is also obtained under the same perturbation  
conditions as th a t which produced the maximum in overall productivity. The 
maximum increase in effective yield is 13.6%, an increase from  0.92 g g 1 
to  1.05 g g"1.
The tru e  yield gives a more interesting resu lt. This is a function of both 
the average antibody concentration and the percentage of glutamine w asted 
in the effluent stream  from the bioreactor. It is immediately clear from
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Figure 6.6c th a t the tru e  yield is generally enhanced when an oscillatory 
concentration in feed stream  is applied; tru e  yield only fa lls  below its  
steady s ta te  value between cycle times of 9 and 11 hours. This supports the 
explanation th a t glutamine is used more efficiently  when fed periodically, 
w ith the ra tio  between the amount of glutamine being consumed in Gla to 
th a t in Gib generally being shifting tow ards Gib; except fo r cycle times 
between 9 and 11 hours. The maximum increase in true  yield is 16.3%, an 
increase from  0.92 g g 1 to  1.07 g g \
As w ith the repeated batch simulations, the overall productivity can be 
compared w ith the conventional batch culture. Considering a fu ll process 
and hence taking into account downtime, repeated batch culture gives a 
73.6% increase in productivity over conventional batch. From the 
experim ental data  obtained from  H ayter(15), continuous culture gives a 346% 
increase. However, using a simple on-off feeding s tra tegy  with an on-off 
ra tio  slightly below 1:1 (50% on) th is may be enhanced fu rth e r, to  give a 
405% increase in productivity. Even if  downtime is ignored the increase is 
s till 202%, compared to  9.1% in repeated batch and 165% in a conventional 
chemostat.
6.3.5.4 A b r ie f comparison w ith  other studies
No studies on the effects  of periodic perturbations in nutrien t 
concentration fo r mammalian cell culture have been published. Of the work
available in the lite ra tu re , the studies conducted by Pickett e t
(440  442) (439)al ’ and Borzani e t al , who both considered square wave
variations in nu trien t concentration, re la te  most closely to  th is study.
In the work conducted by Pickett e t  aZ(440), the ef f ec t  o f  cycle tim e was 
investigated by subjecting cultures of E.coli to  variations in glucose 
concentration between 0.2 and 0.4 g 1 1 over a range of cycle tim es between 
0 and 6 hours. An on /o ff ra tio  of 1:1 was used and these resu lts  were 
compared to those obtained a t steady s ta te  fo r a glucose feed concentration 
of 0.3 g 1 1; i.e. a t the same overall glucose feed ra te . The e ffec t of
(442)amplitude was studied a t a cycle time of 2 hours . The minimum glucose 
concentration remained fixed a t 0 .2 g 1 \  while the maximum glucose 
concentration was varied from  0.2 g 1 1 to 5.0 g 1 !. A dilution ra te  of
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0.144 h r 1 was used throughout these experiments.
In both sets of experim ents Pickett e t a j (440,442) reported  an increase in
biomass yield of up to  11% and decreases of up to 10% when compared to the 
steady s ta te  values. However, no general trend  was apparent in either case. 
The general natu re of the response in viable cell concentration fo r E.coli 
was sim ilar to  th a t obtained a t a cycle time of 16 hours fo r the mm321 cell
(440)line; i.e. sinusoidal in nature. However, Pickett and Bazin report no
evidence of any imposed synchronisation behavior in the cultures.
(439)Borzani e t al applied square wave oscillations in nutrient
concentration to a culture of Saccharom yces cerev isiae  a t a cycle time of 
24 hours, as well as a number of other more complex perturbations. The 
response obtained f  or viable cell concentration to  a square wave
(440 442)perturbation  was very sim ilar to  th a t obtained by P ickett e t al ’
(439)However, Borzani e t al reported no significant change in biomass yield 
in response to  either a square wave or to more complex perturbations.
Both E.coli and Saccharom yces cerevisiae  have significantly shorter 
doubling tim es than mammalian cells. The cycle tim es Pickett e t  a [(440»442) 
imposed on E.coli a re  2 to 3 times the average duration cell cycle times,
(439)while Borzani e t al imposed cycle times almost 12 tim es g rea te r than
the average cell cycle time in Saccharom yces cerevisiae. In the simulations
f  or the mm321 cells lines the cycle times applied are  more or less
comparable to  the average cell cycle time. Simulations were conducted with 
cycle tim es of up to  36 hours (data not shown). A second peak is observed
a t a  cycle time of 32 hours, however the average viable cell and antibody
concentrations are  only 92% and 95% of the ir steady s ta te  concentrations a t 
th is point. As a resu lt, even though they also exhibit a peak, the overall 
antibody production ra te  and the effective yield are  also lower than the ir 
steady s ta te  values a t  3.02 mg 1 1 hr 1 and 0.87 g g \  However, the true  
yield is g rea te r than it steady s ta te  value a t th is  point a t a level of
0.98 g g 1, an increase of 6.1% (not shown).
(440 442)Pickett e t al ’ did not observe measurable quantities of nu trien t a t 
any tim e during the cultures. However, both increases and decreases in
biomass yield a t cycle time equivalent to 2 or 3 cell cycle durations were
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(4 4 0 )observed. Even though Pickett e t al claim to have observed no
synchronisation in the cell population, the c rite ria  employed would not 
discount a partia lly  synchronised population, such as th a t predicted to 
occur by the mm321 model. Such a population could account fo r the observed 
increases and decreases in biomass yield. This may be explained as follows: 
in E .co li, the proportion of the cell cycle during which nu trien t is 
capable of being consumed may be much g rea te r than th a t considered to  be 
the case fo r the mm321 cell line; indeed nutrien t may be capable of being 
consumed throughout the entire cell cycle. However, as with the mm321 line, 
there  is a period of time during which nutrien t consumption is essential to  
the progress through the cell cycle. If th is is the case, nu trien t 
perturbations will have the effec t of partia lly  synchronising the 
population. At certain  cycle times, nutrien t may be more available when the 
m ajority  of cells are  a t the critica l stage of the cell cycle, thus 
enhancing biomass yield. At other cycle times, nutrien t may be a t a reduced 
level a t the c ritica l stage and a reduction in biomass yield is observed. 
However, as nu trien t is consumed throughout the cycle, the likelihood th a t 
excess nu trien t will be le ft over is reduced, until quite dram atic 
reductions in biomass concentration are  observed.
For the simulations generated by the model fo r the mm321 cell line, a 
second peak is observed fo r a cycle time of 32 hours. Even though the 
average cell and antibody concentrations are  reduced due to the w ash-out of 
glutamine, the increase in tru e  product yield indicates an enhancement in 
the effective use of glutamine with respect to  cell cycle kinetics. This is 
in accordance with the explanation proposed above fo r the observations of
D- 1 ++ + ,(4 4 0 ,4 4 2 )Pickett e t al
6.4 CONCLUDING COMMENTS
The specific cell cycle model fo r the mm321 cell line has been used to  
sim ulate the grow th of th is cell line in both repeated-batch culture and in 
continuous culture w ith an oscillatory feed composition.
The model confirm s th a t in repeated-batch culture, the dilution cycle time 
and the harvest frac tion  are  both critica l param eters in the propagation of 
th is cell line by th is method. The data  also confirm  th a t relatively  small
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fluctuations in either of these param eters can cause dram atic variations in 
the perform ance of these cultures. These variations are  a d irect resu lt of 
changes in the cell age distribution; most significantly, the variation in 
the percentage of cells which enter the D phase prior to resuspension. 
These changes may resu lt in poor product yield, washout, high levels of 
variability  or even periodic catastrophic failures. However, if  param eters 
are  tuned correctly  substantial increases in overall productivity may be 
achieved. The best resu lt was obtained a t a dilution cycle time of 45 hours 
and a harvest fraction  of 77.5% where the overall production ra te  of 
antibody was enhanced by 73.6% over conventional batch procedures.
The model indicates th a t stable responses in both viable cell and antibody 
concentration can be obtained as a resu lt of square-wave periodic 
perturbations in glutamine concentration, over a wide range of cycle times, 
amplitudes and on /o ff ra tios. The nature of the responses proved to  be very 
varied and, in some cases, quite complex. However, in each case the 
oscillations were a resu lt of some partia l synchronisation within the cell 
population. The model also indicates th a t th is  feeding s tra tegy  can improve 
productivity. Cycle tim es between 15 and 17 hours give an improvement in 
productivity, w ith the maximum increase over normal continuous culture 
being 14% fo r a cycle time of 16 hours. The simulations also suggest th a t 
the maximum possible amplitude and an on /o ff ra tio  ju s t below 1:1 (50% on) 
should be used fo r optimum performance. Under these conditions a  5 fold 
increase in productivity over conventional batch culture is predicted. This 
compares w ith a 4.5 fold increase with conventional continuous culture.
Finally, these studies have highlighted the potential im portance of 
understanding cell cycle kinetics, not only fo r the purposes of cell 
biology, but also fo r the process engineer.
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CHAPTER 7
CLOSING DISCUSSION AND CONCLUSIONS
7.1 CLOSING DISCUSSION
In th is d issertation  a generic model of the cell cycle has been proposed. 
This has been used to build and develop a specific model fo r the hybridoma 
cell line mm321. Although the model is based on fundamental principles of 
cellular p ro lif eration, a process engineering viewpoint has been adopted 
w ith regard  to  the model’s development and application.
In the study o f many microbial systems, large numbers of experim ents are 
conducted and process conditions are  varied selectively. The vast 
quantities of da ta  thus generated, are  then used to  develop simple 
em pirical descriptions of a system’s kinetics. Although th is approach is 
conventionally adopted, it  is time consuming, labour intensive and resource 
draining. Furtherm ore, the detailed analysis of data  is often a secondary 
consideration to  the generation of data.
The alternative approach explored in th is d issertation  is to  conduct a very 
limited number of complex experiments; to  use the inform ation derived from  
these experim ents to develop a model based on f  undamental biological 
principles, then to  confirm the applicability of th is  model by using it  to 
predict a limited number of experiments conducted under d iffe ren t 
conditions and using d ifferen t propagation methods. Finally, to  use • the 
model as a predictive tool. The next stage, which has not been directly
addressed in th is work, is to use this predictive tool to  suggest new
experim ents and improve existing experimental techniques. These experim ents 
can then be used to  modify the underlying biological concepts upon which 
the model is built, thus enhancing the understanding of the system. This
approach is often adopted in the process engineering field.
The underlying argument here, is not th a t the alternative approach adopted 
in th is d issertation  should supersede th a t conventionally used, but th a t it 
should be used to  complement it. It is likely th a t some of the resource
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applied to  conventional cell and microbiological cultures is w asted and it 
is certa in  th a t very little  emphasis is placed in the approached advocated 
here. These resources may be more effectively employed in the study of cell 
culture by using a more quantitative approach, based on f  undamental 
biological principles.
The approach adopted in th is work has highlighted the importance of the 
sampling procedure. The vast m ajority of the specific model has been 
developed from  the analysis of three post-synchronisation cultures. As with 
any sampling procedure, i t  is of vital im portance th a t the data  are
gathered accurately, frequently, with a high level of resolution and within 
narrow  tolerance lim its. Sampling frequency was of g rea t importance with 
respect to  these data. It was im portant not only to  gain inform ation within 
the period of a cell cycle, but also w ithin the period of a cell cycle
phase. Therefore, it  was desirable to sample a t intervals less than the
maximum duration of the shortest cell cycle phase, i.e. less than 2 hours. 
At such sampling frequencies, logistical considerations and resource
lim itations can influence the quality of the data, and a compromise must be 
achieved. The data  obtained from  the post-synchronisation data  allowed a
number of assumptions to be made with respect to  cell cycle kinetics, phase
durations and variations in glutamine consumption and antibody production 
from  phase to  phase. This was only possible due to the number and frequency 
of data  available fo r  these experiments; on average, the sampling interval 
was a little  under 2 hours.
In addition to  obtaining inform ation pertinent to  the cell cycle, sampling 
frequency may also be critica l in conventional culture techniques. It is 
well established th a t critica l points or events ex ist w ithin the cell cycle 
which determine an individual’s progress around the cycle; such events are  
present in the proposed model f  or the mm321 cell line. The prevalent
environmental conditions and internal make-up will determine an individuals 
behaviour a t these points. As a resu lt, the behaviour of an en tire 
population may change within the course of one cell cycle, fo r  instance 
during the onset of cell death. This being the case, it  is im portant th a t
the sampling frequency is set to a period less than the minimum cell cycle 
time; if  it  is not, im portant events in overall population behaviour may be 
missed.
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There is some doubt as to  the applicability of the inform ation derived from 
the post-synchronisation cultures. Thymidine is a metabolic
block, i t  ac ts by inhibiting the production of DNA in the S phase of the 
cell cycle. The effec t of th is is to  halt the progress of cells through the 
S phase and inhibit the transition  from  the G1 phase to  the S phase. It is 
clear th a t excess thymidine must influence radically the internal 
biochemistry of the cells subjected to it. Therefore, it  may be argued th a t 
the behaviour of cells when released from  the block, may not be the same as 
the ir behaviour in conventional culture. In the thymidine double block 
technique applied by Hayter(15), the minimum amount of thymidine required 
fo r synchronisation was used. This was done so as to  minimise any potential 
detrim ental a ffec ts  of the block. A negative resu lt of th is was th a t 
perf ect synchronisation was not always achieved, however th is was 
compensated fo r in the assumptions (see Section 4.3.4). The evidence 
presented in th is d issertation  would suggest th a t th is approach was indeed 
successful in minimising or even eliminating any detrim ental influence of 
thymidine. The specific model, which has been derived directly  from  the 
analysis of the post-synchronisation data, predicts the grow th of the mm321 
cell line in conventional culture very well, w ith no m odifications to  the 
param eters values; only the nature of the age distribution has been 
altered. This evidence indicates th a t inform ation derived from  thymidine 
induced synchronisation is applicable to  conventional culture, a t least fo r 
th is cell line, provided the blocking protocol is arrived a t carefully.
Despite the argum ents presented above, w ith respect to the applicability of 
post-synchronisation data  derived from  metabolically blocked populations,, 
i t  would be more convenient and less contentious, to  determine cell cycle 
kinetics in conventional culture. The resu lts  presented in Chapter Six, 
suggest th a t a complex response may be obtained in viable cell, glutamine 
and antibody concentration, to periodic perturbations in glutamine f  eed 
concentration. The nature of the response is a d irect resu lt of the 
assumptions made about the cell cycle kinetics of the mm321 cell line. 
Indeed, the model suggests th a t the responses are  due to  the imposition of 
varying degrees of p artia l synchronisation. The resu lts  suggest th a t it 
would be possible to  derive the same cell cycle inf ormation as th a t 
obtained f  rom post-synchronisation culture by conducting cultures under 
such periodic feeding regimes. Indeed, due to  the complex and sustained
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nature of the responses, it  is probable th a t much more inform ation may be 
derived, especially if  more complex feeding stra teg ies  w ere applied.
Overall, the work presented in th is d issertation has a number of potential 
implications f  or the process engineer. Clearly, an understanding of cell 
cycle kinetics would appear to be as im portant f  or the design and 
production engineer as it  is fo r the cell biologist. Critical events in the 
behaviour of a population occur a t the cell cycle level. Even in a 
exponentially growing population, inf ormation about the cell cycle can
reveal the likely cause and duration of these events, and, as has been 
mentioned above, th is  also has implications fo r sampling frequency. It is 
also clear, even when using the model proposed fo r the mm321 cell line, 
th a t cell cycle behaviour is a complex phenomenon. Therefore, the overall 
behaviour of a  cell population, in term s of the cell cycle, can only be 
predicted by the use of m athematical models such as th a t proposed here.
Cyclic propagation methods appear to be influenced significantly by cell
cycle kinetics. Such propagation methods can generate heterogeneous or 
partia lly  synchronised cell populations. These methods can have both 
detrim ental and beneficial resu lts, depending on existing knowledge of the 
cell cycle. In the case of repeated fed-batch culture, the selection of the 
resuspension period and the harvest fraction  are  critica l. These param eters 
determ ine the ra te  of change of the cell age distribution, most
significantly  w ith respect to cells initiating the D phase. In th is case, 
changes in the cell age distribution can cause dram atic f  ailures with
respect to  cell growth.
Changes in cell age distribution can also influence specific production and 
consumption ra te s . Although cells may consume or produce m aterials a t a 
p articu la r ra te  w ithin a  cell cycle phase, the fraction  of the cell 
population which is w ithin th a t phase will determine the magnitude of the 
overall specific ra te . In the case of the mm321 model, the g rea te r the 
proportion of cells in the Gib and S phases, the g rea te r the apparent 
antibody production ra te .
The observation made above has some implications f  or process control. 
Manipulation of the cell age distribution could resu lt in increased product
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yield and more effective consumption of nutrients. This is the case when 
periodic feeding s tra teg ies  are  applied to  a chemostat. In brief, nutrient 
is switched on when the m ajority of the cell population requires it, when 
cells are  in Gib, and switched off when the m ajority are  in the other cell 
cycle phases. This would suggest th a t monitoring of the cell age 
d istribution would be of g rea t use to the production engineer, however this 
is not a simple process. Flow cytometry may be used to  estim ate cell age 
distribution. However, as well as being a complex technique, and thus only 
being suitable fo r o ff-line  application, it  also only distinguishes between 
cells on the basis of DNA content. Hence, flow cytometry, although of use 
in the in itia l form ulation and validation of the model, is unlikely to be 
used fo r process control in the near fu ture.
An alternative approach would be to use the model as an observer and employ 
‘model based observer control’. In th is situation, the model would receive 
inf orm ation about the in itia l f  erm entation conditions and its  subsequent 
progress. This inform ation would be fed to  the model which would then 
predict the cell age distribution a t any point in the ferm entation. The 
process could then be controlled so as to  obtain the most beneficial age 
distribution fo r th a t particu lar process. A more ambitious, and probably 
necessary, approach would be to make the model adaptive. Thus the param eter 
values, and possibly even the cell cycle rules, may be changed to  give the 
best f i t  to  the experimental data  already available. The model, thus 
adapted, could then be used to  control the process, by providing 
predictions of param eters such as cell age distribution which cannot be 
measured on-line.
It was noted in Chapter One, th a t the main lim itations to  the application 
of complex m athem atical models, based on fundamental biological principles, 
was not conceptual but technological. When the f i r s t  population balance 
models were proposed in the mid-1960’s, the computational power was simply 
not available to  solve them in any practical way. Even a t th is outset of 
th is  work in 1987, all of the softw are was developed and solved on a Prime 
9950 m ini-computer. Since 1991 all the code used fo r CELCYMUS has been 
tran sfe rred  to  a PC based system. The model which has been developed fo r 
the mm321 cell line can be run com fortably on a  25 MHz PC w ith 80486 
processor. The only unusual requirem ent is th a t fo r a large memory
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capacity, typically about 10-16 MBytes. Using th is type of machine an hours 
ferm entation may be simulated in about 0.5 seconds.
7.2 OVERALL CONCLUSIONS
The objectives of th is work have been met in that:
a) a generic model of the cell cycle has been proposed and solved
(Chapter Three);
b) a specific model has been developed fo r the mm321 hybridoma cell 
line (Chapter Four);
c) th is  model has been used to  predict successfully the growth of th is 
cell line in post-synchronisation culture, s tirred  flask  culture, 
s ta tic  culture and in a f  erm enter operated in both batch and
continuous modes (Chapter Five); and finally,
d) th is model has been used to investigate the kinetics of th is  cell
line in repeated batch culture and periodically pertu rbated
continuous culture (Chapter Six).
A number of observations can be made from  th is work:
a) variations in cell age distribution can dram atically influence the 
growth, production and consumption kinetics of th is cell line;
b) the adoption of alternative propagation methods and feeding 
stra teg ies, and the ir subsequent optimisation, can lead to
significant increases in product yield, without any increase in
fixed or working capital expenditure;
c) CELCYMUS can exhibit complex kinetics which could not be simulated 
by many other models.
Finally, the development and application of cell cycle models is a 
rea lis tic  proposition with curren t computational facilities. These models 
have other potential applications in addition to  process engineering: in
the medical field  -  the study of cancer and tumour growth, and in cell
biology -  understanding cellular proliferation. Furtherm ore, the s tru c tu re
of CELCYMUS in no way limits its  application to  biological systems. It 
could potentially be used to  simulate the behaviour of many age dependent
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particu la te  systems.
7.3 RECOMMENDATIONS FOR FUTURE WORK ^
\
With regard  to  the generic cell cycle model, CELCYMUS, it  is recommended 
th a t the following work is conducted:
a) a PC-based, user-friendly  front-end, should be developed fo r 
CELCYMUS so as to  make the development of cell cycle models within 
the generic fram ework a simple procedure;
b) currently , CELCYMUS is a one dimensional model in th a t i t  considers 
directly  changes in age distribution only. It is clear f  rom the 
assumptions made with regard  to the Gl-S transition  th a t cell size 
is also an im portant param eter in cell cycle kinetics. The CELCYMUS 
code should be expanded to account fo r cell size. This can be most 
conveniently achieved by considering cell mass.
c) the possibility of using CELCYMUS as a model based observer and 
w ithin an adaptive controller should be investigated. This could 
initially  be achieved by using a duplicate of CELCYMUS to  control 
its  own simulations.
With fu rth e r  experim entation, the specific model proposed fo r the mm321 
cell line may be developed fu rther. The following recommendations are  made 
fo r fu rth e r  work on th is cell line:
a) the reason fo r the apparent production of glutamine in the early 
p a rt of the post-synchronisation cultures needs to  be determined;
b) the exact nature and cause of the in itia l lag period observed in 
the m ajority  of the conventional batch cultures should be 
determined;
c) the ru les proposed fo r cell death need to  be confirmed by 
experim entation. The model may be used to determine the required 
in itia l experiments;
d) curren tly  the phases in which glucose is consumed and lac ta te  and 
ammonia are  produced have been determined by supposition. These 
need to be confirmed by experimentation;
e) the lim itations of the curren t model w ith respect to  continuous
150
Conclusions
culture need to  be addressed.
The resu lts  presented in Chapter Six with regard  to periodic feeding of 
chem ostats suggest a number of exciting avenues fo r fu tu re  research. It is 
recommended th a t the following work is conducted:
a) repeated-batch  cultures should be conducted with the mm321 cell 
line using the optimal process conditions determined from  the 
model;
b) the influence of periodic feeding of a chemostat should also be 
investigated experimentally in th is cell line;
c) methods of determining cell cycle param eters from  periodic feeding 
resu lt should also investigated.
Since the pioneering work of Fredrickson and colleagues in the 1960’s, the
application of population balance modelling techniques to  biological 
systems has received little  attention. The resu lts  presented in th is
d issertation  have dem onstrated th a t these techniques can be applied to  such
systems, both successfully and constructively. Furtherm ore, applying these 
techniques to  the modelling of the cell cycle can contribute to the
understanding of the fundamental biological principles, as well as the 
engineering aspects of a process.
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FIGURES 4.1 to 4.3 
Experimental Data for a Series of Post-Synchronisation 
Experiments conducted by Havter*15*.
In each case a thymidine double block has been applied: cells in mid-exponential growth 
were arrested with 2mM thymidine for 30 hours. Then they were spun down, resuspended 
and incubated in thymidine-free medium for 6 hours. Finally, they were arrested again in 
2mM thymidine for a further 18 hours.
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FIGURE 4.5
Preliminary Simulation of a Post-Synchronisation Culture
FIGURES 4.6 to 4.8 
Model Predictions for Post-Synchronisation Experiments
Using a model built using CELCYMUS, predictions have been made for the post­
synchronisation cultures, data sets SYNC1, SYNC2 and SYNC3.
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for data set SYNC2
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for data set SYNC3
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FIGURE 4.9
Confidence Contoure for data sets SYNC1, SYNC2 and SYNC3.
The 95% and 99% confidence values have been evaluated for the simultaneous fit of RGlut 
and to data sets S YNC1, S YNC2 and S YNC3. A surface has been generated for each
fit by varying the two parameters. Confidence contours corresponding to the above 
confidence values have been plotted on these surfaces.
F-23
Pe
rc
en
ta
ge
 
of 
Sm
ax
-12
95%
99%
Percentage of RGlut
FIGURE 4.9a
95% and 99% Confidence Contours for Data Set SYNC1
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95% and 99% Confidence Contours for Data Set SYNC3
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FIGURES 5.1 to 5.4 
Model Predictions for a Series of Stirred Flask Cultures Carried 
out with Different Initial Glutamine Concentrations
Data set ST1R1: 300 mg ml'1, STIR2: 200 mg ml'1, STIR3:100 mg ml'1, ST1R4: 50 mg 
ml'1. Data are presented together with the models' prediction for viable cell, glutamine, 
glucose, antibody, lactate and ammonia concentration. The models' predictions of cell 
cycle age distribution are also presented.
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FIGURE 5.4a
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FIGURE 5.5
Model Predictions for a Static Flask Culture
Data set STAT1 initial glutamine concentration 235 mg ml'1. Data are presented together 
with the models' prediction for viable cell, glutamine, glucose, antibody, lactate and 
ammonia concentration. The models' predictions of cell cycle age distribution are also 
presented.
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FIGURE 5.6
Model Predictions for a Stirred Batch Fermentation
Data set STIR5 initial glutamine concentration 213 mg ml'1. Data are presented together 
with the models' prediction for viable cell, glutamine, glucose, antibody, lactate and 
ammonia concentration. The models' predictions of cell cycle age distribution are also 
presented.
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FIGURE 5.7
Model Predictions for the Attainment of Steady State in a Chemostat
Dilution rate 0.0238 h r1. Data are presented together with the models' prediction for 
viable cell concentration. The models' predictions for antibody concentration and cell age 
distribution are also presented.
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FIGURE 5.8
Model Predictions for a Glutamine Pulse in a Chemostat
Dilution rate 0.0238 hr'1. Data are presented together with the models' prediction for 
viablecell and glutamineconcentration. The models' predictions for antibody concentration 
and cell age distribution are also presented.
F-52
A
nt
ib
od
y 
Co
nc
en
tra
tio
n 
(u
g/
m
l) 
G
lu
ta
m
in
e 
Co
nc
en
tra
tio
n 
(u
g/
m
l) 
Vi
ab
le 
Ce
ll 
Co
nc
en
tra
tio
n 
(C
ell
sx
 1
0E
6/
m
l)
FIGURE 5.8a
Prediction of Viable Cell Concentration f )
for a Glutamine Pulse in a Chemostat
0 20 40 60 80 100 
Time (Hours)
FIGURE 5.8b 
Prediction of Glutamine Concentration (♦) 
for a Glutamine Pulse in a Chemostat
20 40 60 80 100 
Time (Hours)
FIGURE 5.8c
Prediction of Antibody Concentration
for a Glutamine Pulse in a Chemostat
0 20 40 60 80 100
Time (Hours)
200
150
100
50
0.80
0.60
0.40
0.20
F -53
Pe
rce
nta
ge
 o
f 
Ce
lls 
in 
eac
h 
Ph
as
e
100
75
50
25
0 10060 8040200
T i m e  ( H o u r s )
—  G1 Phase
S Phase
—  G2 Phase
—  M Phase
— D Phase
FIGURE 5.8d 
Prediction of Cell Cycle Age Distribution 
during a Glutamine Pulse in a Chemostat
F-54
FIGURE 5,9
Model Predictions for a Change in Dilution Rate in a Chemostat
Initial dilution rate 0.0238 h r1 changed to 0.033 hr'1. Data are presented together with the 
models' prediction for viable cell and antibody concentration. The models' predictions for 
glutamine concentration and cell age distribution are also presented.
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FIGURE 5.10
Model Predictions for the Washout Kinetics of a Chemostat
Dilution rate increased to 0.042 h r1. Data are presented together with the models' 
prediction for viable cell concentration. The models' predictions for glutamine and 
antibody concentration together with cell age distribution are also presented.
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FIGURE 6.1
Model Predictions for a Repeated Batch Culture: Dilution Cycle Time 55 hours,
Harvest Fraction 80%
The models' prediction for viable cell concentration, cell viability and glutamine and 
antibody concentration are presented over 20 cycles.
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Prediction of Viable Cell Concentration and Cell Viability 
for a Dilution Cycle Time of 55 hours and a Harvest Fraction of 80%
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FIGURE 6.2
Model Predictions for a Repeated Batch Culture: Dilution Cycle Time 50 hours,
Harvest Fraction 80%
The models' prediction for viable cell concentration, cell viability and glutamine and 
antibody concentration are presented over 20 cycles.
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FIGURE 6.3
Model Predictions for a Repeated Batch Culture: Dilution Cycle Time 45,52 and
53 hours, Harvest Fraction 80%
The models' prediction for viable cell concentration and cell viability at different dilution 
cycle times are presented over 20 cycles.
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FIGURE 6.4
Model Predictions for a Repeated Batch Culture: Dilution Cycle Time 45 hours,
Harvest Fraction 70%, 75%, 77.5%, 85% and 90%
The models’ prediction for viable cell concentration and cell viability at different harvest 
fractions are presented over 20 cycles.
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Prediction of Viable Cell Concentration and Cell Viability 
for a Dilution Cycle Time of 45 hours and a Harvest Fraction of 85 %
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FIGURE 6.4e
Prediction of Viable Cell Concentration and Cell Viability 
for a Dilution Cycle Time of 45 hours and a Harvest Fraction of 90%
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FIGURE 6,5
Model Predictions for the Response of a Chemostat to the Imposition of an On/
Off Feeding Strategy
The models' predicted response for viable cell, glutamine and antibody concentration at 
cycle periods of 8 ,12,16 and 20 hours are presented.
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FIGURE 6.5b 
Predicted Response in Glutamine Concentration 
to an On/Off Feeding Strategy
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FIGURE 6.5c 
Predicted Response in Antibody Concentration 
to an On/Off Feeding Strategy
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FIGURE 6.6
Model Predictions for the Response of a Chemostat to the Imposition of an On/
Off Feeding Strategy: The Effect of Cycle Period
The effect of cycle period on the maximum and minimum viable cell and antibody 
concentration is presented, together with its effect on overall productivity and the true and 
effective yields.
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FIGURE 6.6a
The Effect of Cycle Period on the Maximum and Minimum 
Viable Cell and Antibody Concentration 
Presented as Percentage Variations of the Steady State 
Concentrations for the Same Dilution Rate
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FIGURE 6.7
Model Predictions for the Response of a Chemostat to the Imposition of an On/
Off Feeding Strategy: The Effect of Amplitude
The effect of amplitude on the maximum and minimum viable cell and antibody 
concentration is presented, together with its effect on overall productivity and the true and 
effective yields.
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FIGURE 6.7a
The Effect of Amplitude on the Maximum and Minimum 
Viable Cell and Antibody Concentration 
Presented as Percentage Variations of the Steady State 
Concentrations for the Same Dilution Rate
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FIGURE 6.8
Model Predictions for the Response of a Chemostat to the Imposition of an On/
Off Feeding Strategy: The Effect of On/Off Ratio
The effect of on/off ratio on the maximum and minimum viable cell and antibody 
concentration is presented, together with its effect on overall productivity and the true and 
effective yields.
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The Effect of On/Off Ratio on the Maximum and Minimum 
Viable Cell and Antibody Concentration 
Presented as Percentage Variations of the Steady State 
Concentrations for the Same Dilution Rate
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FIGURE 6.9
Model Predictions for the Response of a Chemostat to the Imposition of an On/
Off Feeding Strategy: Cell Age Distribution
The cell age distribution for an on/off feeding strategy with a cycle period of 16 hours and 
an on/off ratio of 1:1 is presented.
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APPENDIX I:
Flow Sheet of the Main Program
FLOWSHEET 1
Overall Structure
Define common blocks, define variables, 
clear temporary arrays
FLOWSHEET 7 
Cell Transition:
Move cells and their contents between phases
FLOWSHEET 4 
Calculate the changes in the 
intra-cellular composition
FLOWSHEET 2 
Calculate the changes in the 
medium composition
FLOWSHEETS 
Update medium composition (inc. washout) 
Update number of non-viable cells
FLOWSHEET 3 
Re-scale medium consumption 
in a  chemostat
FLOWSHEET 6 
Cell Flow
Move cells and their contents in each phase
FLOWSHEETS 
Evaluation of probability distributions
AI2
I=1,N0PHA FLOWSHEET 2
Change in Medium State Vector
J=1,3
K=IMEDNUAA
CECORA>0
L=l,NOTCEL
L=l,3 Update Cell Contents
MEGONkCRMEVA
or
CRMEVA=0
MECORA>0C and MECON>0 ^  
^ S ^ o r M E C O R A < O X ^
Specific Rate 
is Zero
Caluclate the Specific 
Change in Medium 
Concentration
AI3
FLOWSHEET 3
Chemostat Over-consumption
MECON<0
MEDCON> 
 ^MECON .
Reset specific 
consumption 
rate
Set scaling 
parameter to 
zero
Set scaling 
parameter
AI4
FLOWSHEET 4
Update Cytological State Vectorl=l,NOPHA
K=1,MEDNUM
MECON<CRMEVA
CRMEVA=0
M£CHAN>0 
and 
DCDEP>0
AA=l,NOTCEL
PARA>0
Update the 
cytological 
state vector
AI5
FLOWSHEET 5
Evaluation of Probability Distribution
PHATYPoO
PHFLOW>0
Evaluate the 
fraction leaving 
the phase
T
L=1,MEDNUM+1
exit flag.
FtAG=0
Store amount 
leaving In temporary 
variable
I
Transfer amount 
leaving to 
temporary array
FLOWSHEET 6
Flow
Check move 
flag
FLAG=0
Put cells and contents 
in last age element of 
phase into temporary 
array
Move all cells anc 
contents forward 
one age element
Reset first 
age element 
to zero
Make sure 
temporary array 
is clear
Account for 
washout
7
r i
FLOWSHEET 7
Transition
l=l,NOPHA
Check exit flag
FLAG=0
J=l,NOPHA+l
PHFLOW>0 
and 
PHFL0W<=1
=1,MEDNUM+1
K=IMEDNUM+1
Add in cells and 
contents moved by 
probability distributions
MMEDNUM+1)
Move cells and 
contents to new 
phase
Reset cells which 
cannot move 
because flag is set
AI8
FLOWSHEET 8
Final Updates
MODE=0
Update the medium 
state vector. 
Including inlet.
Update the 
medium state 
vector
Update dead 
cells
Update the 
medium state 
vector.
AI9
APPENDIX II:
Printout of the Main Program
C P o p u la tio n  b a la n c e  model
c  -------------------------------------------
C T h is  i s  th e  main p o p u la tio n  b a la n c e  model program  f o r  th e
C g e n e r a l is e d  c e l l  c y c le  model.
C W rit te n  by D .B .F .F araday .
C F ebruary /M arch  1988.
C R ev ised  in  A p ril 1988, A ugust 1988, J a n u a ry /F e b ru a ry  1989, 
C November 1989 and Jan u a ry  1990.
C V ers io n  2. 1
SUBROUTINE MODEL(TIME,R)
C D efin e  program  p a ra m e te rs .
PARAMETER(MN0PHA=10,MN0PAR=20,MNTCEL=2000,MNUTRI=5)
C I n i t i a l i s a t i o n  o f  Common B locks.
COMMON/ACURCY/MACACC 
COMMON/CELCNT/CELLS,DEAD,PARA 
COMMON/CELFLO/PHATIM,PHFLOW,PROLIF 
COMMON/CHCEMV/CONDIT,PHATYP
C0MM0N/GENER1/DT,INNOCU,MODE,OT,PT,REDTIM,RUNFOR,ST,VOLUME 
C0MM0N/GENER2/N0PAR, NOPHA, NOTCEL 
COMMON/MEDIA2/FEC0NC, FESTRA, INMECO
COMMON/MEDIUM/CECORA, CRCEVA,CRMEVA,MECHAN,MECORA, MEDNUM 
COMMON/VARIES/MECON, PHACEL
C I n i t i a l i s a t i o n  o f  v a r ia b le s  common b lo c k s .
DOUBLE PRECISION MACACC,
C CELLS,DEAD,PARA(MNTCEL,MNOPAR,MNOPHA),
C DT,INNOCU,OT,PT,REDTIM,RUNFOR,ST,
C FECONC(MNUTRI) , FESTRA(MNUTRI, 6 ) , INMECO(MNUTRI,3 ) ,
C CECORA(MNUTRI, 3 , MNOPHA), CRCEVA(MNUTRI, 3 , MNOPHA),
C CRMEVA(4 ,MNUTRI,3 ,MNOPHA),
C MECORA(4 ,MNUTRI,3 ,MNOPHA),
C MECON(MNUTRI, 3 ) , PHACEL(MNOPHA)
INTEGER PHATIM(MNOPHA),
C CONDIT(MNUTRI, 3 , MNOPHA,3 ) , PHATYP(MNOPHA),
C MODE,VOLUME,
C NOPAR,NOPHA, NOTCEL(MNOPHA),
C MECHAN( 4 ,MNUTRI,3 ,MNOPHA),MEDNUM(3)
REAL PHFLOW(MNOPHA,MNOPHA,2 ) , PROLIF(MNOPHA,2)
C I n i t i a l i s a t i o n  o f  o th e r  v a r ia b le s .
DOUBLE PRECISION DCDEP(MNUTRI, 3 , MNOPHA), DNH4,LEAVE(MNOPAR,MNOPHA), 
C MM,MEDCON(MNUTRI, 3 ) , R,TOTAL(MNOPAR,MNOPHA),
C NUMCEL, CELKIN, STRATC
INTEGER FLAG, TIME, TYPE
REAL FRAC
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c
C E n try  f l a g .
C PRINT*,’ S u b ro u tin e  -  MODEL’ ,NOPHA
c  ------------------------------------------------------------
C S e t up some i n i t i a l  c o n d itio n s .
FLAG=0
C C le a r  a r r a y s .
DO 10 1=1,NOPHA
DO 10 J=l,NOPHA+1 
10 LEAVECI,J)=0.0D0
DO 20 1=1,3
DO 20 J=l,MEDNUM(I)
20 MEDCON(J , I )= 0 .0D0
DNH4=0. 0D0
* *
* ~   ^       *
* *  
Uo'nHI i n rr  r \ P  M nf r i  ar» t o  M ot a t n  1 i t o e  onr? T a v  i t> o #
c  
c
C * P a r t  One o f  th e  Model *
C 
C
C * H andling  o f  N u tr ie n ts ,  M e ta b o lite s  and Toxins
C *   *
C * *
C * T h is  p a r t  o f  th e  model has been d es ig n ed  to  s im u la te  v e ry  *
C * s im p ly  th e  t r a n s f e r  o f  m a te r ia ls  in  and o u t o f  th e  c e l l .  *
C * A ll m a te r ia ls  d e f in e d  a s  n u t r i e n t s  a re  abso rb ed  in to  th e  c e l l  *
C * a t  a r a t e  w hich i s  p ro p o r t io n a l  to  t h e i r  c o n c e n tr a t io n  and *
C * th e  medium consum ption r a te .  A ll n u t r i e n t s  abso rb ed  a re  *
C * assumed to  be s to r e d  in  th e  c e l l  and hence c e l l  c o n te n ts  *
C * in c re a s e  a s  th e  c e l l  p ro ceed s th ro u g h t a  phase  d u rin g  w hich *
C * n u t r i e n t s  a b s o rb tio n  i s  assumed to  o ccu r, n o t a l l  p h ases  need *
C * have a medium consum ption r a te .  A f a c i l i t y  h as  been added to  *
C * r e s e t  a l l  a n d /o r  some o f c e l l  n u t r i e n t  c o n te n ts  to  ze ro  a t  *
C * th e  b e g in n in g  o f any phase. *
C * *
C * A ll m a te r ia ls  d e f in e d  a s  m e ta b o li te s  o r  to x in s  a re  assumed to  *
C * be p roduced  by th e  c e l l  and im m ediate ly  e x c e te d  ie  th e y  have *
C * no meaning in  c e l l  c o n te n t term s. Each component can have *
C * d i s t i n c t  p ro d u c tio n  r a t e s  in  each  phase . *
C * *
C * C r i t i c a l  v a lu e s  o f  a l l  components can be d e f in e d  and th e s e  *
C * can a f f e c t  c e l l  movement w ith in  a phase , c e l l  movement from  *
C * phase  to  phase  and c e l l  p r o l i f e r a t i o n .  *
C * *
C * D .B .F .F araday  *
C * 2nd March 1988 *
C * *
C * A more g e n e r a l is e d  apporoach has now been  used  to  d e a l w ith  *
C * medium in t e r a c t io n .  Each component can have up to  fo u r  *
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* d i f f e r e n t  mechanisms c o n t r o l l in g  component in t e r a c t io n  over
* d i f f e r e n t  c o n c e n tra t io n  ran g es . These mechanisms have been
* removed and p u t in  th e  fu n c t io n  CELKIN. Medium in t e r a c t io n
* and c e l l  a ccu m u la tio n  have a ls o  been s e p a ra te d .
* *
* D .B .F .F arad ay  *
* 13 th  March 1990 *
* *
****************************************************************** 
Loop around  a l l  p h ases  
DO 70 1=1,NOPHA 
Loop around  each  component c a teg o ry .
DO 70 J= 1 ,3
Loop around  each  component in  c u r r e n t  c a te g o ry .
DO 70 K=1, MEDNUM(J)
* Here I u se  a s im p le  EULER INTEGRATION f o r  a l l  com ponents. *
F i r s t  we d e a l w ith  any m a te r ia l  p roduced  o r  consumed w ith in  th e  
c e l l s .
Check c e l l  consum ption r a t e  f o r  c u r re n t  component.
IF (ABS(CEC0RA(K,J,I)).GT. MACACC) THEN
A lte r  c e l l  c o n te n t a c c o rd in g ly .
DO 30 L=l,NOTCEL( I )
N =((J -l)* 5 )+ K + l
30 PARA(L,N,I)=PARA(L,N,I)-CEC0RA(K,J,I)*PARA(L,1 , I)*DT
END IF
OK, now we d e a l w ith  any m a te r ia l  consumed by th e  c e l l s  from  th e  
medium o r  s e c r e te d  by th e  c e l l s  in to  th e  medium.
F i r s t  we w i l l  f in d  th e  medium c o n c e n tra t io n  range  we a re  in  and 
th e  p a ram e te r  w hich r e l a t e  to  t h a t  range.
DO 40 L=1,3
IF (MECONCK,J).LT.CRMEVA(L,K,J,I)) GOTO 50
IF (ABS(CRMEVA(L,K,J,I)).LT. MACACC) GOTO 50
40 CONTINUE
L=4
Now we make s u re  m a te r ia l  i s  a c tu a l ly  a f f e c te d  in  th a t  range  ie  
t h a t  th e  c o n s ta n t  i s  n o t ze ro  and th a t  some o f  th e  s t u f f  e x i s t s  i f  
i t s  b e in g  consumed.
50 IF ((MEC0RA(L,K,J,I).GT.MACACC. AND.MECONCK,J).GT.MACACC).
C OR. MECORA(L, K , J , I ) . LT.-MACACC) THEN
C I f  i t  i s  th en  c a l c u la te  th e  s p e c i f i c  change in  c o n c e n tra tio n
C induced  by one c e l l .
DCDEP(K,J, I )=CELKIN(DT,MECHAN(L,K,J,I) , MECON(K, J ),
C MECORA(L,K,J,I))
C The o v e r a l l  medium c o n c e n tra t io n  i s  a f f e c te d  by a l l  th e  c e l l s  in
C t h i s  p hase , so c a l c u la te  th e  t o t a l  amount consum ed/produced.
MEDCON(K,J)=MEDCON(K,J)+ (DCDEP(K,J, I ) *PHACEL(I))
IF (K.EQ.2 . AND.J.EQ.1) THEN
MEDCON(2, 3 ) =MEDCON( 2 ,3 ) - ( 1 . 125*DCDEP(K,J,I) *PHACEL( I )) 
END IF
ELSE
DCDEP(K,J,I )=0.0D0 
END IF
70 CONTINUE
q ******************************************************************
C * S p e c ia l case  a t  th e  moment f o r  g lu tam in e  d e g ra d a tio n . *
)j( )|( )|( )j( )|c *  )|c ^  X ^  X ^  ^  ^  ^  )j^  ^  ^  ^  )l(
IF (MECON(1 ,1 ) .  GT. 0) THEN
MEDCON( 1 ,1 ) =MEDC0N( 1 ,1 ) - ( - 5 . 354E-7*INMECO( 1 ,1 ) *EXP(4 .6 0 5 2 - 
C 5.354E-5*TIME))*DT
END IF
C 
C 
C 
C 
C 
C 
C 
C 
C 
C 
C 
C 
C 
C 
C 
C
C Loop around each  n u t r i e n t  to  check f o r  ov er consum ption
DO 77 1=1,MEDNUM(1)
C I f  overconsum ed s e t  th e  s c a le  f a c t o r  and d rop  back in to  th e  loop
C f o r  r e c a lc u la t io n
IF (MEC0N(I, D .L E .O ) THEN
SCALE=0
ELSE
* *
* N u tr ie n t  e x h a u s tio n  in  a  Chem ostat *
*     *
* *
* E xperim en ts on th e  model have d em o n stra ted  th a t  re so n a n t *
* re sp o n se s  can be g e n e ra te d  in  r e s id u a l  n u t r i e n t  c o n c e n tra t-  *
* io n s  a t  v e ry  le v e ls .  The n u t r i e n t  i s  overconsumed and must be *
* re p le n is h e d  b e fo re  grow th can c o n tin u e  le a d in g  to  a harm onic *
* ty p e  re sp o n se . T h is  can be overcome by s c a l in g  th e  consum ption*
* o f  such  n u t r i e n t s .  *
* *
* D .B .F .F araday  *
* 13 th  May 1990 *
* *
IF (MEDC0N(I,1).GT.MEC0N(I,1 )) THEN 
SCALE=MECON( 1 ,1 ) /MEDCON(1 ,1 )
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MEDCON( 1 ,1 ) =MECON(1 ,1 )
DO 76 J=l,NOPHA
76 DCDEP( I , 1 , J)=DCDEP(I,1 ,J)*SCALE
END IF 
END IF
77 CONTINUE
Next s te p  i s  to  see  i f  th e  c e l l  c o n te n ts  a re  to  be a f f e c te d  by 
t h i s  change, i e  i s  th e  mechanism g r e a te r  th a n  10.
DO 65 1=1,NOPHA
DO 65 J= 1 ,3
DO 65 K=1, MEDNUM(J)
DO 78 L=1,3
IF (MECONCK,J).LT.CRMEVA(L,K,J,I)) GOTO 79
IF (ABS(CRMEVA(L,K,J,I)).LT.MACACC) GOTO 79
78 CONTINUE 
L=4
79 IF (MECHAN(L,K,J,I) . GE.1 0 .AND.DCDEP(K,J,I) . GT.0 .0D0) THEN
Loop around  each  elem en t in  th e  phase and in c rem en t/d ecrem en t th e  
t o t a l  c e l l  c o n te n t f o r  th a t  p o p u la tio n .
DO 60 M=1, NOTCEL( I )
T here i s  o n ly  any p o in t  in  do ing  t h i s  i f  th e re  a re  some c e l l s  in  
t h i s  age e lem en t.
IF (PARACM,1 , I).G T .0 .0D 0) THEN 
N =((J-l)* 5 )+ K + l
PARA(M,N,I)=PARA(M,N,I) + (DCDEP(K,J,I)*PARA(M, 1, I ) )
END IF
60 CONTINUE
END IF
65 CONTINUE
q ******************************************************************
C * *
C * P a r t  Two o f  th e  Model *
c  *  *
C * P r o b a b i l i ty  D is t r ib u t io n s  *
C 
C
C * T h is  p a r t  o f  th e  model has been d es ig n ed  to  a llo w  th e  u s e r  to  *
C * a p p ly  p r o b a b i l ty  d i s t r i b u t i o n s  to  c e l l s  le a v in g  a phase a s  *
C * p roposed  in  th e  Sm ith  and M artin  model. C u r re n tly  th e re  a re  *
*        *
* *
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C * fo u r  p o s s ib le  ways in  w hich c e l l s  can le av e  a phase . Type ’ F ’ *
C * i s  f ix e d  i e  a l l  c e l l s  must t r a v e r s e  th e  whole phase . Type *
C * ’ V I’ s t a t e s  t h a t  once a c e l l  has e n te re d  a phase i t  has a  *
C * f ix e d  p r o b a b i l ty  o f le a v in g . Type ’V2’ s t a t e s  th a t  once a *
C * c e l l  has e n te re d  a phase and p ro v id in g  th e  c r i t i c a l  c e l l  *
C * c o n te n t o f  one o r  more o f  th e  n u t r i e n t s  has reach ed  th e  *
C * c r i t i c a l  v a lu e  i t  w i l l  th e n  have a f ix e d  p r o b a b i l ty  o f  *
C * le a v in g . F in a l ly  ty p e  ’V3’ which i s  based  on a norm al *
C * d i s t r i b u t i o n  h av ing  a Band W idth o f BW around th e  c r i t i c a l  *
C * v a lu e  f o r  c e l l  c o n te n t o f  one o f  th e  n u t r i e n t s  su g g es ted  by *
C * N .F .K irkby . I t  i s  hoped to  in tro d u c e  f u r th e r  d i s t r i b u t i o n s  a s  *
C * work on th e  model p ro g re s s e s .  *
C * *
C * D .B .F araday  *
C * 2nd March 1988 *
C * *
C * P r o b a b i l i ty  d i s t r i b u t i o n s  ty p e s  ’V I’ and ’ V2’ a re  s t i l l  th e  *
C * same b u t have now been f u l l y  inp lem en ted . Types ’ V3’ , ’V4’ *
C * and ’ V5’ a re  Normans o r ig in a l  cu b ic  ty p e  r e l a t io n s h ip s ,  a *
C * h y b r id  th e re o f  and a new q u a d ra t ic  ty p e  r e l a t io n s h ip  added in  *
C * November 1988. A new s o lu t io n  method was in tro d u c e d  in  *
C * Ja n u a ry  1990 and two new d i s t r i b u t i o n s  ’V6’ and ’ V7’ w ere *
C * added, th e s e  a re  now in  u se  in  th e  c u r r e n t  s p e c i f i c  c e l l  *
C * c y c le  model f o r  th e  mm321 system . *
c * *
C * D .B .F .F arad ay  *
C * 14 th  March 1990 *
q * *
it*-*-*-***-**-**-**-*-*-*-***-*-*-**-**-**-*-**:-*-***:*******-*
C Loop around  a l l  o f  th e  p h ases
DO 105 1=1,NOPHA
C Has t h i s  Phase g o t a p r o b a b i l i t y  d i s t r i b u t io n ?
IF (PHATYP( I).N E . 0) THEN
O.K. th e  c e l l s  a re  a llow ed  to  le av e . Now we must loop  around th e  
p h ases  and see  w hich p h a s e /s  th e  c e l l s  go to .
Loop around  each  phase  and d ea th .
DO 100 J=l,N0PHA+1
Check i f  c e l l s  le a v e  t h i s  phase , I , and go to  phase  J .
IF (PHFL0W(J,1 , 2 ) . GT.0) THEN
So we’ ve d ec id ed  th a t  so m e /a ll o f th e  c e l l s  le a v in g  t h i s  phase in  
th e  p r o b a b i l ty  d i s t r i b u t i o n  go to  phase J .
Now we loop  around each  age elem ent f o r  phase  I.
DO 90 K=1, NOTCEL( I )
F i r s t  o f  a l l  we s h a l l  see  i f  th e re  a re  any c e l l s  in  th e  c u r r e n t  
age e lem en t -  i f  th e re  a r e n ’ t  any th e r e ’ s  no p o in t  in  do ing  any 
c a l c u la t io n s  f o r  them.
IF (PARA(K, 1, D .G T .0 ) THEN
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o Now we c a l l  up th e  p ro b a b i l ty  d i s t r i b t i o n  to  see  what f r a c t i o n  o f 
c e l l s  w i l l  le av e .
TYPE=PHATYP( I )
CALL PROB(DT,DCDEP,FRAC,I, K,TYPE)
Move th e  re q u ire d  f r a c t i o n  o f  c e l l s  and c e l l  c o n te n ts  FRAC 
depend ing  on p hase  flow  PHFLOW, deg ree  o f  p r o l i f e r a t i o n  PROLIF 
from  t h i s  Phase and e x i t  c o n d itio n s .
DO 80 L=l,MEDNUM(1 )+l 
NUMCEL=0. 0D0
But a re  th e  c e l l s  a llow ed  to  le av e , we must check e x i t  c o n d itio n s .
CALL EXIT(FLAG,K,1 ,3 )
I f  th e  FLAG i s  n o t s e t  we a re  OK.
IF (FLAG.EQ.0) THEN
S to re  th e  amount o f  th e  c u r re n t  p a ram ete r le a v in g  v ia  th e  
p r o b a b i l i t y  d i s t r i b u t i o n .
NUMCEL=PARA(K,L,I) *FRAC*PHFL0W(J ,1 ,2 )*
C PROLIFCI,2)
A lte r  th e  p e rm an en tly  s to re d  v a lu e  f o r  th e  c u r r e n t  p a ram eter.
PARA(K,L,I)=PARA(K,L,I) -PARA(K,L,I) *FRAC*
C PHFL0W(J,1 ,2 )
END IF
Sum c e l l s  and c e l l  c o n te n ts  le a v in g  t h i s  phase  v ia  th e  p r o b a b i l i t y  
d i s t r i b u t i o n  w hich e n te r  phase J  -  we can ’ t  add them in  y e t  o r 
th e y ’ 11 move again !
LEAVE(L,J)=LEAVE(L, J )+ (NUMCEL*R)
80 CONTINUE
END IF
90 CONTINUE
END IF 
100 CONTINUE
END IF 
105 CONTINUE
C * *
C * P a r t  T hree o f  th e  Model *
C *-----------------------------------------  *
C * *
C * Moving th e  c e l l s  *
C *-----------------------------  *
q * *
C * T h is  p a r t  o f  th e  model moves th e  c e l l s  w ith in  each  phase . *
C * F i r s t  o f  a l l  a l l  c e l l s  and c e l l  c o n te n ts  o f  c e l l s  in  th e  l a s t  *
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* age e lem en t o f  each  phase  a re  s to r e d  in  TOTAL(*,*). The c e l l s  *
* and c e l l  c o n te n ts  o f c e l l s  w ith in  th e  phase a re  th e n  moved *
* fo rw ard  one tim e c e l l  and th e  f i r s t  tim e c e l l  i s  c le a re d  *
* u n le s s  movement i s  p ro h ib te d . *
* *
* D .B .F araday  *
* 3 rd  March 1988 *
* *
^ ^ ^ ^ ^ ^ ^ ^ ^ ^  ^  ^  ^ ^ ^ ^ ^ |t 9|f ^ ^ ^  ^^
Loop around a l l  p h ases
DO 160 1=1,NOPHA
F i r s t  l e t ’ s  see  i f  th e  c e l l s  can a c tu a l ly  move.
CALL MOVE(FLAG,I)
IF (FLAG.EQ.0) THEN
O.K. th e  c e l l s  can move, so th e  f i r s t  s te p  i s  to  s to r e  c e l l s  and 
c e l l  c o n te n ts  l e f t  in  l a s t  phase  in  TOTAL.
DO 110 J=l,MEDNUM(1 )+ l
T0TAL(J,I)=PARA(NOTCEL(I), J , I)*R
CONTINUE
Now move a l l  o f  th e  c e l l s  and t h e i r  a s s o c ia te d  c o n te n ts  fo rw ard  
one tim e c e l l .
DO 120 J=l,MEDNUM(1 )+ l
DO 120 K=N0TCEL(I)-l , 1 , - 1  
PARA(K+1,J,I)=PARA(K,J,I)*R
CONTINUE
And f i n a l l y  we must c l e a r  th e  f i r s t  tim e c e l l  in  each  phase.
DO 130 J=1,MEDNUM(1)+1 
PA R A (1,J,I)=0. 0D0 
CONTINUE
ELSE
O .K ., i f  th e y  c a n ’ t  move don’ t  move th e  c e l l s ,  however some a re  
f lu s h e d  o u t i f  we a re  ru n n in g  C ontinuous. We must a l s o  make su re  
TOTAL(* ,* )  i s  c l e a r .
IF (MODE.EQ.1) THEN
DO 140 J=l,MEDNUM(1 )+ l
DO 140 K=NOTCEL(I),1 ,-1  
PARA(K,J,I)=PARA(K,J,I)*R
CONTINUE
END IF
C lose  a r r a y  TOTAL(* ,* ) .
o 
n
150
DO 150 J=l,MEDNUM(1 )+ l 
TOTAL(J,I)=0.0D0 
CONTINUE
END IF 
160 CONTINUE
Q It###########*#####*###**###*######*####******####*#****#*#***###*#
c  *  *
C * P a r t  Four o f  th e  Model *
P ^ A/<VA//V/V^VA//V/V/N/f\//V<VA//V/V/V/V/VA//VA/ ^
c  *
C * Movement betw een P hases *
Q ^ / V A / A / A / A / A / ^ / V A / / V / V A / / V A / A / / V / V / V ^ A / A / / V / V  ^
C * *
C * T h is  p a r t  o f  th e  model c o n t ro l s  th e  movement o f c e l l s  when *
C * th e y  le a v e  a  phase . The co n n e c tio n s  betw een c e l l s  a re  d e f in e d  *
C * in  PHFLOWd,* ,* )  and d eg ree  o f  p r o l i f e r a t i o n  o r d e a th  i s  *
C * d e f in e d  in  P R 0L IF(* ,*). F i r s t  o f  a l l  c e l l s  s to r e d  in  *
C * T0TAL(*,*) a re  moved to  t h e i r  f i n a l  d e s t in a t io n .  Then a l l  *
C * c e l l s  p a sse d  on by any P ro b a b il ty  D is t r ib u t io n  a re  moved to  *
C * th e  b e g in in g  o f  a phase . *
C * *
C * D .B .Faraday  *
C * 3 rd  March 1988 *
C * *
C Move c e l l s  in  l a s t  tim e c e l l  ( s to re d  in  TOTAL) to  n e x t phase.
C Loop around  p h ases  to  d e a l w ith  c e l l s  w hich have l e f t  each  phase.
DO 210 1=1,NOPHA
C F i r s t  l e t s  see  i f  c e l l s  a r e  a c tu a l ly  a llow ed  to  le a v e  t h i s  phase .
CALL EXIT(FLAG,NOTCEL(I),1 ,2 )
IF (FLAG.EQ.0) THEN
Loop around  p h ases  to  see  where and what p e rc e n ta g e  o f  c e l l s  le av e  
phase  I and go to  phase  J .
DO 180 J= 1 , N0PHA+1
C Check i f  th e r e  i s  any flow  from phase I to  phase J .
IF (PHFLOVKJ,1 , 1 ) . GT.0 .AND.PHFL0W(J,1 , 1 ) . LE. 1) THEN
C Loop around  each  p a ram ete r.
DO 170 K=1, MEDNUM(1)+1
C Move th e  c e l l s  and t h e i r  c o n te n ts .
PARA(1,K,J)=PARA(1,K,J)+(T0TAL(K,I)*PHFL0W(J,1 ,1 )*
C PROLIF( I ,1 ) )
170 CONTINUE
END IF
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180 CONTINUE
C Add in  c e l l s  and c o n te n ts  p assed  on by th e  p r o b a b i l i t y  d i s t r i b u t i o n .
DO 190 J= 1 , MEDNUM(1 )+ l
PA R A (1,J,I)=PA RA (1,J,I)+LEA V E(J,I)
190 CONTINUE
ELSE
P u t th e  c e l l s  w hich we th o u g h t had l e f t  back in to  th e  l a s t  tim e 
c e l l  o f  th e  phase  th e y  l e f t .
DO 200 J= 1 , MEDNUM(1 )+ l
PARA(NOTCEL( I ), J , I )=PARA(NOTCEL( I ) , J ,I)+ T O T A L (J,I)
200 CONTINUE
END IF
210 CONTINUE
C ******************************************************************
C * *
C * And F in a l ly *
C * A/A/Ay/VA//V/VAy/VA/A/ *
C * *
C * The new c o n c e n tra t io n s  o f  a l l  N u tr ie n ts ,  M e ta b o lite s  and *
C * T oxins in  th e  medium a re  c a c u la te d  and any c e l l  c o n te n t *
C * v a lu e s  w hich need to  be r e s e t  a re  d e a l t  w ith . Dead C e l ls  a re *
C * a ls o  summed. *
C * *
c * T h is  i s  th e  f i r s t  b a s ic  model, once f u l l y  debugged i t  must be *
c * r ig o r o u s ly  te s t e d  b e fo re  any im provem ents can be made. *
c * S ubsequent developm ent must a ls o  in v o lv e  th e  a d d i t io n  o f  an *
c * o p t im is a t io n  ro u t in e . *
c * *
c * D .B .Faraday *
c * 3 rd  March 1988 *
c * *
c * The o p t im is a t io n  r o u t in e  was added in  J u ly  1988 *
c * *
c * D .B .F .F araday *
c * 3 0 th  August 1988 *
c * *
c * A r o u t in e  to  accoun t f o r  g lu tam in e  d e g ra d a tio n  was added to *
c * t h i s  program . Scope f o r  t h i s  s o r t  o f chem ical breakdown has *
c * n o t y e t  been  in c o rp o ra te d  in to  th e  g e n e ra l c e l l  c y c le  model. *
c * *
c * D .B .F .F araday *
c * 5 th  May 1989 *
c * *
c * We have to  look  a t  what i s  go ing  on a t  v e ry  low g lu tam in e *
c * c o n c e n tr a t io n s .  T h is  h as  s ig n i f i c a n t  re v e la n c e  in  co n tin u o u s *
c * o p e ra t io n  when v e ry  low c o n c e n tr a t io n s  can o ccu r. *
c * *
c * D .B .F .F arad ay *
c * 14th  March 1990 *
c * *
c ^ ^ ^  ^  ^  ^  ^  ^  ^  ^ ^ ^  ^  ^ ^  ^  ^  ^ ^  ^ ^  ^  ^  ^ ^ ^ ^ ^ ^  ^ ^  ^ ^  ^  ^  ^  ^ ^
c Now we can a d ju s t  th e  Medium c o n c e n tra t io n s .
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C Loop around each  component c a te g o ry .
DO 260 1=1,3
C I f  BATCH j u s t  remove th e  amount consumed.
IF (MODE.EQ. 0) THEN
C Loop around each  component.
DO 220 J= 1 , MEDNUM( I )
220 MECON(J,I)=MEC0N(J,I) -MEDCON(J , I)
ELSE
I f  CSTR we have to  remove th e  amount consumed p lu s  th a t  f lu s h e d  o u t 
and, in  th e  ca se  o f  n u t r i e n t s ,  add in  t h a t  from  th e  feed .
C N u rie n ts .
IF ( I .E Q .1) THEN
DO 230 J= 1 , MEDNUM( I )
MECON(J , I)=M EC0N(J,I)-M EDC0N(J,I)+
C ( (STRATC(TIME,DT,I) -MECON(J,I) ) * (1 -R ))
230 CONTINUE
ELSE
C M e ta b o lite s  and to x in s .
DO 240 J=l,MEDNUM(I)
240 MEC0N(J,I)=MEC0N(J,I)-MEDC0N(J, I)-(MEC0N(J, I ) * ( l - R ) )
END IF
END IF
260 CONTINUE
C Add in  any r e c e n t ly  d eceased  c e l l s  ( i e  n o t happy ones ! ! ! )
DEAD=DEAD+LEAVE( 1 ,N0PHA+1) +PARA( 1 ,1 ,N0PHA+1)
C F in a l ly  we must acco u n t f o r  dead c e l l  w ashout
DEAD=DEAD*R
C C le a r  f i r s t  e lem en t o f  d e a th  phase
PARA( 1 ,1 ,N0PHA+1)=0. 0D0 
PARA( 1 ,2 ,3 ) = 0 .0D0
C PRINT*,’ End -  MODEL’
RETURN
C End o f  r o u t in e
END
C ------------------------------------------------------------------------------------------------------------------
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Component consumption/production mechanisms
W ritte n  by D.B. F .F a rad a y  
Ja n u a ry  1990
FUNCTION CELKIN(TIME,MECH,CONC,CONST) 
I n i t i a l i s a t i o n  o f  o th e r  v a r ia b le  
DOUBLE PRECISION CELKIN,CONC,CONST, TIME 
INTEGER MECH
Zero o rd e r
IF (MECH. EQ. 0. OR. MECH.EQ.10) 
CELKIN=C0NST*TIME 
END IF
THEN
F i r s t  o rd e r
IF (MECH.EQ.1. OR. MECH. EQ. 11) 
CELKIN=CONST*CONC*TIME 
END IF
THEN
RETURN
End o f  f u n c t io n
END
Feed s t r a t e g y  p ro c e s s in g  r o u t in e
W rit te n  by D .B .F .F arad ay  
March 1991
FUNCTION STRATC(TIME,DT,I)
C D efine  program  p a ra m e te rs
PARAMETER(MNUTRI= 5 ,P I=3. 14159)
C I n i t i a l i s a t i o n  o f  Common B locks
COMMON/MEDIA2/FEC0NC,FESTRA,INMECO 
C I n i t i a l i s a t i o n  o f  common b lo ck  v a r ia b le s
DOUBLE PRECISION FECONC(MNUTRI) , FESTRA(MNUTRI, 6 ) , INMECO(MNUTR1 ,3 ) 
C I n i t i a l i s a t i o n  o f  o th e  v a r ia b le s
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DOUBLE PRECISION DT,STRATC
INTEGER I,TIME
C No fe e d  s t r a t e g y
IF (FESTRACI,1).EQ.0 .0 )  THEN 
STRATC=FECONC( I )
END IF
C A s in g le  p u ls e
IF (FESTRACI,1).EQ.1 .0 ) THEN
IF (ABS(FESTRA(I,2)-TIME).LE.DT) THEN 
STRATC=FESTRA(1 ,3 )
ELSE
STRATC=FECONC( I )
END IF
END IF
C A s te p  change
IF (FESTRACI,1).EQ.2.0) THEN
IF (TIME.GE.FESTRACI,2 ))  THEN 
STRATC=FESTRA(1 ,3 )
ELSE
STRATC=FECONC( I )
END IF
END IF
C A ramp fu n c t io n
IF (FESTRACI,1).EQ.3 .0 )  THEN
IF (TIME.GE.FESTRACI,2 ) )  THEN
IF (TIME.GE.FESTRACI,6 ))  THEN 
FRAC=( ( FESTRA( 1 ,6 ) -FESTRA( 1 ,2 ) ) /FESTRA( 1 ,5 ) ) -  
C INT( ( FESTRA( 1 ,6 ) -FESTRA( 1 ,2 ) ) /FESTRA( 1 ,5 ) )
ELSE
FRAC=( ( TIME-FESTRA( 1 ,2 ) ) /FESTRA( I , 5 ) ) - INT( ( TIME-FESTRA(1 ,2 ) )  
C /FESTRACI,5 ))
END IF
STRATC=FESTRA ( 1 ,3 ) -  (FRAC* (FESTRA (1 ,3 )  -FESTRA ( 1 , 4 ) ) )  +
C FESTRACI,4)
ELSE
STRATC=FECONC( I )
END IF
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A sq u a re  wave
IF (FESTRACI,1).EQ.4 .0 )  THEN 
IF (TIME. GE.FESTRACI,2 ))  THEN
IF (TIME.GE.FESTRACI,6 ))  THEN 
FRAC=( ( FESTRA( 1 ,6 ) -FESTRA( 1 ,2 ) ) /FESTRA( 1 ,5 ) ) -  
C INT( (FESTRA( 1 ,6 ) -FESTRA( 1 ,2 ) )/FESTRA(1 ,5 ) )
ELSE
FRAC=( ( TIME-FESTRA( 1 ,2 ) ) /FESTRA( I , 5 ) ) - INT( ( TIME-FESTRA(1 ,2 ) )  
C /FESTRA(1 ,5 ) )
END IF
PRINT*,FRAC 
IF (FRAC.GE.0 .5 )  THEN 
STRATC=FESTRA(1 ,4 )
ELSE
STRATC=FESTRA(1 ,3 )
END IF
ELSE
STRATC=FECONC( I )
END IF
END IF
A saw to o th  wave
A s in e /c o s in e  wave
IF (FESTRACI,1).EQ. 6 . 0 )  THEN
IF (TIME.GE.FESTRACI,2 ) )  THEN
IF (TIME.GE.FESTRACI,6 ))  THEN 
FRAC=( ( FESTRA( 1 ,6 ) -FESTRA( 1 ,2 ) ) /FESTRA( 1 ,5 ) ) -  
C INT( ( FESTRA( 1 ,6 ) -FESTRA( 1 ,2 ) ) /FESTRA(1 ,5 ) )
ELSE
FRAC=( (TIME-FESTRA( I , 2 ) ) /FESTRA( I , 5 ) ) -IN T ( (TIME-FESTRA(1 ,2 ) )  
C /FESTRACI,5 ))
END IF
STRATC=( ( ( ( COS(FRAC*2*PI))+ 1 )/ 2 )* (FESTRA( 1 ,3 ) -FESTRA(1 ,4 ) ) )+
C FESTRACI,4)
END IF
END IF
RETURN
END
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